
<html lang="en"     class="pb-page"  data-request-id="0921c5cb-4734-490e-8ad5-44d0959c1efa"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-24;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.6b01470;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models" /></meta><meta name="dc.Creator" content="Benjamin  Spangler" /></meta><meta name="dc.Creator" content="Shaun D.  Fontaine" /></meta><meta name="dc.Creator" content="Yihui  Shi" /></meta><meta name="dc.Creator" content="Lidia  Sambucetti" /></meta><meta name="dc.Creator" content="Aras N.  Mattis" /></meta><meta name="dc.Creator" content="Byron  Hann" /></meta><meta name="dc.Creator" content="James A.  Wells" /></meta><meta name="dc.Creator" content="Adam R.  Renslo" /></meta><meta name="dc.Description" content="Here we describe a new approach for tumor targeting in which augmented concentrations of Fe(II) in cancer cells and/or the tumor microenvironment triggers drug release from an Fe(II)-reactive prodr..." /></meta><meta name="Description" content="Here we describe a new approach for tumor targeting in which augmented concentrations of Fe(II) in cancer cells and/or the tumor microenvironment triggers drug release from an Fe(II)-reactive prodr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 12, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01470" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01470" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01470" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01470" /></link>
        
    
    

<title>A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01470" /></meta><meta property="og:title" content="A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0007.jpeg" /></meta><meta property="og:description" content="Here we describe a new approach for tumor targeting in which augmented concentrations of Fe(II) in cancer cells and/or the tumor microenvironment triggers drug release from an Fe(II)-reactive prodrug conjugate. The 1,2,4-trioxolane scaffold developed to enable this approach can in principle be applied to a broad range of cancer therapeutics and is illustrated here with Fe(II)-targeted forms of a microtubule toxin and a duocarmycin-class DNA-alkylating agent. We show that the intrinsic reactivity/toxicity of the duocarmycin analog is masked in the conjugated form and this greatly reduced toxicity in mice. This in turn permitted elevated dosing levels, leading to higher systemic exposure and a significantly improved response in tumor xenograft models. Overall our results suggest that Fe(II)-dependent drug delivery via trioxolane conjugates could have significant utility in expanding the therapeutic index of a range of clinical and preclinical stage cancer chemotherapeutics." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Here we describe a new approach for tumor targeting in which augmented concentrations of Fe(II) in cancer cells and/or the tumor microenvironment triggers drug release from an Fe(II)-reactive prodrug conjugate. The 1,2,4-trioxolane scaffold developed to enable this approach can in principle be applied to a broad range of cancer therapeutics and is illustrated here with Fe(II)-targeted forms of a microtubule toxin and a duocarmycin-class DNA-alkylating agent. We show that the intrinsic reactivity/toxicity of the duocarmycin analog is masked in the conjugated form and this greatly reduced toxicity in mice. This in turn permitted elevated dosing levels, leading to higher systemic exposure and a significantly improved response in tumor xenograft models. Overall our results suggest that Fe(II)-dependent drug delivery via trioxolane conjugates could have significant utility in expanding the therapeutic index of a range of clinical and preclinical stage cancer chemotherapeutics." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0007.jpeg" /></meta><meta name="twitter:title" content="A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01470"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01470">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01470&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01470&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01470&amp;href=/doi/10.1021/acs.jmedchem.6b01470" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 11161-11170</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01450" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01506" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin++Spangler">Benjamin Spangler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shaun+D.++Fontaine">Shaun D. Fontaine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yihui++Shi">Yihui Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lidia++Sambucetti">Lidia Sambucetti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aras+N.++Mattis">Aras N. Mattis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Byron++Hann">Byron Hann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+A.++Wells">James A. Wells</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam+R.++Renslo">Adam R. Renslo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-1240-2846" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Graduate Program in Chemistry and Chemical Biology, University of California—San Francisco, San Francisco, California 94158, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmaceutical Chemistry, University of California—San Francisco, San Francisco, California 94158, United States</span></div><div class="aff-info" id="aff3d1"><span class="aff-symbol">§</span> <span class="aff-text">SRI International, Menlo Park, California 94025-3493, United States</span></div><div class="aff-info" id="aff3"><span class="aff-text"><sup>∥</sup>Department of Pathology, University of California—San Francisco, San Francisco, California 94158, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">⊥</span> <span class="aff-text">Preclinical Therapeutic Core, University of California—San Francisco, San Francisco, California 94158, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">#</span> <span class="aff-text">Department of Cellular and Molecular Pharmacology, University of California—San Francisco, San Francisco, California 94158, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 415-514-9698. Fax: 415-514-4507. E-mail: <a href="/cdn-cgi/l/email-protection#b6d7d2d7db98c4d3d8c5dad9f6c3d5c5d098d3d2c3"><span class="__cf_email__" data-cfemail="94f5f0f5f9bae6f1fae7f8fbd4e1f7e7f2baf1f0e1">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01470&amp;href=/doi/10.1021%2Facs.jmedchem.6b01470" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 11161–11170</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 21, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 October 2016</li><li><span class="item_label"><b>Published</b> online</span>12 December 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 December 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01470" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01470</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01470"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3238</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01470" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;Spangler&quot;},{&quot;first_name&quot;:&quot;Shaun&quot;,&quot;last_name&quot;:&quot;D. Fontaine&quot;},{&quot;first_name&quot;:&quot;Yihui&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Lidia&quot;,&quot;last_name&quot;:&quot;Sambucetti&quot;},{&quot;first_name&quot;:&quot;Aras&quot;,&quot;last_name&quot;:&quot;N. Mattis&quot;},{&quot;first_name&quot;:&quot;Byron&quot;,&quot;last_name&quot;:&quot;Hann&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;A. Wells&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;R. Renslo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;11161-11170&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01470&quot;},&quot;abstract&quot;:&quot;Here we describe a new approach for tumor targeting in which augmented concentrations of Fe(II) in cancer cells and/or the tumor microenvironment triggers drug release from an Fe(II)-reactive prodrug conjugate. The 1,2,4-trioxolane scaffold developed to enable this approach can in principle be applied to a broad range of cancer therapeutics and is illustrated here with Fe(II)-targeted forms of a microtubule toxin and a duocarmycin-class DNA-alkylating agent. We show that the intrinsic reactivity/toxicity of the duocarmycin analog is masked in the conjugated form and this greatly reduced toxicity in mice. This in turn permitted elevated dosing levels, leading to higher systemic exposure and a significantly improved response in tumor xenograft models. Overall our results suggest that Fe(II)-dependent drug delivery via trioxolane conjugates could have significant utility in expanding the therapeutic index of a range of clinical and preclinical stage cancer chemotherapeutics.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01470&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01470" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01470&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01470" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01470&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01470" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01470&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01470&amp;href=/doi/10.1021/acs.jmedchem.6b01470" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01470" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01470" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01470%26sid%3Dliteratum%253Aachs%26pmid%3D27936709%26genre%3Darticle%26aulast%3DSpangler%26date%3D2016%26atitle%3DA%2BNovel%2BTumor-Activated%2BProdrug%2BStrategy%2BTargeting%2BFerrous%2BIron%2BIs%2BEffective%2Bin%2BMultiple%2BPreclinical%2BCancer%2BModels%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D24%26spage%3D11161%26epage%3D11170%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292263" title="Iron">Iron</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/24" title="Go to Volume 59, Issue 24"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/jmcmar.2016.59.issue-24/20161222/jmcmar.2016.59.issue-24.largecover.jpg" alt="Go to Volume 59, Issue 24"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Here we describe a new approach for tumor targeting in which augmented concentrations of Fe(II) in cancer cells and/or the tumor microenvironment triggers drug release from an Fe(II)-reactive prodrug conjugate. The 1,2,4-trioxolane scaffold developed to enable this approach can in principle be applied to a broad range of cancer therapeutics and is illustrated here with Fe(II)-targeted forms of a microtubule toxin and a duocarmycin-class DNA-alkylating agent. We show that the intrinsic reactivity/toxicity of the duocarmycin analog is masked in the conjugated form and this greatly reduced toxicity in mice. This in turn permitted elevated dosing levels, leading to higher systemic exposure and a significantly improved response in tumor xenograft models. Overall our results suggest that Fe(II)-dependent drug delivery via trioxolane conjugates could have significant utility in expanding the therapeutic index of a range of clinical and preclinical stage cancer chemotherapeutics.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The recent development of molecularly targeted cancer therapeutics has been accompanied by renewed interest in technologies for the tumor/cell-selective delivery of potent but intrinsically nonselective cytotoxic agents. These technologies include antibody–drug conjugates (ADCs) that recognize cell-surface antigens and tumor-activated prodrugs (TAPs) that exploit nutrient transporters<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> or differences in hypoxia associated with the tumor microenvironment.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Accumulating evidence suggests that an increase in reactive, “labile” intracellular iron is another metabolic signature of cancer, as recently reviewed.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Tumor targeting strategies designed to exploit changes in iron homeostasis remain largely unexplored however, despite clinical precedent for iron-dependent pharmacology in antimalarial therapy with artemisinins.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a></div><div class="NLM_p">Redox cycling of iron in enzyme cofactors is essential for cellular processes ranging from de novo nucleotide synthesis to the maintenance of genomic stability, cell cycle regulation, and mitochondrial respiration.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> However, when unbound and unregulated, redox active iron promotes the disproportionation of hydrogen peroxide (Fenton reaction) to produce hydroxyl and hydroperoxyl radicals, reactive oxygen species (ROS) that confer cellular damage and can lead to apoptosis or ferroptosis.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Iron homeostasis is therefore highly regulated to ensure sufficient labile iron is available to support essential enzyme function while limiting exposure to unbound, redox active iron species.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a></div><div class="NLM_p">Rapidly proliferating cells have increased requirements for DNA synthesis, repair, and mitochondrial respiration and therefore have increased demands for iron cofactor biosynthesis. Accordingly, iron acquisition and export pathways are altered in many cancers so as to increase the labile iron pool.<a onclick="showRef(event, 'ref6 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref6 ref15 ref16 ref17 ref18">(6, 15-18)</a> Furthermore, iron has been shown to contribute to tumor initiation and growth<a onclick="showRef(event, 'ref15 ref19'); return false;" href="javascript:void(0);" class="ref ref15 ref19">(15, 19)</a> and epidemiological evidence has established links between tumor iron metabolism and clinical outcomes in breast cancer patients.<a onclick="showRef(event, 'ref17 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref20">(17, 20)</a> Given that labile Fe(II) promotes Fenton chemistry, we sought to develop a tumor-targeting strategy in which Fenton reaction of a peroxidic prodrug was coupled to release of drug payloads. Recognizing that antimalarial agents such as arterolane<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21-24)</a> exhibit finely tuned iron(II) reactivity,<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25-28)</a> we subsequently developed<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> an arterolane-inspired small molecule platform (denoted TRX herein) for Fe(II)-dependent drug delivery. These TRX-drug conjugates function via initial Fe(II)-promoted fragmentation of a 1,2,4-trioxolane ring to afford a cyclohexanone intermediate, followed by spontaneous β-elminiation and decarboxylation to release the drug payload (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information Figure S1</a>). In previous studies, we demonstrated the utility of the TRX scaffold by efficiently and selectively delivering antimalarial payloads to ferrous iron/heme rich compartments of the malaria parasite, both in vitro<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> and in vivo.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mechanism of iron(II)-dependent payload release from 1,2,4-trioxolane conjugates. Iron(II)-promoted Fenton-type reduction of the trioxolane ring affords the cyclohexanone species shown which then undergoes spontaneous β-elimination and decarboxylation to release free payload. This process occurs with high efficiency and ferrous-iron selectivity in mammalian cancer cell lines, as described recently.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While the iron-dependent pharmacology of 1,2,4-trioxanes and 1,2,4-trioxolanes in malaria is widely accepted,<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25-28)</a> extending this concept to TAPs for oncology applications required a means to assess whether sufficient labile iron is present in cancer cells to efficiently and selectively activate TRX-based conjugates. To address this question, we synthesized a TRX conjugate of the aminonucleoside antibiotic puromycin (i.e., TRX-PURO) as a probe of intracellular labile iron (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> where R–NH<sub>2</sub> = puromycin). We found that puromycin release from TRX-PURO in cells was dependent on ferrous iron as expected and was not affected by the addition of other biologically relevant metal ions and reducing agents.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> These initial studies with TRX-PURO also confirmed that labile iron pools are generally augmented in cancer cells when compared to nontumorigenic cells.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Our findings thus suggested that the TRX scaffold might indeed be applied to produce a novel class of TAPs for cancer chemotherapy.</div><div class="NLM_p last">Here we describe prototypical TRX-drug conjugates designed to confer tumor-selective delivery of a microtubule toxin (a combretastatin analog) or DNA-alkylating agent (a duocarmycin analog) in an Fe(II)-dependent fashion. We show that the intrinsic cytotoxicity of these agents can be ablated in TAP forms and then restored following activation in cancer cells. We show that cancer cell lines of diverse origins are generally susceptible to TRX-based TAPs but that a nontumorigenic cell line (MCF10A) is highly resistant. We further show that the resistant MCF10A cell line can be measurably sensitized to the TAP when transformed with the oncogene cMyc and that this likely derives from oncogenic changes to iron metabolism. Finally, we show that the TAP of a duocarmycin analog is tolerated in mice at doses up to 50-fold higher than the parent cytotoxin and this, combined with targeted toxin release within tumor, translates to superior efficacy in PC-3 and MDA-MB-231 xenograft models. These studies provide the first evidence that reactive iron in tumor cells and/or the tumor microenvironment can be exploited to afford improved selectivity in the delivery of cancer chemotherapeutics.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Conjugate Design, Synthesis, and Validation in Cell Culture</h3><div class="NLM_p">To explore ferrous iron-dependent drug delivery in cancer cells we synthesized a known small molecule microtubule toxin (<b>1</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and its trioxolane conjugate <b>2</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information Figure S2</a>). A nonperoxidic dioxolane conjugate (<b>3</b>) was also prepared to confirm that the cytotoxicity of <b>1</b> is ablated in conjugated forms and that intracellular release of active <b>1</b> from <b>2</b> is peroxide-dependent (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Figure S2</a>). Finally, trioxolane analog <b>4</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> lacking the microtubule toxin was prepared to control for intrinsic cytotoxicity of the TRX moiety (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a). The cytotoxicity of the trioxolane-conjugate <b>2</b> and control compounds <b>1</b>, <b>3</b>, and <b>4</b> was then assessed across a small panel of cell lines. The results were unequivocal. In MDA-MB-231 cells, trioxolane-conjugate <b>2</b> displayed activity in the low nM range (EC<sub>50</sub> = 21 nM), 3 orders of magnitude more potent than either of the negative controls (<b>3</b> or <b>4</b>) and nearly as potent as the free toxin (<b>1</b>) applied directly (EC<sub>50</sub> = 11 nM) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b). These results confirm that release of <b>1</b> from <b>2</b> in these cells is both efficient and peroxide-dependent. Moreover, the lack of measurable toxicity exhibited by <b>3</b> demonstrates that the intrinsic cytotoxicity of <b>1</b> is effectively blocked in TAP form.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Exploiting augmented ferrous iron pools for selective drug delivery. (a) Chemical structure of microtubule inhibitor <b>1</b> and corresponding conjugates and controls <b>2</b>–<b>4</b>. (b) Cytotoxicity of compounds <b>1</b>–<b>4</b> in MDA-MB-231 cells after 24 h of exposure as determined by cell counting (<i>n</i> = 3; error bar, mean ± SEM). (c) Cytotoxicity of <b>1</b> and its trioxolane-conjugate <b>2</b> after 24 h of exposure in MDA-MB-231 and MCF10A cells as determined by cell counting (<i>n</i> = 3; error bar, mean ± SEM). The shift in EC<sub>50</sub> value for <b>1</b> and its trioxolane conjugate <b>2</b> is illustrated. Dividing the EC<sub>50</sub> value for <b>1</b> by that for <b>2</b> in a given cell line produces an “EC<sub>50</sub> ratio” that is used to compare the efficiency of drug release across cell lines. This ratio is 0.54 for sensitive MDA-MB-231 cells (2-fold EC<sub>50</sub> shift) and 0.04 for relatively resistant, nontumorigenic MCF10A cells (25-fold EC<sub>50</sub> shift). (d) EC<sub>50</sub> ratios calculated as described in (c) for a small panel of cell lines. Error bars represent SEM from three individual experiments each conducted in biological triplicates. (e) EC<sub>50</sub> ratios for an expanded panel of mammalian cell lines. The EC<sub>50</sub> values for <b>1</b> and <b>2</b> were determined after a 72 h incubation using the CellTiter-Glo cell viability assay. Error bars represent SEM (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Normalizing the activity of conjugate <b>2</b> to that of its cytotoxic payload (<b>1</b>) provided a convenient metric (“EC<sub>50</sub> ratio”) to compare efficiency of payload release from <b>2</b> across different cell lines. In MDA-MB-231 cells, this ratio was found to be 0.54 (EC<sub>50</sub> = 11 nM and 21 nM for <b>1</b> and <b>2</b>, respectively). Among the other cell lines examined, U2OS and RKO cells were nearly as susceptible to <b>2</b> as MDA-MB-231 cells (EC<sub>50</sub> ratio of 0.46) while PC-3 and HeLa cells were somewhat less sensitive (EC<sub>50</sub> ratio of 0.30–0.32), though <b>2</b> was still effective in these cells at therapeutically relevant, low-nM concentrations (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>d and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information Table S1</a>). Consistent with our previous finding that nontumorigenic cells possess a smaller reactive iron pool,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> MCF10A cells were highly resistant to the trioxolane-conjugate <b>2</b> with an EC<sub>50</sub> ratio of just 0.04 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c,d).</div><div class="NLM_p last">Encouraged by these initial findings, we further explored the cytotoxicity of <b>1</b> and <b>2</b> across a larger panel of cancer cell lines from diverse origins using a CellTiter-Glo assay to assess cell viability (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>e). We found EC<sub>50</sub> ratios varied by about 9-fold across the different cell lines, from 0.89 for the most susceptible cells (PC-3) cells to 0.11 for the least susceptible cells (EKVX). Despite the range of responses, TAP <b>2</b> produced EC<sub>50</sub> values in the nM range for even the least responsive cell lines (e.g., EKVX EC<sub>50</sub> = 43 nM, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information Table S2</a>). As expected, the EC<sub>50</sub> values for trioxolane control <b>4</b> across this panel were in the μM regime and typically ≥2 log units less potent than <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information Table S2</a>). This confirms that the cytotoxicity of TAP <b>2</b> derives from release of <b>1</b> and not significantly from the trioxolane moiety itself.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Oncogenic Transformation and Susceptibility to Trioxolane Conjugates</h3><div class="NLM_p">Having found that nontumorigenic MCF10A cells were highly resistant to TRX-conjugates, we explored whether oncogenic transformation of these cells would increase their reactive iron pools and thus sensitize them to trioxolane conjugates. Bandyopadhyay and co-workers recently reported the generation of a panel of cell lines expressing single oncogenes in MCF10A cells.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Using these well-characterized cell lines, we examined the effects of the oncogenes Ras and Myc, whose effects on iron metabolism have been studied previously.<a onclick="showRef(event, 'ref6 ref16 ref18 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref6 ref16 ref18 ref37 ref38">(6, 16, 18, 37, 38)</a> First, we used qRT-PCR to evaluate the transcriptional profile of a panel of iron regulatory proteins in the MCF10A cells constitutively expressing HRas. In previous work in different cell types, oncogenic HRas has been variously reported to decrease ferritin mRNA levels and increase labile iron<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> or to have no effect on ferritin levels or labile iron.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In the MCF10A cells expressing HRas we observed no significant transcriptional changes to ferritin, transferrin receptor, or any other of the iron regulatory transcripts probed (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information Figure S3</a>). It was therefore unsurprising that the HRas-expressing MCF10A cells were no more susceptible to <b>2</b> than MCF10A cells transformed with the empty vector (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b). In contrast, MCF10A cells transformed with cMyc showed substantial down regulation of the iron exporter ferroportin and up regulation of the ferrireductase STEAP3 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a). Interestingly, we did not observe an effect of cMyc on ferritin heavy chain mRNA, as has been reported previously.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Nevertheless, the changes observed predict for increased labile iron in the cMyc-transformed MCF10A cells, and indeed, these cells were found to be more sensitive to trioxolane-conjugate <b>2</b> than cells transformed with the empty vector, as evidenced by a significant 3.2-fold shift in the EC<sub>50</sub> ratio (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b). These results indicate that oncogene induced changes to the reactive iron pool can sensitize cells to the delivery of potent cytotoxins from TRX-based TAPs in an otherwise isogenic background.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Profiling the effects of oncogenic transformation on the ferrous iron pool of MCF10A cells. (a) Relative mRNA levels for ferroportin, ferritin, and the ferrireductase STEAP3 in MCF10A cells stably transfected with empty vector (control) or with vectors expressing the oncogenes Myc or Hras (<i>n</i> = 3; error bar, mean ± SEM; (∗∗) <i>P</i> ≤ 0.01, (∗∗∗∗) <i>P</i> ≤ 0.0001, two-way ANOVA with Dunnett’s multiple comparisons test). (b) EC<sub>50</sub> ratio (<b>1</b>/<b>2</b>) for MCF10A cells stably transfected with HRas or cMyc oncogenes or the empty vector (control) as assessed by cell counting after 24 h of compound exposure. Error bars represent SEM from three independent experiments each conducted in biological triplicates ((∗∗) <i>P</i> ≤ 0.01, one-way ANOVA with Dunnett’s multiple comparisons test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> In Vivo PK/PD Studies of a Duocarmycin Conjugate</h3><div class="NLM_p">The highly cytotoxic cyclopropylbenzindoline (CBI) class of natural products like CC-1065 and duocarmycin SA function by alkylating adenine bases in duplex DNA.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42">(39-42)</a> Synthetic “seco”-CBI analogs are latent cytotoxins that can undergo spontaneous Winstein-type spirocylization to form the active cyclopropylbenzindoline (CBI) species (i.e., <i>seco</i>-<b>5</b> → <b>5</b>, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information Figure S4</a>). This activation step can be prevented by acylation or carbamoylation of the aniline or phenolic function, and the ability to “cage” <i>seco</i>-CBI derivatives in this way has made these compounds popular as cytotoxic effectors in antibody–drug conjugates<a onclick="showRef(event, 'ref2 ref42'); return false;" href="javascript:void(0);" class="ref ref2 ref42">(2, 42)</a> and tumor-activated prodrugs.<a onclick="showRef(event, 'ref3 ref41'); return false;" href="javascript:void(0);" class="ref ref3 ref41">(3, 41)</a> We synthesized a known seco-CBI analog<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and further converted the material into the desired TAP <b>6</b> and the 1,3-dioxolane-CBI conjugate <b>7</b> (DXL-CBI), a nonperoxidic control (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures and in vitro activity of trioxolane–duocarmycin conjugates. (a) Structure of duocarmycin type DNA-alkylator <i>seco</i>-<b>5</b> (latent form), the corresponding activated form <b>5</b> that reacts with nucleophilic bases of DNA (:Nu), trioxolane–duocarmycin conjugate <b>6</b>, and negative control dioxolane-conjugate <b>7</b>. (b) Cytotoxicity of compounds <b>5</b> and <b>6</b> in PC-3 cells after 72 h of exposure as determined by cell counting (<i>n</i> = 3; error bar, mean ± SEM). (c) Cytotoxicity of compounds <b>5</b> and <b>6</b> in MDA-MB-231 cells after 72 h of exposure as determined by cell counting (<i>n</i> = 3; error bar, mean ± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We evaluated the cytotoxicity of <i>seco</i>-<b>5</b>, TAP <b>6</b>, and control <b>7</b> following 72 h of exposure in MDA-MB-231 and PC-3 cells (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b,c). As expected, <i>seco</i>-<b>5</b> and its TAP <b>6</b> exhibited potent cytotoxic effects in cells, while the dioxolane conjugate <b>7</b> was noncytotoxic at all concentrations examined. The inactivity of <b>7</b> confirms that conjugation of <i>seco</i>-<b>5</b> via its aniline function effectively blocks formation of the activated (and toxic) CBI electrophile. The potent effects of <b>6</b> in cells are thus due to peroxide-dependent release of free <i>seco</i>-<b>5</b> as desired. We further found that conversion of <i>seco</i>-<b>5</b> to the TAP <b>6</b> dramatically improves its chemical stability in the extracellular environment. Thus, while free <i>seco</i>-<b>5</b> degraded over several hours upon thawing from a DMSO stock solution, TRX conjugate <b>6</b> (and DXL conjugate <b>7</b>) were chemically stable for more than a year at room temperature in DMSO (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information Figure S5</a>). Stability toward premature hydrolysis likely explains why TAP <b>6</b> was measurably <i>more</i> potent than <i>seco</i>-<b>5</b> itself in both cell lines examined (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b,c). Control experiments confirmed that <b>6</b> is stable for more than a week in cell culture media at 37 °C, indicating that its cellular toxicity in the 72 h assays (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b,c) results from <i>intracellular</i> release of <i>seco</i>-<b>5</b> as desired.</div><div class="NLM_p">The cell culture studies of <b>5</b>–<b>7</b> above revealed the effective ablation of <b>5</b>-mediated toxicity by chemical conjugation at an aniline function (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a–c). We next asked whether this caging effect would translate to reduced in vivo toxicity for TAP <b>6</b> as compared to <b>5</b>. To determine a maximally tolerated dose (MTD), nontumor bearing female NSG mice were administered three ip doses of either <i>seco</i>-<b>5</b> or <b>6</b> at 4-day intervals (Q4d). These studies revealed that <i>seco</i>-<b>5</b> is highly toxic to mice (MTD ≈ 0.3 mg/kg), consistent with previous observations for related duocarmycin analogs.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> By contrast, TAP <b>6</b> could be administered at significantly higher doses, with an MTD of 7.5 mg/kg, using the same three dose Q4d regimen. A subsequent MTD study of <b>6</b> with Q7d dosing returned a somewhat higher MTD of ∼10 mg/kg.</div><div class="NLM_p">Previous work with duocarmycin analogs related to <b>5</b> has shown dose-limiting hepatotoxicity in mice<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and insufficient therapeutic index leading to failures in human clinical trials.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> We were therefore interested in exploring the toxic effects of <b>5</b> in mice and whether administration in the TRX-conjugated form <b>6</b> could protect from these toxicities. In fact, mice treated with 0.3 mg/kg <i>seco</i>-<b>5</b> showed substantially (∼10-fold) higher concentrations of liver transaminase enzymes (ALT and AST) than did mice treated with 7.5 mg/kg of <b>6</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>c). Since hepatotoxicity of duocarmycin analogs has previously been observed to occur with a delayed onset, mice receiving escalating doses of <b>5</b> or <b>6</b> were observed for 50 days postdosing, then sacrificed and their livers collected and assessed for altered morphology and signs of toxicity. Even at well-tolerated doses of <b>5</b>, mice grossly showed darkened and roughened capsular and parenchymal changes indicative of hepatotoxicity in addition to enlarged intestines and serosanguinous ascites near the site of administration. The liver pathology showed increased hepatic lobular lymphohistiocytic infiltrates, reactive cellular changes, and minimal periportal fibrosis. In contrast, the livers of mice treated with 7.5 mg/kg of <b>6</b> appeared normal, and the dose limiting toxicity appeared instead to be localized toxicity at the site of administration as evidenced by enlarged intestines. The pathology in these was free of significant inflammation or fibrosis (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>d).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Pharmacokinetic profile and in vivo tolerability of <b>5</b> and its trioxolane conjugate <b>6</b>. (a) Plasma concentrations of <b>5</b> in female NSG mice following a single 0.3 mg/kg ip dose. Three mice were sampled at each time point. (b) Plasma concentrations of <b>6</b>, released <b>5</b>, and the retro-Michael intermediate <b>16</b> in female NSG mice following a single 7.5 mg/kg ip dose of <b>6</b>. An authentic sample of <b>16</b> was synthesized as described in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information</a>. The study design and numbers of mice per group were the same as in (a). (c) Measured levels of alkaline phosphatase (Alk. Phosp.), serum alanine aminotransferases (ALT), aspartate aminotransferase (AST), and creatine phosphokinase (CPK) in blood samples from mice treated with either <b>5</b> (0.3 mg/kg) or trioxolane-conjugate <b>6</b> (7.5 mg/kg). (d) Microscopic histology stains of representative mouse liver samples show only mildly increased reactive changes in the group receiving 0.3 mg/kg <b>5</b>, including minimally increased lobular lymphohistiocytic infiltrates. In mice receiving the higher 7.5 mg/kg dose of <b>6</b> (right column), only mild simple steatosis was detected. Top two rows of images show representative H&E sections of centrizonal or periportal areas. Bottom row of images show representative trichrome stains for evaluation of relative fibrosis, which shows no significant fibrosis; scale bars are in μm as indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To compare the pharmacokinetic properties of <i>seco</i>-<b>5</b> and its TRX conjugate <b>6</b>, healthy NSG mice were administered a single ip dose of <i>seco</i>-<b>5</b> (0.3 mg/kg) or conjugate <b>6</b> (7.5 mg/kg), representing the respective MTD values. Analysis of blood samples showed <i>seco</i>-<b>5</b> to have a reasonably long half-life (<i>t</i><sub>1/2</sub> = 3.8 h), moderate clearance (CL/<i>F</i> = 20 mL min<sup>–1</sup> kg<sup>–1</sup>) and a high volume of distribution (<i>V</i><sub><i>z</i></sub>/<i>F</i> = 6.7 L/kg) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a,b, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information Table S3</a>). Conjugate <b>6</b> exhibited a significantly longer half-life (<i>t</i><sub>1/2</sub> = 20.4 h), moderate-high clearance (CL/<i>F</i> = 31.3 mL min<sup>–1</sup> kg<sup>–1</sup>) and a very high volume of distribution (<i>V</i><sub><i>z</i></sub>/<i>F</i> = 55 L/kg). In animals receiving <b>6</b>, total exposure to <b>6</b> (AUC = 5050 h·ng/mL) exceeded that of released <i>seco</i>-<b>5</b> by approximately 8-fold, indicating a small degree of drug release in normal tissues of healthy mice. Maximum plasma concentrations of free <i>seco</i>-<b>5</b> in mice receiving 7.5 mg/kg of <b>6</b> were still lower than those in mice treated with 0.3 mg/kg of <i>seco</i>-<b>5</b> directly (<i>C</i><sub>max</sub> = 48 ng/mL vs 108 ng/mL). Most importantly, the total systemic exposure of <b>6</b> was ∼20-fold greater than for <i>seco</i>-<b>5</b> when both agents were administered at their respective MTD (AUC<sub>0–24h</sub> = 5050 and 246 h·ng/mL, respectively). The higher in vivo exposure achievable with TAP <b>6</b> was thus expected to result in superior efficacy in tumor bearing mice, where <b>6</b> would be converted to the active agent (<b>5</b>) selectively in the tumor.</div><div class="NLM_p">To see whether the higher in vivo exposure levels achievable with conjugate <b>6</b> translated to improved in vivo efficacy, we treated PC-3 and MDA-MB-231 xenograft-bearing mice with <b>6</b> or <i>seco</i>-<b>5</b> and compared body weights and rates of tumor growth under different dosing regimens (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). In MDA-MB-231 xenograft mice, three 0.3 mg/kg doses of <i>seco</i>-<b>5</b> given Q4d produced only a minor reduction in the rate of tumor growth (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>a). Significantly, the mice in this group showed substantial weight loss over the course of the study, presumably reflecting compound-related toxicity (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>b). Comparatively, mice treated under the same regimen with 2.5 mg/kg of <b>6</b> exhibited a similar reduction in tumor growth rate but unlike <b>5</b>-treated mice had negligible weight loss, suggesting reduced toxicity under a comparably efficacious regimen (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>a). Using the same regimen but increasing the dose of <b>6</b> to its MTD of 7.5 mg/kg produced a substantially improved effect on tumor growth and with much less severe weight loss than was observed with a 25-fold lower dose of <i>seco</i>-<b>5</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>a,b). These findings were replicated in a follow-up study that also included the evaluation of dioxolane conjugate <b>7</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information Figure S6</a>). As expected, compound <b>7</b> at 10 mg/kg had no effect on tumor growth or mouse weight, indicating that the beneficial in vivo effects of <b>6</b> result from peroxide-dependent activation and release of <b>5</b> in tumor.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Efficacy of <b>5</b> and <b>6</b> in mouse xenograft models. (a) Changes in tumor volume over time as determined by calipers in MDA-MB-231 xenograft bearing female SCID-beige mice treated with the indicated doses of <b>5</b> or <b>6</b> via ip administration on a Q4d dosing schedule (3 total doses) as compared to mice treated with vehicle. Error bars represent SEM from dosing cohorts of 8 mice per condition. (b) Changes in mouse weight over time for the mice in (a). (c) Changes in tumor volume over time as determined by calipers in PC-3 xenograft bearing female nude mice (NCR nu/nu, Taconic) treated with the indicated doses of <b>5</b> or <b>6</b> via ip administration on a Q4d dosing schedule (3 total doses) as compared to mice treated with vehicle. Mice treated with the highest dose of <b>6</b> (15 mg/kg, orange line) received three ip doses on a Q7d schedule. Error bars represent SEM from dosing cohorts of 8 mice per condition. (d) Changes in mouse weight over time for the mice in (c).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The results described above for MDA-MB-231 xenograft mice were qualitatively replicated in PC-3 xenograft bearing mice. Thus, administration of <b>6</b> at 7.5 mg/kg (3×, Q4d, ip) produced comparable if not superior effects on tumor growth rate without the weight loss observed in mice receiving <i>seco</i>-<b>5</b> at 0.3 mg/kg (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>c,d). Since the MTD and pathology studies had suggested that the dose-limiting toxicity of TAP <b>6</b> was localized GI toxicity near the site of administration, we considered that an altered dosing regimen might mitigate this toxicity and enable a higher dose. Indeed, by increasing the dose of <b>6</b> to 15 mg/kg but extending the dosing interval from Q4d to Q7d (once weekly), we observed robust tumor regression (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>c, orange line), albeit with weight loss that was similar to the animals receiving the 0.3 mg/kg Q4d regimen of <b>5</b>. The tumor regression produced with 15 mg/kg Q7d dosing of <b>6</b> was found to be quite durable, with no evidence of further tumor growth observed for the remainder of the study, several weeks after the third and final dose.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The search for more effective and better tolerated cancer therapies has yielded the first molecularly targeted agents<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> (e.g., kinase inhibitors, PARP inhibitors) and new technologies to more selectively deliver potent cytotoxins to tumors (e.g., antibody–drug conjugates). Herein we have described a new class of tumor activated prodrugs engineered to release a drug payload upon encountering reactive iron(II) in the tumor microenvironment. The trioxolane-based scaffold employed in these studies is the same one we used previously to study intracellular labile ferrous iron in cells, revealing larger iron(II) pools in cancer-derived cell lines compared to nontumorigenic lines.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Here we exploited this knowledge and the tools we developed to deliver cytotoxic payloads to diverse cancer cell lines and to target tumors in two different mouse xenograft models.</div><div class="NLM_p">The trioxolane TAP scaffold used here was engineered to confer “traceless” release of drug payloads, thereby enabling a broad scope of potential applications encompassing molecularly targeted and generally cytotoxic agents possessing suitable amine or alcohol functionality for conjugation. When this strategy is employed, the site of drug conjugation is selected so that the intrinsic activity/toxicity of tethered drug is ablated, thereby preventing or minimizing exposure of active drug in nontargeted tissues. To exemplify this approach, we prepared amine-linked TAP conjugates <b>2</b> and <b>6</b> from the microtubule inhibitor <b>1</b> and duocarmycin analog <i>seco</i>-<b>5</b>, respectively. We confirmed that the activity/toxicity of these agents was ablated in the TAP form by preparing dioxolane-drug conjugates <b>3</b> and <b>7</b>, which proved inactive at the highest concentrations tested (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b,c). The lack of measurable activity for <b>3</b> and <b>7</b> thus confirms that drug release from <b>2</b> and <b>6</b> is peroxide dependent. Consistent with the expected mechanism of iron(II)-dependent drug release, the relative sensitivity of cells to <b>2</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>d) largely mirrored the response of the TRX-PURO probe to intracellular labile iron in the same cell lines.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">We found that sensitivity to TRX-CMB conjugate <b>2</b> varied by about 9-fold across a panel of cancer cell lines from diverse origins (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>e). Further interrogation of these data may provide insight into the specific alterations of iron metabolism that predict for increased tumor susceptibility toward TRX-drug conjugates. In our preliminary study of oncogenic changes and related effects on iron metabolism, we observed that Myc-driven changes in MCF10A cells produced increased sensitivity to trioxolane conjugate <b>2</b>. Consistent with these observations, several of the most <b>2</b>-susceptible cell lines examined here, such as RKO and MDA-MB-231, are known to overexpress Myc.<a onclick="showRef(event, 'ref36 ref47'); return false;" href="javascript:void(0);" class="ref ref36 ref47">(36, 47)</a> Thus, iron(II)-dependent drug delivery could find utility in targeting Myc-driven tumors indirectly via the alteration of iron metabolism induced by this prevalent oncogene. These findings are particularly relevant given how intractable Myc driven tumors have been toward other targeted therapies.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">To examine the utility of trioxolane-mediated drug delivery in vivo, we prepared trioxolane TAP <b>6</b> in which a potent duocarmycin-class cytotoxin (<i>seco</i>-<b>5</b>) is stabilized chemically and inactivated biologically (while in prodrug form). Significantly, conjugate <b>6</b> was tolerated in mice at doses up to 50-fold higher than <i>seco</i>-<b>5</b> and produced superior efficacy in two different xenograft models when administered at or near its MTD. A pharmacokinetic study in healthy mice revealed that administration of <i>seco</i>-<b>5</b> in the form <b>6</b> not only limited exposure to free drug (to ∼15% of the total dose) but also significantly improved distribution to tissues and the total duration of drug exposure. These properties of <b>6</b> enabled safe administration at a relatively high dose of 15 mg/kg once weekly, and this dosing regimen produced a particularly robust and durable tumor regression in a PC-3 xenograft model. Overall, our studies indicate that trioxolane-based TAPs release their drug payload in proportion to the concentration of labile iron(II) encountered in different cell/tissue types. While intracellular iron(II) pools are likely implicated in TAP activation, it is possible that other aspects of tumor biology in vivo (e.g., hypoxia, macrophage infiltration, tumor necrosis) contribute to the presence of excess reactive iron(II) in the tumor microenvironment.</div><div class="NLM_p last">In conclusion, trioxolane-mediated iron(II)-dependent drug delivery is a new approach for cell/tissue selective drug targeting that leverages elevated reactive iron(II) concentrations in tumor cells and in the tumor microenvironment. Here we described two prototypical trioxolane-drug conjugates bearing cytotoxins with distinct mechanisms of cellular toxicity. We confirmed that the intrinsic toxicity of these agents could be ablated in conjugated forms and yet fully realized following cell- or tumor-selective release at their intended site of action. These results should encourage further study of this concept to identify drugs and tumor types that best leverage this new drug delivery approach.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The known cytotoxic agents <b>1</b><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and <i>seco</i>-<b>5</b><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> were prepared as previously described. These compounds were coupled to known trioxolane<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and dioxolane<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> intermediates via activated nitrophenyl carbonate or isocyanate intermediates as we have described previously<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29-31)</a> and as further detailed in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_p">All compounds tested in cells or animals were judged to be of >95% purity as determined using a Waters Micromass ZQTM, equipped with Waters 2795 separation module, Waters 2996 photodiode array detector (254 nm), and Waters 2424 ELS detector. Separations were carried out with an XTerra MS C18, 5 μm, 4.6 mm × 50 mm column, at ambient temperature (unregulated) using a mobile phase of water–methanol containing a constant 0.10% formic acid. Representative LC chromatograms are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_p">Mammalian cell lines were maintained in an atmosphere of 5% CO<sub>2</sub> in RPMI 1640 media purchased from HyClone supplemented with 10% FBS (Gibco), Pen/Strep (1× final concentration, Gemini Bio-Products), and nonessential amino acids (UCSF Cell Culture Facility). Unless otherwise noted, cell lines were obtained from ATCC and verified by STR profiling. Graphing and analysis of data were done using GraphPad Prism 6 software and Microsoft Excel 2010. Figures were prepared with Adobe Design Standard CS6 software.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Statistics</h3><div class="NLM_p last">Error bars in all figures represent SEM unless otherwise indicated. When three or more mean values were compared, one- or two-way ANOVA tests were applied as required with Dunnett’s multiple comparisons tests used to determine significance. Statistical significance is indicated as follows: ∗ = <i>P</i> ≤ 0.05, ∗∗ = <i>P</i> ≤ 0.01, ∗∗∗ = <i>P</i> ≤ 0.001, ∗∗∗∗ = <i>P</i> ≤ 0.0001.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Toxicity by Nuclei Counting</h3><div class="NLM_p last">Cells were plated in 96-well Greiner black μClear tissue culture plates at 3000–6000 cells per well in RPMI 1640 cell culture media (or the appropriate growth medium as specified) and incubated at 37 °C in 5% CO<sub>2</sub> incubators for at least 16 h prior to exposure to compounds. Cells were then treated in triplicate with escalating concentrations of compounds performed in medium containing 0.1% DMSO (100 μL of media, per well). 24–72 h after treatment (as specified), medium was removed and cells were washed with 100 μL of PBS and then fixed in 4% paraformaldehyde for 10 min at rt and stained with Hoechst nuclear stain at a final concentration of 10 μg/mL in PBS for 10 min at rt. After fixing, the cells were stored in 100 μL of PBS for imaging. Wells were imaged with an IN Cell 2000 automated cell imager at 10× magnification with 9 images per well (complete coverage) in bright field and DAPI channel fluorescence, and images were analyzed for nuclei count by IN Cell developer software. EC<sub>50</sub> values were calculated in GraphPad Prism from normalized dose–response curves.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Toxicity by CellTiter-Glo</h3><div class="NLM_p last">Cells were harvested, resuspended, and plated with a Wellmate liquid handler (Thermo Scientific) into 384-well plates and cultured for 24 h before dosing. Master compound plates were made with a Janus (PerkinElmer), then further diluted to achieve uniform final concentrations of DMSO of 0.1% in media for all treatment conditions. Compound treatments in media were added to the cell plates with a Matrix Platemate (Thermo Scientific). Cell viabilities were determined 72 h after treatment by Cell-Titer Glo assay (Promega) on the Envision multilabel plate reader (PerkinElmer). Relative luminescent units (RLU) were plotted against corresponding drug concentrations and fitted with a standard four-parameter sigmoidal curve with GraphPad Prism 6. Data were further fit for EC<sub>50</sub> shift parameters in GraphPad Prism 6 to determine EC<sub>50</sub> ratios for <b>1</b>/<b>2</b>. Data are reported as the EC<sub>50</sub> ratio, and error bars represent SEM (<i>n</i> = 3). Data for cell lines in which EC<sub>50</sub> ratio fits were ambiguous, <i>R</i><sup>2</sup> values were less than 0.9, or response to the free drug was less than 40% were not reported.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Quantitative PCR</h3><div class="NLM_p last">Cells were seeded at 300 000 cells per well in 6-well plates and grown to confluence and then collected with trypsin (0.05%), washed with PBS, and snap-frozen in liquid N<sub>2</sub> and then stored at −78 °C. Cell pellets were processed for mRNA isolation using Qiagen RNeasy Mini Kit with QIAshredder lysate homogenizers and on column DNA digest. Isolated mRNA was analyzed for concentration and purity on a ThermoScientific NanoDrop 2000c spectrophotometer, and 1000 ng of mRNA from each sample was translated to cDNA using Invitrogen SuperScript III First-Strand Synthesis System. The resulting cDNA was used for qRT-PCR analysis (10 ng/reaction) with SsoAdvanced Universal SYBR Green Supermix in a Roche LightCycler 480. GAPDH was used as an endogenous control, and relative mRNA levels were calculated from a standard curve of pooled samples with LightCycler 480 software used for second derivative maximum analysis and standard curve fitting. Samples were prepared and run in biological triplicates, and error bars represent SEM. A list of the gene specific primers used is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Maximum Tolerable Dose Studies</h3><div class="NLM_p last">To evaluate the tolerability of the experimental agents, groups of three NSG (NOD SCID gamma) mice were treated with three ip injections of test article (Q4d or Q7d in separate studies) in a formulation comprising 50:40:10 PEG 400/20% 2-hydroxypropylcylcodextrine in water/DMSO. Individual groups (<i>n</i> = 3) received doses that increased in 2- or 3-fold steps until a given dose caused one or more mice in the group to reach protocol limits for tolerance (>20% weight loss) at any point post dosing.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Pharmacokinetics Studies</h3><div class="NLM_p last">To evaluate the in vivo pharmacokinetic properties of the experimental agents, female NSG mice were treated with a single ip injection of test compounds formulated in 50:40:10 PEG 400/20% 2-hydroxypropylcylcodextrine in water/DMSO. Blood samples were collected 5 min, 15 min, 30 min, 1 h, 2 h, 4 h, 8 h, 12 h, and 24 h after dosing (3 mice were sampled per time point; each group of mice was sampled ≤3 times over 24 h) and analyzed for plasma concentrations of each compound via MS/MS analysis conducted by Integrated Analytical Solutions, Inc. (Berkeley, CA). The resulting data were analyzed with WinNonlin software to calculate standard PK parameters.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Efficacy Studies</h3><div class="NLM_p last">To evaluate the in vivo properties of the experimental agents, we used the heterotopic indirect tumor xenograft model in nude mice (NCR nu/nu, Taconic) and SCID-beige mice. Early passage PC-3 cells were harvested, and a cell suspension (1:1 serum free DMEM/Matrigel) was injected subcutaneously (sc) into the right flank of anesthetized donor nude mice (10<sup>6</sup> cells/mouse in 0.1 mL). For MDA-MB-231 xenografts, cells were injected into the mammary fat pad of anesthetized female SCID-beige mice (10<sup>6</sup> cells/mouse in 0.1 mL of PBS). When the mean tumor volume was 250–400 mm<sup>3</sup>, tumor-bearing mice were treated with the indicated doses of compounds formulated in 50:40:10 PEG 400/20% 2-hydroxypropylcylcodextrine in water/DMSO via ip administration with the indicated frequency. Tumor volume (by caliper) and mouse weight were monitored twice weekly.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01470">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63768" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63768" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01470" class="ext-link">10.1021/acs.jmedchem.6b01470</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Supplemental tables, figures and schemes; synthetic procedures and compound characterization for new compounds; animal welfare statement; and a list of gene-specific primers used for qRT-PCR analysis (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_liveslides.mp4">jm6b01470_liveslides.mp4 (6.19 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf">jm6b01470_si_001.pdf (1.13 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_002.csv">jm6b01470_si_002.csv (2.51 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01470" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam R. Renslo</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, University
of California—San Francisco, San Francisco, California 94158, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1240-2846" title="Orcid link">http://orcid.org/0000-0002-1240-2846</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1f7e7b7e72316d7a716c73705f6a7c6c79317a7b6a"><span class="__cf_email__" data-cfemail="9afbfefbf7b4e8fff4e9f6f5daeff9e9fcb4fffeef">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin Spangler</span> - <span class="hlFld-Affiliation affiliation">Graduate
Program in Chemistry and Chemical Biology, University of California—San Francisco, San Francisco, California 94158, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, University
of California—San Francisco, San Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaun D. Fontaine</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, University
of California—San Francisco, San Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yihui Shi</span> - <span class="hlFld-Affiliation affiliation">SRI
International, Menlo Park, California 94025-3493, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lidia Sambucetti</span> - <span class="hlFld-Affiliation affiliation">SRI
International, Menlo Park, California 94025-3493, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aras N. Mattis</span> - <span class="hlFld-Affiliation affiliation">Graduate
Program in Chemistry and Chemical Biology, University of California—San Francisco, San Francisco, California 94158, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, University
of California—San Francisco, San Francisco, California 94158, United States</span>; 
    <span class="hlFld-Affiliation affiliation">SRI
International, Menlo Park, California 94025-3493, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Department of Pathology, University of
California—San Francisco, San Francisco, California 94158, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Preclinical
Therapeutic Core, University of California—San
Francisco, San Francisco, California 94158, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Cellular and Molecular Pharmacology, University of California—San Francisco, San Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Byron Hann</span> - <span class="hlFld-Affiliation affiliation">Preclinical
Therapeutic Core, University of California—San
Francisco, San Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James A. Wells</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, University
of California—San Francisco, San Francisco, California 94158, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Cellular and Molecular Pharmacology, University of California—San Francisco, San Francisco, California 94158, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>B.S., J.A.W., and A.R.R. designed compounds and conceived experiments. B.S. and S.D.F. synthesized compounds. B.S., S.D.F, Y.S., and B.H. acquired data. All authors analyzed the data. A.R.R. supervised the project. B.S. and A.R.R wrote the manuscript. All authors reviewed, edited, and commented on the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ACK-d7e1702-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">A.R.R. acknowledges funding from the U.S. National Institutes of Health (R01 Grant AI105106) and from the NIH National Center for Advancing Translational Science (UCSF-CTSI Grant UL1 TR000004). B.S. acknowledges funding from the NIH Research Training Grant in Chemistry and Chemical Biology (Grant T32 GM064337). The authors thank Prof. S. Bandyopadhyay (UCSF) for providing the MCF10A cell lines used in these studies, Steven Chen for technical support in automated cell imaging and image analysis with InCell Developer software, Dr. Tetsuya Matsuguchi for his assistance with qRT-PCR set up and analysis, Dr. Alan Wolfe for his assistance in calculating pharmacokinetic parameters, and the Preclinical Therapeutic Core at UCSF where in vivo experiments were performed.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i19" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i19"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i20" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i20"> Abbreviations Used</h2><tr><td class="NLM_term">TAP</td><td class="NLM_def"><p class="first last">tumor-activated prodrug</p></td></tr><tr><td class="NLM_term">ADC</td><td class="NLM_def"><p class="first last">antibody–drug conjugate</p></td></tr><tr><td class="NLM_term">TRX</td><td class="NLM_def"><p class="first last">a 1,2,4-trioxolane scaffold for payload delivery</p></td></tr><tr><td class="NLM_term">DXL</td><td class="NLM_def"><p class="first last">1,3-dioxolane scaffold used as nonperoxidic controls</p></td></tr><tr><td class="NLM_term">PURO</td><td class="NLM_def"><p class="first last">puromycin</p></td></tr><tr><td class="NLM_term">qRT-PCR</td><td class="NLM_def"><p class="first last">quantitative real-time polymerase chain reaction</p></td></tr><tr><td class="NLM_term">CBI</td><td class="NLM_def"><p class="first last">cyclopropylbenzindoline</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximally tolerated dose</p></td></tr><tr><td class="NLM_term">Q4d</td><td class="NLM_def"><p class="first last">dosed every 4 days</p></td></tr><tr><td class="NLM_term">Q7d</td><td class="NLM_def"><p class="first last">dosed every 7 days</p></td></tr><tr><td class="NLM_term">ALT</td><td class="NLM_def"><p class="first last">alanine transaminase</p></td></tr><tr><td class="NLM_term">AST</td><td class="NLM_def"><p class="first last">aspartate transaminase</p></td></tr><tr><td class="NLM_term">CPK</td><td class="NLM_def"><p class="first last">creatine phosphokinase</p></td></tr><tr><td class="NLM_term">H&E</td><td class="NLM_def"><p class="first last">hematoxylin and eosin stained</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">fraction of drug achieving systemic exposure following an ip dose</p></td></tr><tr><td class="NLM_term"><i>V</i><sub><i>z</i></sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lorusso, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bever, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malburg, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span> </span><span class="NLM_article-title">Phase I study of folate conjugate EC145 (vintafolide) in patients with refractory solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4011</span><span class="NLM_x">–</span> <span class="NLM_lpage">4016</span><span class="refDoi"> DOI: 10.1200/JCO.2011.41.4946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1200%2FJCO.2011.41.4946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=23032618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FitFCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=4011-4016&author=P.+M.+Lorussoauthor=M.+J.+Edelmanauthor=S.+L.+Beverauthor=K.+M.+Formanauthor=M.+Pilatauthor=M.+F.+Quinnauthor=J.+Liauthor=E.+I.+Heathauthor=L.+M.+Malburgauthor=P.+J.+Kleinauthor=C.+P.+Leamonauthor=R.+A.+Messmannauthor=E.+A.+Sausville&title=Phase+I+study+of+folate+conjugate+EC145+%28vintafolide%29+in+patients+with+refractory+solid+tumors&doi=10.1200%2FJCO.2011.41.4946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumors</span></div><div class="casAuthors">Lorusso Patricia M; Edelman Martin J; Bever Susan L; Forman Karen M; Pilat Maryjo; Quinn Mary F; Li Jing; Heath Elisabeth I; Malburg Lisa M; Klein Patrick J; Leamon Christopher P; Messmann Richard A; Sausville Edward A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4011-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  EC145 (vintafolide), a conjugate of folic acid and the vinca alkaloid desacetylvinblastine hydrazide (DAVLBH), is a ligand for the folate receptor (FR), with activity against FR-positive tumor xenografts in vivo.  This phase I study determined the maximum-tolerated dose (MTD) of EC145 administered as a bolus intravenous injection or 1-hour infusion in patients with refractory solid tumors.  PATIENTS AND METHODS:  EC145 was administered as a bolus injection or 1-hour infusion on days 1, 3, and 5 and days 15, 17, and 19 of each 28-day cycle with dose escalation in cohorts of three to six patients until the MTD was identified.  Plasma pharmacokinetics were determined on days 1 and 3 of the first cycle.  RESULTS:  The MTD of EC145 was 2.5 mg when administered as either a bolus injection or 1-hour infusion.  Constipation was the dose-limiting toxicity with both routes.  Constipation, nausea, fatigue, and vomiting were the most commonly reported adverse events.  One partial response to therapy was observed in a patient with metastatic ovarian cancer.  CONCLUSION:  EC145 administered by bolus injection or as a 1-hour infusion at a dose of 2.5 mg on days 1, 3, and 5 and days 15, 17, and 19 of a 28-day cycle has an acceptable safety profile in patients with advanced cancer.  On the basis of these findings, phase II studies of EC145 have been initiated in patients with advanced epithelial ovarian cancer and non-small-cell lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTgjStBWJ3DPJQHPYJuLg8TfW6udTcc2eZlylQKccdZ2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FitFCrsA%253D%253D&md5=cfbc76346785033ebb51e7cf4494cd68</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.41.4946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.41.4946%26sid%3Dliteratum%253Aachs%26aulast%3DLorusso%26aufirst%3DP.%2BM.%26aulast%3DEdelman%26aufirst%3DM.%2BJ.%26aulast%3DBever%26aufirst%3DS.%2BL.%26aulast%3DForman%26aufirst%3DK.%2BM.%26aulast%3DPilat%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DM.%2BF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHeath%26aufirst%3DE.%2BI.%26aulast%3DMalburg%26aufirst%3DL.%2BM.%26aulast%3DKlein%26aufirst%3DP.%2BJ.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DMessmann%26aufirst%3DR.%2BA.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DPhase%2520I%2520study%2520of%2520folate%2520conjugate%2520EC145%2520%2528vintafolide%2529%2520in%2520patients%2520with%2520refractory%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D30%26spage%3D4011%26epage%3D4016%26doi%3D10.1200%2FJCO.2011.41.4946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Beck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, J. M.</span><span> </span><span class="NLM_article-title">Antibody-drug conjugates: present and future</span> <span class="citation_source-journal">MAbs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.4161/mabs.27436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.4161%2Fmabs.27436" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=15-17&author=A.+Beckauthor=J.+M.+Reichert&title=Antibody-drug+conjugates%3A+present+and+future&doi=10.4161%2Fmabs.27436"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4161%2Fmabs.27436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fmabs.27436%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DA.%26aulast%3DReichert%26aufirst%3DJ.%2BM.%26atitle%3DAntibody-drug%2520conjugates%253A%2520present%2520and%2520future%26jtitle%3DMAbs.%26date%3D2014%26volume%3D6%26spage%3D15%26epage%3D17%26doi%3D10.4161%2Fmabs.27436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kratz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryppa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnecke, A.</span><span> </span><span class="NLM_article-title">Prodrug strategies in anticancer chemotherapy</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1002/cmdc.200700159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1002%2Fcmdc.200700159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=17963208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1KqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=20-53&author=F.+Kratzauthor=I.+A.+M%C3%BCllerauthor=C.+Ryppaauthor=A.+Warnecke&title=Prodrug+strategies+in+anticancer+chemotherapy&doi=10.1002%2Fcmdc.200700159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrug strategies in anticancer chemotherapy</span></div><div class="casAuthors">Kratz, Felix; Mueller, Ivonne A.; Ryppa, Claudia; Warnecke, Andre</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-53</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The majority of clin. approved anticancer drugs are characterized by a narrow therapeutic window that results mainly from a high systemic toxicity of the drugs in combination with an evident lack of tumor selectivity.  Besides the development of suitable galenic formulations such as liposomes or micelles, several promising prodrug approaches have been followed in the last decades with the aim of improving chemotherapy.  In this review we elucidate the two main concepts that underlie the design of most anticancer prodrugs: drug targeting and controlled release of the drug at the tumor site.  Consequently, active and passive targeting using tumor-specific ligands or macromol. carriers are discussed as well as release strategies that are based on tumor-specific characteristics such as low pH or the expression of tumor-assocd. enzymes.  Furthermore, other strategies such as ADEPT (antibody-directed enzyme prodrug therapy) and the design of self-eliminating structures are introduced.  Chem. realization of prodrug approaches is illustrated by drug candidates that have or may have clin. importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7KWHTS-qaUbVg90H21EOLACvtfcHk0ljuBWmqmEgQDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1KqsrY%253D&md5=1f43c66a71a6291f392f01cc73380479</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700159%26sid%3Dliteratum%253Aachs%26aulast%3DKratz%26aufirst%3DF.%26aulast%3DM%25C3%25BCller%26aufirst%3DI.%2BA.%26aulast%3DRyppa%26aufirst%3DC.%26aulast%3DWarnecke%26aufirst%3DA.%26atitle%3DProdrug%2520strategies%2520in%2520anticancer%2520chemotherapy%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D20%26epage%3D53%26doi%3D10.1002%2Fcmdc.200700159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Brown, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccia, A. J.</span><span> </span><span class="NLM_article-title">The unique physiology of solid tumors: opportunities (and problems) for cancer therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1408</span><span class="NLM_x">–</span> <span class="NLM_lpage">1416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=9537241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A280%3ADyaK1c7ps1Ggsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=1408-1416&author=J.+M.+Brownauthor=A.+J.+Giaccia&title=The+unique+physiology+of+solid+tumors%3A+opportunities+%28and+problems%29+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The unique physiology of solid tumors: opportunities (and problems) for cancer therapy</span></div><div class="casAuthors">Brown J M; Giaccia A J</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1408-16</span>
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">The physiology of solid tumors differs from that of normal tissues in a number of important aspects, the majority of which stem from differences between the two vasculatures.  Compared with the regular, ordered vasculature of normal tissues, blood vessels in tumors are often highly abnormal, distended capillaries with leaky walls and sluggish flow.  Tumor growth also requires continuous new vessel growth, or angiogenesis.  These physiological differences can be problems for cancer treatment; for example, hypoxia in solid tumors leads to resistance to radiotherapy and to some anticancer drugs.  However, these differences can also be exploited for selective cancer treatment.  Here we review four such areas that are under active investigation: (a) hypoxia-selective cytotoxins take advantage of the unique low oxygen tension in the majority of human solid tumors.  Tirapazamine, a drug in the final stages of clinical trials, is one of the more promising of these agents; (b) leaky tumor blood vessels can be exploited using liposomes that have been sterically stabilized to have a long intravascular half-life, allowing them to selectively accumulate in solid tumors; (c) the tumor microenvironment is a stimulus to angiogenenesis, and inhibition of angiogenesis can be a powerful anticancer therapy not susceptible to acquired drug resistance; and (d) we discuss attempts to use gene therapy activated either by the low oxygen environment or by necrotic regions of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbGK72nOV2SmPgL4LrC-0VfW6udTcc2eZp8MPUOZD3Orntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7ps1Ggsw%253D%253D&md5=dda0dfcc02cdcf971a6754b04dcc1a1a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520unique%2520physiology%2520of%2520solid%2520tumors%253A%2520opportunities%2520%2528and%2520problems%2529%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D1408%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Brown, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, W. R.</span><span> </span><span class="NLM_article-title">Exploiting tumour hypoxia in cancer treatment</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1038/nrc1367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnrc1367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=15170446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVaisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=437-447&author=J.+M.+Brownauthor=W.+R.+Wilson&title=Exploiting+tumour+hypoxia+in+cancer+treatment&doi=10.1038%2Fnrc1367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting tumor hypoxia in cancer treatment</span></div><div class="casAuthors">Brown, J. Martin; Wilson, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">437-447</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Solid tumors contain regions at very low oxygen concns. (hypoxia), often surrounding areas of necrosis.  The cells in these hypoxic regions are resistant to both radiotherapy and chemotherapy.  However, the existence of hypoxia and necrosis also provides an opportunity for tumor-selective therapy, including prodrugs activated by hypoxia, hypoxia-specific gene therapy, targeting the hypoxia-inducible factor 1 transcription factor, and recombinant anaerobic bacteria.  These strategies could turn what is now an impediment into a significant advantage for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy-CURLXLUoLVg90H21EOLACvtfcHk0ljuBWmqmEgQDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVaisbs%253D&md5=25e29e73de40c207277fe8b61a19e675</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc1367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1367%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26atitle%3DExploiting%2520tumour%2520hypoxia%2520in%2520cancer%2520treatment%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D437%26epage%3D447%26doi%3D10.1038%2Fnrc1367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Torti, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torti, F. M.</span><span> </span><span class="NLM_article-title">Iron and cancer: more ore to be mined</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1038/nrc3495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnrc3495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=23594855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvF2isL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=342-355&author=S.+V.+Tortiauthor=F.+M.+Torti&title=Iron+and+cancer%3A+more+ore+to+be+mined&doi=10.1038%2Fnrc3495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Iron and cancer: more ore to be mined</span></div><div class="casAuthors">Torti, Suzy V.; Torti, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">342-355</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Iron is an essential nutrient that facilitates cell proliferation and growth.  However, iron also has the capacity to engage in redox cycling and free radical formation.  Therefore, iron can contribute to both tumor initiation and tumor growth; recent work has also shown that iron has a role in the tumor microenvironment and in metastasis.  Pathways of iron acquisition, efflux, storage and regulation are all perturbed in cancer, suggesting that reprogramming of iron metab. is a central aspect of tumor cell survival.  Signalling through hypoxia-inducible factor (HIF) and WNT pathways may contribute to altered iron metab. in cancer.  Targeting iron metabolic pathways may provide new tools for cancer prognosis and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo77TD3b0CvrVg90H21EOLACvtfcHk0ljuBWmqmEgQDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvF2isL8%253D&md5=9d950f3dab0010974d1ef25f8c9c1733</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrc3495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3495%26sid%3Dliteratum%253Aachs%26aulast%3DTorti%26aufirst%3DS.%2BV.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26atitle%3DIron%2520and%2520cancer%253A%2520more%2520ore%2520to%2520be%2520mined%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D342%26epage%3D355%26doi%3D10.1038%2Fnrc3495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chaturvedi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goswami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saikia, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barua, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. G.</span><span> </span><span class="NLM_article-title">Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span><span class="refDoi"> DOI: 10.1039/B816679J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1039%2FB816679J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=20111769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1WltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=435-454&author=D.+Chaturvediauthor=A.+Goswamiauthor=P.+P.+Saikiaauthor=N.+C.+Baruaauthor=P.+G.+Rao&title=Artemisinin+and+its+derivatives%3A+a+novel+class+of+anti-malarial+and+anti-cancer+agents&doi=10.1039%2FB816679J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents</span></div><div class="casAuthors">Chaturvedi, Devdutt; Goswami, Abhishek; Pratim Saikia, Partha; Barua, Nabin C.; Rao, Paruchuri G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">435-454</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this tutorial review, an effort towards presentation of a comprehensive account of the recent developments on various kinds of artemisinin derivs. including artemisinin dimers, trimers and tetramers has been made and their efficacy towards malaria parasites and different cancer cells lines was compared with that of artemisinins, and various other anti-malarial and anti-cancer drugs.  It is expected that this review will provide first-hand information on artemisinin chem. to org./medicinal chemists, and pharmacologists working on anticancer and anti-malarial drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIvZuubFYF1rVg90H21EOLACvtfcHk0ljZTOQzpAqSpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1WltLg%253D&md5=57707fe746adeda3ef58828da251c8d3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2FB816679J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB816679J%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DD.%26aulast%3DGoswami%26aufirst%3DA.%26aulast%3DSaikia%26aufirst%3DP.%2BP.%26aulast%3DBarua%26aufirst%3DN.%2BC.%26aulast%3DRao%26aufirst%3DP.%2BG.%26atitle%3DArtemisinin%2520and%2520its%2520derivatives%253A%2520a%2520novel%2520class%2520of%2520anti-malarial%2520and%2520anti-cancer%2520agents%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2010%26volume%3D39%26spage%3D435%26epage%3D454%26doi%3D10.1039%2FB816679J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">O’Neill, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posner, G. H.</span><span> </span><span class="NLM_article-title">A medicinal chemistry perspective on artemisinin and related endoperoxides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2945</span><span class="NLM_x">–</span> <span class="NLM_lpage">2964</span><span class="refDoi"> DOI: 10.1021/jm030571c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030571c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVSgsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2945-2964&author=P.+M.+O%E2%80%99Neillauthor=G.+H.+Posner&title=A+medicinal+chemistry+perspective+on+artemisinin+and+related+endoperoxides&doi=10.1021%2Fjm030571c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemistry Perspective on Artemisinin and Related Endoperoxides</span></div><div class="casAuthors">O'Neill, Paul M.; Posner, Gary H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2945-2964</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on aspects of the chem., mechanism of action, metab., and toxicity of the endoperoxide class of antimalarial drugs with a focus on lead compds. (semisynthetic and synthetic) that have emerged as potential next-generation analogs.  The authors also briefly cover artemisinin combination therapy (ACT) of malaria and discuss the potential of drug hybrids and prodrugs as new approaches to delivering combination chemotherapy through a sing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH6vj_Dt15orVg90H21EOLACvtfcHk0ljZTOQzpAqSpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVSgsrc%253D&md5=d39dbc04bfb86ab753bbe96d52411070</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm030571c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030571c%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DPosner%26aufirst%3DG.%2BH.%26atitle%3DA%2520medicinal%2520chemistry%2520perspective%2520on%2520artemisinin%2520and%2520related%2520endoperoxides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2945%26epage%3D2964%26doi%3D10.1021%2Fjm030571c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mercer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copple, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. K.</span><span> </span><span class="NLM_article-title">The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span><span class="refDoi"> DOI: 10.1074/jbc.M110.144188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1074%2Fjbc.M110.144188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=987-996&author=A.+E.+Mercerauthor=I.+M.+Coppleauthor=J.+L.+Maggsauthor=P.+M.+O%E2%80%99Neillauthor=B.+K.+Park&title=The+role+of+heme+and+the+mitochondrion+in+the+chemical+and+molecular+mechanisms+of+mammalian+cell+death+induced+by+the+artemisinin+antimalarials&doi=10.1074%2Fjbc.M110.144188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.144188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.144188%26sid%3Dliteratum%253Aachs%26aulast%3DMercer%26aufirst%3DA.%2BE.%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DThe%2520role%2520of%2520heme%2520and%2520the%2520mitochondrion%2520in%2520the%2520chemical%2520and%2520molecular%2520mechanisms%2520of%2520mammalian%2520cell%2520death%2520induced%2520by%2520the%2520artemisinin%2520antimalarials%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D987%26epage%3D996%26doi%3D10.1074%2Fjbc.M110.144188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Mercer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadwick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. K.</span><span> </span><span class="NLM_article-title">Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">9372</span><span class="NLM_x">–</span> <span class="NLM_lpage">9382</span><span class="refDoi"> DOI: 10.1074/jbc.M610375200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1074%2Fjbc.M610375200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=9372-9382&author=A.+E.+Mercerauthor=J.+L.+Maggsauthor=X.-M.+Sunauthor=G.+M.+Cohenauthor=J.+Chadwickauthor=P.+M.+O%E2%80%99Neillauthor=B.+K.+Park&title=Evidence+for+the+involvement+of+carbon-centered+radicals+in+the+induction+of+apoptotic+cell+death+by+artemisinin+compounds&doi=10.1074%2Fjbc.M610375200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M610375200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M610375200%26sid%3Dliteratum%253Aachs%26aulast%3DMercer%26aufirst%3DA.%2BE.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DSun%26aufirst%3DX.-M.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26aulast%3DChadwick%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DEvidence%2520for%2520the%2520involvement%2520of%2520carbon-centered%2520radicals%2520in%2520the%2520induction%2520of%2520apoptotic%2520cell%2520death%2520by%2520artemisinin%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D9372%26epage%3D9382%26doi%3D10.1074%2Fjbc.M610375200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Dixon, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">The role of iron and reactive oxygen species in cell death</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1038/nchembio.1416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnchembio.1416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=24346035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCjtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=9-17&author=S.+J.+Dixonauthor=B.+R.+Stockwell&title=The+role+of+iron+and+reactive+oxygen+species+in+cell+death&doi=10.1038%2Fnchembio.1416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The role of iron and reactive oxygen species in cell death</span></div><div class="casAuthors">Dixon, Scott J.; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The transition metal, Fe, is essential for life, yet potentially toxic Fe-catalyzed reactive O species (ROS) are unavoidable in an O2-rich environment.  Fe and ROS are increasingly recognized as important initiators and mediators of cell death in a variety of organisms and pathol. situations.  Here, the authors review recent discoveries regarding the mechanism by which Fe and ROS participate in cell death.  The authors describe the different roles of Fe in triggering cell death, targets of Fe-dependent ROS that mediate cell death and a new form of Fe-dependent cell death termed ferroptosis.  Recent advances in understanding the role of Fe and ROS in cell death offer unexpected surprises and suggest new therapeutic avenues to treat cancer, organ damage, and degenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP3ojDaWMX-LVg90H21EOLACvtfcHk0lgUdzQ6PoEMxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCjtrzO&md5=bc9a0c19f4740dd450e0aa855e4da139</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1416%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DThe%2520role%2520of%2520iron%2520and%2520reactive%2520oxygen%2520species%2520in%2520cell%2520death%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D9%26epage%3D17%26doi%3D10.1038%2Fnchembio.1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Pantopoulos, K.</span><span> </span><span class="NLM_article-title">Iron metabolism and the IRE/IRP regulatory system: an update</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1196/annals.1306.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1196%2Fannals.1306.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=15105251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVOnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1012&publication_year=2004&pages=1-13&author=K.+Pantopoulos&title=Iron+metabolism+and+the+IRE%2FIRP+regulatory+system%3A+an+update&doi=10.1196%2Fannals.1306.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Iron metabolism and the IRE/IRP regulatory system: An update</span></div><div class="casAuthors">Pantopoulos, Kostas</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Cellular iron homeostasis is accomplished by the coordinated regulated expression of the transferrin receptor and ferritin, which mediate iron uptake and storage, resp.  The mechanism is posttranscriptional and involves two cytoplasmic iron regulatory proteins, IRP1 and IRP2.  Under conditions of iron starvation, IRPs stabilize the transferrin receptor and inhibit the translation of ferritin mRNAs by binding to "iron responsive elements" (IREs) within their untranslated regions.  The IRE/IRP system also controls the expression of addnl. IRE-contg. mRNAs, encoding proteins of iron and energy metab.  The activities of IRP1 and IRP2 are regulated by distinct posttranslational mechanisms in response to cellular iron levels.  Thus, in iron-replete cells, IRP1 assembles a cubane iron-sulfur cluster, which prevents IRE binding, while IRP2 undergoes proteasomal degrdn.  IRP1 and IRP2 also respond, albeit differently, to iron-independent signals, such as hydrogen peroxide, hypoxia, or nitric oxide.  Basic principles of the IRE/IRP system and recent advances in understanding the regulation and the function of IRP1 and IRP2 are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI7JVY6X9b7LVg90H21EOLACvtfcHk0lgUdzQ6PoEMxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVOnu78%253D&md5=454cf46ba6b836d1d5d0d174dccedb69</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1196%2Fannals.1306.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1306.001%26sid%3Dliteratum%253Aachs%26aulast%3DPantopoulos%26aufirst%3DK.%26atitle%3DIron%2520metabolism%2520and%2520the%2520IRE%252FIRP%2520regulatory%2520system%253A%2520an%2520update%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1012%26spage%3D1%26epage%3D13%26doi%3D10.1196%2Fannals.1306.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantopoulos, K.</span><span> </span><span class="NLM_article-title">Regulation of cellular iron metabolism</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1042/BJ20101825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1042%2FBJ20101825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=21348856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVajtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2011&pages=365-381&author=J.+Wangauthor=K.+Pantopoulos&title=Regulation+of+cellular+iron+metabolism&doi=10.1042%2FBJ20101825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of cellular iron metabolism</span></div><div class="casAuthors">Wang, Jian; Pantopoulos, Kostas</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-381</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Iron is an essential but potentially hazardous biometal.  Mammalian cells require sufficient amts. of iron to satisfy metabolic needs or to accomplish specialized functions.  Iron is delivered to tissues by circulating transferrin, a transporter that captures iron released into the plasma mainly from intestinal enterocytes or reticuloendothelial macrophages.  The binding of iron-laden transferrin to the cell-surface transferrin receptor 1 results in endocytosis and uptake of the metal cargo.  Internalized iron is transported to mitochondria for the synthesis of heme or iron-sulfur clusters, which are integral parts of several metalloproteins, and excess iron is stored and detoxified in cytosolic ferritin.  Iron metab. is controlled at different levels and by diverse mechanisms.  The present review summarizes basic concepts of iron transport, use and storage and focuses on the IRE (iron-responsive element)/IRP (iron-regulatory protein) system, a well known post-transcriptional regulatory circuit that not only maintains iron homeostasis in various cell types, but also contributes to systemic iron balance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDvcVkfIpAJLVg90H21EOLACvtfcHk0lgUdzQ6PoEMxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVajtb8%253D&md5=b7f566a85726694f9921e6eb0a489f15</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2FBJ20101825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20101825%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPantopoulos%26aufirst%3DK.%26atitle%3DRegulation%2520of%2520cellular%2520iron%2520metabolism%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D434%26spage%3D365%26epage%3D381%26doi%3D10.1042%2FBJ20101825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Richardson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponka, P.</span><span> </span><span class="NLM_article-title">The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1331</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/S0304-4157(96)00014-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2FS0304-4157%2896%2900014-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=9325434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADyaK2sXhsFKmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1331&publication_year=1997&pages=1-40&author=D.+R.+Richardsonauthor=P.+Ponka&title=The+molecular+mechanisms+of+the+metabolism+and+transport+of+iron+in+normal+and+neoplastic+cells&doi=10.1016%2FS0304-4157%2896%2900014-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells</span></div><div class="casAuthors">Richardson, Des R.; Ponka, Prem</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Biomembranes</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1331</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-40</span>CODEN:
                <span class="NLM_cas:coden">BRBMC5</span>;
        ISSN:<span class="NLM_cas:issn">0304-4157</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 518 refs.  Topics discussed include iron transport in the serum bound to transferrin; the transferrin receptor; mechanisms of iron uptake by normal and neoplastic cells; pathophysiol. significance of iron uptake mediated by the human melanoma-assocd. tumor antigen, melanotransferrin (p97); intracellular iron metab.; and coordinate regulation of iron uptake storage and utilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3uHZXIV2Ec7Vg90H21EOLACvtfcHk0li6gO8YQ5kk9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsFKmt7g%253D&md5=9a7860ca58dc4f07ffc35d16d534793d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0304-4157%2896%2900014-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-4157%252896%252900014-7%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26aulast%3DPonka%26aufirst%3DP.%26atitle%3DThe%2520molecular%2520mechanisms%2520of%2520the%2520metabolism%2520and%2520transport%2520of%2520iron%2520in%2520normal%2520and%2520neoplastic%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Biomembr.%26date%3D1997%26volume%3D1331%26spage%3D1%26epage%3D40%26doi%3D10.1016%2FS0304-4157%2896%2900014-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Boult, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bury, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spychal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tselepis, C.</span><span> </span><span class="NLM_article-title">Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-07-1054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1158%2F1078-0432.CCR-07-1054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=18223212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=379-387&author=J.+Boultauthor=K.+Robertsauthor=M.+J.+Brookesauthor=S.+Hughesauthor=J.+P.+Buryauthor=S.+S.+Crossauthor=G.+J.+Andersonauthor=R.+Spychalauthor=T.+Iqbalauthor=C.+Tselepis&title=Overexpression+of+cellular+iron+import+proteins+is+associated+with+malignant+progression+of+esophageal+adenocarcinoma&doi=10.1158%2F1078-0432.CCR-07-1054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Cellular Iron Import Proteins Is Associated with Malignant Progression of Esophageal Adenocarcinoma</span></div><div class="casAuthors">Boult, Jessica; Roberts, Keith; Brookes, Matthew J.; Hughes, Sharon; Bury, Jonathan P.; Cross, Simon S.; Anderson, Gregory J.; Spychal, Robert; Iqbal, Tariq; Tselepis, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-387</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: There is growing evidence that iron is important in esophageal adenocarcinoma, a cancer whose incidence is rising faster than any other in the Western world.  However, how iron mediates carcinogenesis at the mol. level remains unclear.  In this study, we investigated the expression of iron transport proteins involved in cellular iron import, export, and storage in the premalignant lesion Barrett's metaplasia and esophageal adenocarcinoma.  Exptl. Design: Perls' staining was used to examine iron deposition in tissue. mRNA expression in samples of Barrett's metaplasia matched with esophageal adenocarcinoma and samples of Barrett's metaplasia without evidence of adenocarcinoma were examd. by real-time PCR.  Semiquant. immunohistochem. was used to examine cellular localization and protein levels.  The effect of iron loading on cellular proliferation and iron transporter expression was detd. in esophageal cell lines OE33 and SEG-1 using a bromodeoxyuridine assay and real-time PCR, resp.  RESULTS: In the progression of Barrett's metaplasia to adenocarcinoma, there was overexpression of divalent metal transporter 1 (DMT1), transferrin receptor 1, duodenal cytochrome b, ferroportin, and H-ferritin, and these changes were assocd. with increased iron deposition.  Overexpression of DMT1 was further assocd. with metastatic adenocarcinoma.  Iron loading OE33 and SEG-1 cells caused increased cellular proliferation, which was assocd. with increased H-ferritin and decreased transferrin receptor 1 and DMT1 expression.  CONCLUSIONS: Progression to adenocarcinoma is assocd. with increased expression of iron import proteins.  These events culminate in increased intracellular iron and cellular proliferation.  This may represent a novel mechanism of esophageal carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq418Mt92Q23bVg90H21EOLACvtfcHk0li6gO8YQ5kk9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKitrY%253D&md5=666b13ad311f20ad57e1b3fc8bd8998e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1054%26sid%3Dliteratum%253Aachs%26aulast%3DBoult%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DK.%26aulast%3DBrookes%26aufirst%3DM.%2BJ.%26aulast%3DHughes%26aufirst%3DS.%26aulast%3DBury%26aufirst%3DJ.%2BP.%26aulast%3DCross%26aufirst%3DS.%2BS.%26aulast%3DAnderson%26aufirst%3DG.%2BJ.%26aulast%3DSpychal%26aufirst%3DR.%26aulast%3DIqbal%26aufirst%3DT.%26aulast%3DTselepis%26aufirst%3DC.%26atitle%3DOverexpression%2520of%2520cellular%2520iron%2520import%2520proteins%2520is%2520associated%2520with%2520malignant%2520progression%2520of%2520esophageal%2520adenocarcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D379%26epage%3D387%26doi%3D10.1158%2F1078-0432.CCR-07-1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kakhlon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruenbaum, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabantchik, Z.</span><span> </span><span class="NLM_article-title">Ferritin expression modulates cell cycle dynamics and cell responsiveness to H-ras-induced growth via expansion of the labile iron pool</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span><span class="refDoi"> DOI: 10.1042/bj3630431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1042%2Fbj3630431" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2002&pages=431-436&author=O.+Kakhlonauthor=Y.+Gruenbaumauthor=Z.+Cabantchik&title=Ferritin+expression+modulates+cell+cycle+dynamics+and+cell+responsiveness+to+H-ras-induced+growth+via+expansion+of+the+labile+iron+pool&doi=10.1042%2Fbj3630431"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1042%2Fbj3630431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3630431%26sid%3Dliteratum%253Aachs%26aulast%3DKakhlon%26aufirst%3DO.%26aulast%3DGruenbaum%26aufirst%3DY.%26aulast%3DCabantchik%26aufirst%3DZ.%26atitle%3DFerritin%2520expression%2520modulates%2520cell%2520cycle%2520dynamics%2520and%2520cell%2520responsiveness%2520to%2520H-ras-induced%2520growth%2520via%2520expansion%2520of%2520the%2520labile%2520iron%2520pool%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D363%26spage%3D431%26epage%3D436%26doi%3D10.1042%2Fbj3630431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Pinnix, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Agostino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kute, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willingham, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesfay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torti, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torti, F. M.</span><span> </span><span class="NLM_article-title">Ferroportin and iron regulation in breast cancer progression and prognosis</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">43ra56</span><span class="refDoi"> DOI: 10.1126/scisignal.3001127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1126%2Fscisignal.3001127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=20686179" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=43ra56&author=Z.+K.+Pinnixauthor=L.+D.+Millerauthor=W.+Wangauthor=R.+D%E2%80%99Agostinoauthor=T.+Kuteauthor=M.+C.+Willinghamauthor=H.+Hatcherauthor=L.+Tesfayauthor=G.+Suiauthor=X.+Diauthor=S.+V.+Tortiauthor=F.+M.+Torti&title=Ferroportin+and+iron+regulation+in+breast+cancer+progression+and+prognosis&doi=10.1126%2Fscisignal.3001127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.3001127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.3001127%26sid%3Dliteratum%253Aachs%26aulast%3DPinnix%26aufirst%3DZ.%2BK.%26aulast%3DMiller%26aufirst%3DL.%2BD.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DD%25E2%2580%2599Agostino%26aufirst%3DR.%26aulast%3DKute%26aufirst%3DT.%26aulast%3DWillingham%26aufirst%3DM.%2BC.%26aulast%3DHatcher%26aufirst%3DH.%26aulast%3DTesfay%26aufirst%3DL.%26aulast%3DSui%26aufirst%3DG.%26aulast%3DDi%26aufirst%3DX.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26atitle%3DFerroportin%2520and%2520iron%2520regulation%2520in%2520breast%2520cancer%2520progression%2520and%2520prognosis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D43ra56%26doi%3D10.1126%2Fscisignal.3001127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wu, K.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalla-Favera, R.</span><span> </span><span class="NLM_article-title">Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">676</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span><span class="refDoi"> DOI: 10.1126/science.283.5402.676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1126%2Fscience.283.5402.676" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1999&pages=676-679&author=K.-J.+Wuauthor=A.+Polackauthor=R.+Dalla-Favera&title=Coordinated+regulation+of+iron-controlling+genes%2C+H-ferritin+and+IRP2%2C+by+c-MYC&doi=10.1126%2Fscience.283.5402.676"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.283.5402.676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.283.5402.676%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.-J.%26aulast%3DPolack%26aufirst%3DA.%26aulast%3DDalla-Favera%26aufirst%3DR.%26atitle%3DCoordinated%2520regulation%2520of%2520iron-controlling%2520genes%252C%2520H-ferritin%2520and%2520IRP2%252C%2520by%2520c-MYC%26jtitle%3DScience%26date%3D1999%26volume%3D283%26spage%3D676%26epage%3D679%26doi%3D10.1126%2Fscience.283.5402.676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Toyokuni, S.</span><span> </span><span class="NLM_article-title">Role of iron in carcinogenesis: cancer as a ferrotoxic disease</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1111/j.1349-7006.2008.01001.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1111%2Fj.1349-7006.2008.01001.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=19018762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2009&pages=9-16&author=S.+Toyokuni&title=Role+of+iron+in+carcinogenesis%3A+cancer+as+a+ferrotoxic+disease&doi=10.1111%2Fj.1349-7006.2008.01001.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Role of iron in carcinogenesis: cancer as a ferrotoxic disease</span></div><div class="casAuthors">Toyokuni, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-16</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Iron is abundant universally.  During the evolutionary processes, humans have selected iron as a carrier of oxygen inside the body.  However, iron works as a double-edged sword, and its excess is a risk for cancer, presumably via generation of reactive oxygen species.  Thus far, pathol. conditions such as hemochromatosis, chronic viral hepatitis B and C, exposure to asbestos fibers, as well as endometriosis have been recognized as iron overload-assocd. risks for human cancer.  Indeed, iron is carcinogenic in animal expts.  These reports unexpectedly revealed that there are target genes in iron-induced carcinogenesis and that iron-catalyzed oxidative DNA damage is not random in vivo.  Several iron transporters and hepcidin, a peptide hormone regulating iron metab., were discovered in the past decade.  Furthermore, a recent epidemiol. study reported that iron redn. by phlebotomy decreased cancer risk in the apparently normal population.  These results warrant reconsideration of the role of iron in carcinogenesis and suggest that fine control of body iron stores would be a wise strategy for cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3SZCdLhvdsrVg90H21EOLACvtfcHk0lhpOxxuUiGYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGguro%253D&md5=6e3682d8e895bbc72a1a091ee6ce92e6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.01001.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.01001.x%26sid%3Dliteratum%253Aachs%26aulast%3DToyokuni%26aufirst%3DS.%26atitle%3DRole%2520of%2520iron%2520in%2520carcinogenesis%253A%2520cancer%2520as%2520a%2520ferrotoxic%2520disease%26jtitle%3DCancer%2520Sci.%26date%3D2009%26volume%3D100%26spage%3D9%26epage%3D16%26doi%3D10.1111%2Fj.1349-7006.2008.01001.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Miller, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Agostino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torti, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torti, F. M.</span><span> </span><span class="NLM_article-title">An iron regulatory gene signature predicts outcome in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">6728</span><span class="NLM_x">–</span> <span class="NLM_lpage">6737</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-1870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1158%2F0008-5472.CAN-11-1870" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=6728-6737&author=L.+D.+Millerauthor=L.+G.+Coffmanauthor=J.+W.+Chouauthor=M.+A.+Blackauthor=J.+Berghauthor=R.+D%E2%80%99Agostinoauthor=S.+V.+Tortiauthor=F.+M.+Torti&title=An+iron+regulatory+gene+signature+predicts+outcome+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-11-1870"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-1870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-1870%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BD.%26aulast%3DCoffman%26aufirst%3DL.%2BG.%26aulast%3DChou%26aufirst%3DJ.%2BW.%26aulast%3DBlack%26aufirst%3DM.%2BA.%26aulast%3DBergh%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Agostino%26aufirst%3DR.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26atitle%3DAn%2520iron%2520regulatory%2520gene%2520signature%2520predicts%2520outcome%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D6728%26epage%3D6737%26doi%3D10.1158%2F0008-5472.CAN-11-1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Valecha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Looareesuwan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martensson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdulla, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krudsood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tangpukdee, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohanty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moehrle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paliwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dash, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björkman, A.</span><span> </span><span class="NLM_article-title">Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1086/655831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1086%2F655831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=20687837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yhsbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=684-691&author=N.+Valechaauthor=S.+Looareesuwanauthor=A.+Martenssonauthor=S.+M.+Abdullaauthor=S.+Krudsoodauthor=N.+Tangpukdeeauthor=S.+Mohantyauthor=S.+K.+Mishraauthor=P.+K.+Tyagiauthor=S.+K.+Sharmaauthor=J.+Moehrleauthor=A.+Gautamauthor=A.+Royauthor=J.+K.+Paliwalauthor=M.+Kothariauthor=N.+Sahaauthor=A.+P.+Dashauthor=A.+Bj%C3%B6rkman&title=Arterolane%2C+a+new+synthetic+trioxolane+for+treatment+of+uncomplicated+Plasmodium+falciparum+malaria%3A+a+phase+II%2C+multicenter%2C+randomized%2C+dose-finding+clinical+trial&doi=10.1086%2F655831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial</span></div><div class="casAuthors">Valecha, Neena; Looareesuwan, Sornchai; Martensson, Andreas; Abdulla, Salim Mohammed; Krudsood, Srivicha; Tangpukdee, Noppadon; Mohanty, Sanjib; Mishra, Saroj K.; Tyagi, P. K.; Sharma, S. K.; Moehrle, Joerg; Gautam, Anirudh; Roy, Arjun; Paliwal, Jyoti K.; Kothari, Monica; Saha, Nilanjan; Dash, Aditya P.; Bjorkman, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">684-691</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background. Drug-resistant Plasmodium falciparum malaria necessitates development of novel drugs for treatment.  The present study assessed the efficacy and safety of 3 dose levels of arterolane (RBx 11160), a synthetic trioxolane, for treatment of acute uncomplicated falciparum malaria.  Methods. In this randomized, double-blind, multicenter, parallel-group, dose-finding, phase II trial, 230 patients from 4 centers in Thailand, India, and Tanzania (mainland and Zanzibar) received either 50 mg (n = 78), 100 mg (n = 76), or 200 mg (n = 76) of arterolane once daily for 7 days.  Patients (aged 13-65 years) with asexual parasite d. of 1000-100,000 parasites/μL were included and were followed up for 28 days.  The median time to 90% parasite clearance (PC90) was evaluated.  Results. The median PC90 was longer in the group receiving the 50-mg dose (19.4 h), compared with the groups receiving the 100-mg dose (12.8 h) and 200-mg dose (12.6 h) (P<.01).  The polymerase chain reaction-cor. adequate clin. and parasitol. responses on day 28 were 63%, 71%, and 72% for the groups receiving the 50-mg, 100-mg, and 200-mg doses, resp., by intention-to-treat anal. (odds ratio, 1.55; 95% confidence interval, 0.78-3.06, for comparison of the 200-mg and 50-mg dose groups).  Treatment was generally well tolerated.  No patient died or experienced any serious adverse event.  Mild complaints were reported in <10% of the patients and were similar in the 3 groups.  Biochem. and hematol. analyses did not show any sign of drug toxicity in any patient.  Conclusion. Arterolane at daily doses of 100 and 200 mg is a rapidly acting, effective, and safe synthetic antimalarial drug, which may potentially represent an alternative to artemisinin derivs. in antimalarial combination therapy.  Trial registration. ClinicalTrials.gov identifier NCT00362050.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlfwUJP3cnerVg90H21EOLACvtfcHk0lhpOxxuUiGYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yhsbfM&md5=c02d01aebc2d7d6dcf341db9e0fc23c5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1086%2F655831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F655831%26sid%3Dliteratum%253Aachs%26aulast%3DValecha%26aufirst%3DN.%26aulast%3DLooareesuwan%26aufirst%3DS.%26aulast%3DMartensson%26aufirst%3DA.%26aulast%3DAbdulla%26aufirst%3DS.%2BM.%26aulast%3DKrudsood%26aufirst%3DS.%26aulast%3DTangpukdee%26aufirst%3DN.%26aulast%3DMohanty%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DS.%2BK.%26aulast%3DTyagi%26aufirst%3DP.%2BK.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DMoehrle%26aufirst%3DJ.%26aulast%3DGautam%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DPaliwal%26aufirst%3DJ.%2BK.%26aulast%3DKothari%26aufirst%3DM.%26aulast%3DSaha%26aufirst%3DN.%26aulast%3DDash%26aufirst%3DA.%2BP.%26aulast%3DBj%25C3%25B6rkman%26aufirst%3DA.%26atitle%3DArterolane%252C%2520a%2520new%2520synthetic%2520trioxolane%2520for%2520treatment%2520of%2520uncomplicated%2520Plasmodium%2520falciparum%2520malaria%253A%2520a%2520phase%2520II%252C%2520multicenter%252C%2520randomized%252C%2520dose-finding%2520clinical%2520trial%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2010%26volume%3D51%26spage%3D684%26epage%3D691%26doi%3D10.1086%2F655831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Borstnik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paik, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posner, G. H.</span><span> </span><span class="NLM_article-title">Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds</span> <span class="citation_source-journal">Int. J. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1661</span><span class="NLM_x">–</span> <span class="NLM_lpage">1667</span><span class="refDoi"> DOI: 10.1016/S0020-7519(02)00195-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2FS0020-7519%2802%2900195-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=12435451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFCitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=1661-1667&author=K.+Borstnikauthor=I.+Paikauthor=T.+A.+Shapiroauthor=G.+H.+Posner&title=Antimalarial+chemotherapeutic+peroxides%3A+artemisinin%2C+yingzhaosu+A+and+related+compounds&doi=10.1016%2FS0020-7519%2802%2900195-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds</span></div><div class="casAuthors">Borstnik, Kristina; Paik, Ik-hyeon; Shapiro, Theresa A.; Posner, Gary H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal for Parasitology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1661-1667</span>CODEN:
                <span class="NLM_cas:coden">IJPYBT</span>;
        ISSN:<span class="NLM_cas:issn">0020-7519</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Mechanism-based rational design and gram-scale chem. synthesis have produced some new trioxane and endoperoxide antimalarial drug candidates that are efficacious and safe.  This review summarizes recent achievements in this area of peroxide drug development for malaria chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMoMg8blhpBbVg90H21EOLACvtfcHk0lhpOxxuUiGYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFCitbo%253D&md5=2ce9858e952cba87115571bb9ff4c801</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0020-7519%2802%2900195-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-7519%252802%252900195-9%26sid%3Dliteratum%253Aachs%26aulast%3DBorstnik%26aufirst%3DK.%26aulast%3DPaik%26aufirst%3DI.%26aulast%3DShapiro%26aufirst%3DT.%2BA.%26aulast%3DPosner%26aufirst%3DG.%2BH.%26atitle%3DAntimalarial%2520chemotherapeutic%2520peroxides%253A%2520artemisinin%252C%2520yingzhaosu%2520A%2520and%2520related%2520compounds%26jtitle%3DInt.%2520J.%2520Parasitol.%26date%3D2002%26volume%3D32%26spage%3D1661%26epage%3D1667%26doi%3D10.1016%2FS0020-7519%2802%2900195-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbe-Barnes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunziker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanilayam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santo Tomas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorneaux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span> </span><span class="NLM_article-title">Identification of an antimalarial synthetic trioxolane drug development candidate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1038/nature02779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnature02779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=15318224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslCnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2004&pages=900-904&author=J.+L.+Vennerstromauthor=S.+Arbe-Barnesauthor=R.+Brunauthor=S.+A.+Charmanauthor=F.+C.+Chiuauthor=J.+Cholletauthor=Y.+Dongauthor=A.+Dornauthor=D.+Hunzikerauthor=H.+Matileauthor=K.+McIntoshauthor=M.+Padmanilayamauthor=J.+Santo+Tomasauthor=C.+Scheurerauthor=B.+Scorneauxauthor=Y.+Tangauthor=H.+Urwylerauthor=S.+Wittlinauthor=W.+N.+Charman&title=Identification+of+an+antimalarial+synthetic+trioxolane+drug+development+candidate&doi=10.1038%2Fnature02779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an antimalarial synthetic trioxolane drug development candidate</span></div><div class="casAuthors">Vennerstrom, Jonathan L.; Arbe-Barnes, Sarah; Brun, Reto; Charman, Susan A.; Chiu, Francis C. K.; Chollet, Jacques; Dong, Yuxiang; Dorn, Arnulf; Hunziker, Daniel; Matile, Hugues; McIntosh, Kylie; Padmanilayam, Maniyan; Santo Tomas, Josefina; Scheurer, Christian; Scorneaux, Bernard; Tang, Yuanqing; Urwyler, Heinrich; Wittlin, Sergio; Charman, William N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">7002</span>),
    <span class="NLM_cas:pages">900-904</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The discovery of artemisinin more than 30 yr ago provided a completely new antimalarial structural prototype; i.e., a mol. with a pharmacophoric peroxide bond in a unique 1,2,4-trioxane heterocycle.  Available evidence suggests that artemisinin and related peroxidic antimalarial drugs exert their parasiticidal activity subsequent to reductive activation by hem, released as a result of Hb digestion by the malaria-causing parasite.  This irreversible redox reaction produces carbon-centered free radicals, leading to alkylation of hem and proteins (enzymes), one of which-the sarcoplasmic-endoplasmic reticulum ATPase PfATP6 (ref. 7)-may be crit. to parasite survival.  Notably, there is no evidence of drug resistance to any member of the artemisinin family of drugs.  The chemotherapy of malaria has benefited greatly from the semi-synthetic artemisinins artemether and artesunate as they rapidly reduce parasite burden, have good therapeutic indexes and provide for successful treatment outcomes.  However, as a drug class, the artemisinins suffer from chem. (semi-synthetic availability, purity and cost), biopharmaceutical (poor bioavailability and limiting pharmacokinetics) and treatment (noncompliance with long treatment regimens and recrudescence) issues that limit their therapeutic potential.  Here the authors describe how a synthetic peroxide antimalarial drug development candidate was identified in a collaborative drug discovery project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFwBOuKiqjSbVg90H21EOLACvtfcHk0liyptmvAyivww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslCnurY%253D&md5=71070255d32c12fe3c227d5091225b31</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature02779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02779%26sid%3Dliteratum%253Aachs%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DArbe-Barnes%26aufirst%3DS.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DChiu%26aufirst%3DF.%2BC.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DHunziker%26aufirst%3DD.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DK.%26aulast%3DPadmanilayam%26aufirst%3DM.%26aulast%3DSanto%2BTomas%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DScorneaux%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26atitle%3DIdentification%2520of%2520an%2520antimalarial%2520synthetic%2520trioxolane%2520drug%2520development%2520candidate%26jtitle%3DNature%26date%3D2004%26volume%3D430%26spage%3D900%26epage%3D904%26doi%3D10.1038%2Fnature02779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Valecha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krudsood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tangpukdee, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohanty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anvikar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohanty, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J. P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paliwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saha, N.</span><span> </span><span class="NLM_article-title">Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated plasmodium falciparum malaria: A comparative, multicenter, randomized clinical trial</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span><span class="refDoi"> DOI: 10.1093/cid/cis475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1093%2Fcid%2Fcis475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=22586253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ajsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=663-671&author=N.+Valechaauthor=S.+Krudsoodauthor=N.+Tangpukdeeauthor=S.+Mohantyauthor=S.+K.+Sharmaauthor=P.+K.+Tyagiauthor=A.+Anvikarauthor=R.+Mohantyauthor=B.+S.+Raoauthor=A.+C.+Jhaauthor=B.+Shahiauthor=J.+P.+N.+Singhauthor=A.+Royauthor=P.+Kaurauthor=M.+Kothariauthor=S.+Mehtaauthor=A.+Gautamauthor=J.+K.+Paliwalauthor=S.+Aroraauthor=N.+Saha&title=Arterolane+maleate+plus+piperaquine+phosphate+for+treatment+of+uncomplicated+plasmodium+falciparum+malaria%3A+A+comparative%2C+multicenter%2C+randomized+clinical+trial&doi=10.1093%2Fcid%2Fcis475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial</span></div><div class="casAuthors">Valecha, Neena; Krudsood, Srivicha; Tangpukdee, Noppadon; Mohanty, Sanjib; Sharma, S. K.; Tyagi, P. K.; Anvikar, Anupkumar; Mohanty, Rajesh; Rao, B. S.; Jha, A. C.; Shahi, B.; Singh, Jai Prakash Narayan; Roy, Arjun; Kaur, Pawandeep; Kothari, Monica; Mehta, Shantanu; Gautam, Anirudh; Paliwal, Jyoti K.; Arora, Sudershan; Saha, Nilanjan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">663-671</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Arterolane, a rapidly acting synthetic trioxolane in combination with piperaquine, exhibits similar safety and efficacy to Coartem for the treatment of patients with uncomplicated P. falciparum malaria in a multicentre clin. trial in Thailand and India.  Background.  Artemisinin-based combination therapy is the first-line treatment for uncomplicated falciparum malaria.  This study assessed the antimalarial efficacy and safety of a combination of 150 mg of arterolane maleate and 750 mg of piperaquine phosphate (AM-PQP) in comparison to Coartem (artemether and lumefantrine) in patients with acute uncomplicated P. falciparum malaria.  Methods. In this open-label, randomized, multicentric, parallel group clin. trial, 240 patients were randomized to receive AM-PQP (160 patients) or Coartem (80 patients).  Patients with P. falciparum monoinfection and initial parasite densities ranging from 1000 to 100 000 asexual parasites/μL of blood were followed for 28 days.  Polymerase chain reaction-cor. adequate clin. and parasitol. response on day 28, parasite clearance time, and fever clearance time were evaluated.  Results. A total of 151 (94.4%) of 160 patients in the AM-PQP group completed the trial, while 77 (96.3%) of 80 patients in the Coartem group completed the trial.  No treatment failure was noted in the AM-PQP group, while one patient receiving Coartem failed treatment on day 28.  There was no difference in the median parasite clearance time (30 h in both groups) or median fever clearance time (24 h in both groups) after administration of the 2 study treatments.  Conclusions.  The available data support the evaluation of a drug combination in a larger population as a fixed-dose combination.  Clin. Trials Registration.  CTRI/2007/091/000031.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot63AoQHyfUrVg90H21EOLACvtfcHk0liyptmvAyivww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ajsr%252FJ&md5=f58d676f3462b61743cbda82acee963b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcis475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcis475%26sid%3Dliteratum%253Aachs%26aulast%3DValecha%26aufirst%3DN.%26aulast%3DKrudsood%26aufirst%3DS.%26aulast%3DTangpukdee%26aufirst%3DN.%26aulast%3DMohanty%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DTyagi%26aufirst%3DP.%2BK.%26aulast%3DAnvikar%26aufirst%3DA.%26aulast%3DMohanty%26aufirst%3DR.%26aulast%3DRao%26aufirst%3DB.%2BS.%26aulast%3DJha%26aufirst%3DA.%2BC.%26aulast%3DShahi%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DJ.%2BP.%2BN.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DKothari%26aufirst%3DM.%26aulast%3DMehta%26aufirst%3DS.%26aulast%3DGautam%26aufirst%3DA.%26aulast%3DPaliwal%26aufirst%3DJ.%2BK.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DSaha%26aufirst%3DN.%26atitle%3DArterolane%2520maleate%2520plus%2520piperaquine%2520phosphate%2520for%2520treatment%2520of%2520uncomplicated%2520plasmodium%2520falciparum%2520malaria%253A%2520A%2520comparative%252C%2520multicenter%252C%2520randomized%2520clinical%2520trial%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26spage%3D663%26epage%3D671%26doi%3D10.1093%2Fcid%2Fcis475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prankerd, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span> </span><span class="NLM_article-title">Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span><span class="refDoi"> DOI: 10.1128/AAC.01033-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1128%2FAAC.01033-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=18268087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFajsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1291-1296&author=D.+J.+Creekauthor=W.+N.+Charmanauthor=F.+C.+K.+Chiuauthor=R.+J.+Prankerdauthor=Y.+Dongauthor=J.+L.+Vennerstromauthor=S.+A.+Charman&title=Relationship+between+antimalarial+activity+and+heme+alkylation+for+spiro-+and+dispiro-1%2C2%2C4-trioxolane+antimalarials&doi=10.1128%2FAAC.01033-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials</span></div><div class="casAuthors">Creek, Darren J.; Charman, William N.; Chiu, Francis C. K.; Prankerd, Richard J.; Dong, Yuxiang; Vennerstrom, Jonathan L.; Charman, Susan A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1291-1296</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The reaction of spiro- and dispiro-1,2,4-trioxolane antimalarials with heme has been investigated to provide further insight into the mechanism of action for this important class of antimalarials.  A series of trioxolanes with various antimalarial potencies was found to be unreactive in the presence of Fe(III) hemin, but all were rapidly degraded by reduced Fe(II) heme.  The major reaction product from the heme-mediated degrdn. of biol. active trioxolanes was an alkylated heme adduct resulting from addn. of a radical intermediate.  Under standardized reaction conditions, a correlation (R2 = 0.88) was found between the extent of heme alkylation and in vitro antimalarial activity, suggesting that heme alkylation may be related to the mechanism of action for these trioxolanes.  Significantly less heme alkylation was obsd. for the clin. utilized artemisinin derivs. compared to the equipotent trioxolanes included in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7LyAjV9hg6rVg90H21EOLACvtfcHk0lh4wxb6flRafw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFajsbc%253D&md5=2fca35fc91ffbb69fa8220d7b050e393</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.01033-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01033-07%26sid%3Dliteratum%253Aachs%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DPrankerd%26aufirst%3DR.%2BJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26atitle%3DRelationship%2520between%2520antimalarial%2520activity%2520and%2520heme%2520alkylation%2520for%2520spiro-%2520and%2520dispiro-1%252C2%252C4-trioxolane%2520antimalarials%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1291%26epage%3D1296%26doi%3D10.1128%2FAAC.01033-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Creek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prankerd, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mccullough, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span> </span><span class="NLM_article-title">Iron-mediated degradation kinetics of substituted dispiro-1, 2, 4-trioxolane antimalarials</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">2945</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1002/jps.20958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1002%2Fjps.20958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=2945-56&author=D.+Creekauthor=W.+Charmanauthor=F.+C.+K.+Chiuauthor=R.+J.+Prankerdauthor=K.+J.+Mcculloughauthor=Y.+Dongauthor=J.+L.+Vennerstromauthor=S.+A.+Charman&title=Iron-mediated+degradation+kinetics+of+substituted+dispiro-1%2C+2%2C+4-trioxolane+antimalarials&doi=10.1002%2Fjps.20958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fjps.20958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20958%26sid%3Dliteratum%253Aachs%26aulast%3DCreek%26aufirst%3DD.%26aulast%3DCharman%26aufirst%3DW.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DPrankerd%26aufirst%3DR.%2BJ.%26aulast%3DMccullough%26aufirst%3DK.%2BJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26atitle%3DIron-mediated%2520degradation%2520kinetics%2520of%2520substituted%2520dispiro-1%252C%25202%252C%25204-trioxolane%2520antimalarials%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D2945%26epage%3D56%26doi%3D10.1002%2Fjps.20958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriraghavan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">Dispiro-1,2,4-trioxane analogues of a prototype dispiro-1,2,4-trioxolane: mechanistic comparators for artemisinin in the context of reaction pathways with iron(II)</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">5103</span><span class="NLM_x">–</span> <span class="NLM_lpage">5110</span><span class="refDoi"> DOI: 10.1021/jo050385+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo050385%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVWjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=5103-5110&author=Y.+Tangauthor=Y.+Dongauthor=X.+Wangauthor=K.+Sriraghavanauthor=J.+K.+Woodauthor=J.+L.+Vennerstrom&title=Dispiro-1%2C2%2C4-trioxane+analogues+of+a+prototype+dispiro-1%2C2%2C4-trioxolane%3A+mechanistic+comparators+for+artemisinin+in+the+context+of+reaction+pathways+with+iron%28II%29&doi=10.1021%2Fjo050385%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Dispiro-1,2,4-trioxane Analogues of a Prototype Dispiro-1,2,4-trioxolane: Mechanistic Comparators for Artemisinin in the Context of Reaction Pathways with Iron(II)</span></div><div class="casAuthors">Tang, Yuanqing; Dong, Yuxiang; Wang, Xiaofang; Sriraghavan, Kamaraj; Wood, James K.; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5103-5110</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Single electron redn. of the 1,2,4-trioxane heterocycle of artemisinin (I) forms primary and secondary carbon-centered radicals.  The complex structure of I does not lend itself to a satisfactory dissection of the electronic and steric effects that influence the formation and subsequent reaction of these carbon-centered free radicals.  To help demarcate these effects, we characterized the reactions of achiral dispiro-1,2,4-trioxolane II and dispiro-1,2,4-trioxanes III (X = O, Y = CH2; X = CH2, Y = O) and IV with ferrous bromide and 4-oxo-TEMPO.  Our results suggest a small preference for attack of Fe(II) on the nonketal peroxide oxygen atom of I.  For II , but not for III, there was a strong preference for attack of Fe(II) on the less hindered peroxide bond oxygen atom.  The steric hindrance afforded by a spiroadamantane in a five-membered trioxolane is evidently much greater than that for a corresponding six-membered trioxane.  Unlike I, III and IV fragment by entropically favored β-scission pathways forming relatively stable α-oxa carbon-centered radicals.  These data suggest that formation of either primary or secondary carbon-centered radicals is a necessary but insufficient criterion for antimalarial activity of I and synthetic peroxides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkp2I-noVZcLVg90H21EOLACvtfcHk0lh4wxb6flRafw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVWjt7w%253D&md5=2901899c9c998ed80e9403f7d9e4b24b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo050385%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050385%252B%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSriraghavan%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BK.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DDispiro-1%252C2%252C4-trioxane%2520analogues%2520of%2520a%2520prototype%2520dispiro-1%252C2%252C4-trioxolane%253A%2520mechanistic%2520comparators%2520for%2520artemisinin%2520in%2520the%2520context%2520of%2520reaction%2520pathways%2520with%2520iron%2528II%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D5103%26epage%3D5110%26doi%3D10.1021%2Fjo050385%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiaffo, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">Spiroadamantyl 1,2,4-trioxolane, 1,2,4-trioxane, and 1,2,4-trioxepane pairs: relationship between peroxide bond iron(II) reactivity, heme alkylation efficiency, and antimalarial activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4542</span><span class="NLM_x">–</span> <span class="NLM_lpage">4545</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2Fj.bmcl.2009.07.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4542-4545&author=X.+Wangauthor=D.+J.+Creekauthor=C.+E.+Schiaffoauthor=Y.+Dongauthor=J.+Cholletauthor=C.+Scheurerauthor=S.+Wittlinauthor=S.+A.+Charmanauthor=P.+H.+Dussaultauthor=J.+K.+Woodauthor=J.+L.+Vennerstrom&title=Spiroadamantyl+1%2C2%2C4-trioxolane%2C+1%2C2%2C4-trioxane%2C+and+1%2C2%2C4-trioxepane+pairs%3A+relationship+between+peroxide+bond+iron%28II%29+reactivity%2C+heme+alkylation+efficiency%2C+and+antimalarial+activity&doi=10.1016%2Fj.bmcl.2009.07.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DSchiaffo%26aufirst%3DC.%2BE.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDussault%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DJ.%2BK.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DSpiroadamantyl%25201%252C2%252C4-trioxolane%252C%25201%252C2%252C4-trioxane%252C%2520and%25201%252C2%252C4-trioxepane%2520pairs%253A%2520relationship%2520between%2520peroxide%2520bond%2520iron%2528II%2529%2520reactivity%252C%2520heme%2520alkylation%2520efficiency%252C%2520and%2520antimalarial%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4542%26epage%3D4545%26doi%3D10.1016%2Fj.bmcl.2009.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fontaine, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dipasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Efficient and Stereocontrolled Synthesis of 1,2,4-trioxolanes useful for ferrous iron-dependent drug delivery</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5776</span><span class="NLM_x">–</span> <span class="NLM_lpage">5779</span><span class="refDoi"> DOI: 10.1021/ol5028392</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5028392" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOlurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=5776-5779&author=S.+D.+Fontaineauthor=A.+G.+Dipasqualeauthor=A.+R.+Renslo&title=Efficient+and+Stereocontrolled+Synthesis+of+1%2C2%2C4-trioxolanes+useful+for+ferrous+iron-dependent+drug+delivery&doi=10.1021%2Fol5028392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and Stereocontrolled Synthesis of 1,2,4-Trioxolanes Useful for Ferrous Iron-Dependent Drug Delivery</span></div><div class="casAuthors">Fontaine, Shaun D.; DiPasquale, Antonio G.; Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5776-5779</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ferrous iron-promoted redn. of a hindered peroxide bond underlies the antimalarial action of the 1,2,4-trioxane artemisinin and the 1,2,4-trioxolane arterolane.  In appropriately designed systems, a 1,2,4-trioxolane ring can serve as a trigger to realize ferrous iron-dependent and parasite-selective drug delivery, both in vitro and in vivo.  A stereocontrolled, expeditious (three steps), and efficient (67-71% overall yield) synthesis of 1,2,4-trioxolanes, e.g., I possessing the requisite 3'' substitution pattern that enables ferrous iron-dependent drug delivery is reported.  The key synthetic step involves a diastereoselective Griesbaum co-ozonolysis reaction to afford primarily products with a trans relationship between the 3'' substituent and the peroxide bridge, as confirmed by X-ray structural anal. of a 3''-substituted 4-nitrobenzoate analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofRW_OGGkPS7Vg90H21EOLACvtfcHk0lhspQKi3sMUig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOlurvE&md5=960d52771a3c0b91d4fc3b07c2d4a0ba</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fol5028392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5028392%26sid%3Dliteratum%253Aachs%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DDipasquale%26aufirst%3DA.%2BG.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DEfficient%2520and%2520Stereocontrolled%2520Synthesis%2520of%25201%252C2%252C4-trioxolanes%2520useful%2520for%2520ferrous%2520iron-dependent%2520drug%2520delivery%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D5776%26epage%3D5779%26doi%3D10.1021%2Fol5028392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Fontaine, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauterwasser, E. M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Drug delivery to the malaria parasite using an arterolane-like scaffold</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1002/cmdc.201402362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1002%2Fcmdc.201402362" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=47-51&author=S.+D.+Fontaineauthor=B.+Spanglerauthor=J.+Gutauthor=E.+M.+W.+Lauterwasserauthor=P.+J.+Rosenthalauthor=A.+R.+Renslo&title=Drug+delivery+to+the+malaria+parasite+using+an+arterolane-like+scaffold&doi=10.1002%2Fcmdc.201402362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402362%26sid%3Dliteratum%253Aachs%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DSpangler%26aufirst%3DB.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DLauterwasser%26aufirst%3DE.%2BM.%2BW.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DDrug%2520delivery%2520to%2520the%2520malaria%2520parasite%2520using%2520an%2520arterolane-like%2520scaffold%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D47%26epage%3D51%26doi%3D10.1002%2Fcmdc.201402362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Mahajan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauterwasser, E. M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyva, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">A fragmenting hybrid approach for targeted delivery of multiple therapeutic agents to the malaria parasite</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1002/cmdc.201100002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1002%2Fcmdc.201100002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=21360816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFCjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=415-419&author=S.+S.+Mahajanauthor=E.+Deuauthor=E.+M.+W.+Lauterwasserauthor=M.+J.+Leyvaauthor=J.+A.+Ellmanauthor=M.+Bogyoauthor=A.+R.+Renslo&title=A+fragmenting+hybrid+approach+for+targeted+delivery+of+multiple+therapeutic+agents+to+the+malaria+parasite&doi=10.1002%2Fcmdc.201100002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A fragmenting hybrid approach for targeted delivery of multiple therapeutic agents to the malaria parasite</span></div><div class="casAuthors">Mahajan, Sumit S.; Deu, Edgar; Lauterwasser, Erica M. W.; Leyva, Melissa J.; Ellman, Jonathan A.; Bogyo, Matthew; Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">415-419</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Artemisinin combination therapies (ACT) represent the current std. of care in the treatment of uncomplicated malaria.  The authors set out to explore a single-mol. fragmenting hybrid strategy in which an artemisinin-like peroxide is employed to deliver a partner drug, only upon activation by ferrous iron in the parasite.  Thus, the authors prepd. artemisinin deriv.-ML4118S (DPAP1 inhibitor) hybrid with a carbamate, and demonstrated the successful release of the potent and irreversible ML4118S from the fragmenting hybrid in living parasites (P. falciparum).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofwQpt2b-28LVg90H21EOLACvtfcHk0lhspQKi3sMUig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFCjsL0%253D&md5=81cbc03fa36f85d472abd776309d0cf4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100002%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DS.%2BS.%26aulast%3DDeu%26aufirst%3DE.%26aulast%3DLauterwasser%26aufirst%3DE.%2BM.%2BW.%26aulast%3DLeyva%26aufirst%3DM.%2BJ.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DA%2520fragmenting%2520hybrid%2520approach%2520for%2520targeted%2520delivery%2520of%2520multiple%2520therapeutic%2520agents%2520to%2520the%2520malaria%2520parasite%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D415%26epage%3D419%26doi%3D10.1002%2Fcmdc.201100002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Deu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauterwasser, E. M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valderramos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgington, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span> </span><span class="NLM_article-title">Ferrous iron-dependent drug delivery enables controlled and selective release of therapeutic agents in vivo</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">18244</span><span class="NLM_x">–</span> <span class="NLM_lpage">18249</span><span class="refDoi"> DOI: 10.1073/pnas.1312782110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1073%2Fpnas.1312782110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=18244-18249&author=E.+Deuauthor=I.+T.+Chenauthor=E.+M.+W.+Lauterwasserauthor=J.+Valderramosauthor=H.+Liauthor=L.+E.+Edgingtonauthor=A.+R.+Rensloauthor=M.+Bogyo&title=Ferrous+iron-dependent+drug+delivery+enables+controlled+and+selective+release+of+therapeutic+agents+in+vivo&doi=10.1073%2Fpnas.1312782110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1312782110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1312782110%26sid%3Dliteratum%253Aachs%26aulast%3DDeu%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DI.%2BT.%26aulast%3DLauterwasser%26aufirst%3DE.%2BM.%2BW.%26aulast%3DValderramos%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DEdgington%26aufirst%3DL.%2BE.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DFerrous%2520iron-dependent%2520drug%2520delivery%2520enables%2520controlled%2520and%2520selective%2520release%2520of%2520therapeutic%2520agents%2520in%2520vivo%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D18244%26epage%3D18249%26doi%3D10.1073%2Fpnas.1312782110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lauterwasser, E. M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katneni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Trioxolane-mediated delivery of mefloquine limits brain exposure in a mouse model of malaria</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1149</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1145-1149&author=E.+M.+W.+Lauterwasserauthor=S.+D.+Fontaineauthor=H.+Liauthor=J.+Gutauthor=K.+Katneniauthor=S.+A.+Charmanauthor=P.+J.+Rosenthalauthor=M.+Bogyoauthor=A.+R.+Renslo&title=Trioxolane-mediated+delivery+of+mefloquine+limits+brain+exposure+in+a+mouse+model+of+malaria&doi=10.1021%2Facsmedchemlett.5b00296"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00296%26sid%3Dliteratum%253Aachs%26aulast%3DLauterwasser%26aufirst%3DE.%2BM.%2BW.%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DTrioxolane-mediated%2520delivery%2520of%2520mefloquine%2520limits%2520brain%2520exposure%2520in%2520a%2520mouse%2520model%2520of%2520malaria%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D1145%26epage%3D1149%26doi%3D10.1021%2Facsmedchemlett.5b00296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Spangler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vander Wal, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">A reactivity-based probe of the intracellular labile ferrous iron pool</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span><span class="refDoi"> DOI: 10.1038/nchembio.2116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnchembio.2116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=27376690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKntLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=680-685&author=B.+Spanglerauthor=C.+W.+Morganauthor=S.+D.+Fontaineauthor=M.+N.+Vander+Walauthor=C.+J.+Changauthor=J.+A.+Wellsauthor=A.+R.+Renslo&title=A+reactivity-based+probe+of+the+intracellular+labile+ferrous+iron+pool&doi=10.1038%2Fnchembio.2116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A reactivity-based probe of the intracellular labile ferrous iron pool</span></div><div class="casAuthors">Spangler, Benjamin; Morgan, Charles W.; Fontaine, Shaun D.; Vander Wal, Mark N.; Chang, Christopher J.; Wells, James A.; Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">680-685</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Improved methods for studying intracellular reactive Fe(II) are of significant interest for studies of iron metab. and disease-relevant changes in iron homeostasis.  Here we describe a highly selective reactivity-based probe in which a Fenton-type reaction with intracellular labile Fe(II) leads to unmasking of the aminonucleoside puromycin.  Puromycin leaves a permanent and dose-dependent mark on treated cells that can be detected with high sensitivity and precision using a high-content, plate-based immunofluorescence assay.  Using this new probe and screening approach, we detected alteration of cellular labile Fe(II) in response extracellular iron conditioning, overexpression of iron storage and/or export proteins, and post-translational regulation of iron export.  We also used this new tool to demonstrate that labile Fe(II) pools are larger in cancer cells than in nontumorigenic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJOkZyEdhXbbVg90H21EOLACvtfcHk0lhKkX6C4waFqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKntLfO&md5=3f09730054cfb57e487ca7fc48e41a19</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2116%26sid%3Dliteratum%253Aachs%26aulast%3DSpangler%26aufirst%3DB.%26aulast%3DMorgan%26aufirst%3DC.%2BW.%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DVander%2BWal%26aufirst%3DM.%2BN.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DA%2520reactivity-based%2520probe%2520of%2520the%2520intracellular%2520labile%2520ferrous%2520iron%2520pool%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D680%26epage%3D685%26doi%3D10.1038%2Fnchembio.2116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Odlo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentzen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dit Chabert, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gani, O. A. B. S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylte, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florenes, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, T. V.</span><span> </span><span class="NLM_article-title">1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4829</span><span class="NLM_x">–</span> <span class="NLM_lpage">4838</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.03.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2Fj.bmc.2008.03.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=18396050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=4829-4838&author=K.+Odloauthor=J.+Hentzenauthor=J.+F.+dit+Chabertauthor=S.+Duckiauthor=O.+A.+B.+S.+M.+Ganiauthor=I.+Sylteauthor=M.+Skredeauthor=V.+A.+Florenesauthor=T.+V.+Hansen&title=1%2C5-Disubstituted+1%2C2%2C3-triazoles+as+cis-restricted+analogues+of+combretastatin+A-4%3A+Synthesis%2C+molecular+modeling+and+evaluation+as+cytotoxic+agents+and+inhibitors+of+tubulin&doi=10.1016%2Fj.bmc.2008.03.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin</span></div><div class="casAuthors">Odlo, Kristin; Hentzen, Jean; Fournier, Jeremie; Ducki, Sylvie; Gani, Osman A. B. S. M.; Sylte, Ingebrigt; Skrede, Martina; Florenes, Vivi Ann; Hansen, Trond Vidar</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4829-4838</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of cis-restricted 1,5-disubstituted 1,2,3-triazole analogs of combretastatin A-4 (1) have been prepd.  The triazole 12f, 2-methoxy-5-(1-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-5-yl)aniline, displayed potent cytotoxic activity against several cancer cell lines with IC50 values in the nanomolar range.  The ability of triazoles to inhibit tubulin polymn. has been evaluated, and 12f inhibited tubulin polymn. with IC50 = 4.8 μM.  Mol. modeling expts. involving 12f and the colchicine binding site of α,β-tubulin showed that the triazole moiety interacts with β-tubulin via hydrogen bonding with several amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv-nZt2OlVYrVg90H21EOLACvtfcHk0lhKkX6C4waFqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSqtrk%253D&md5=de08d18064b626f65a8979bdd6e5a85f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.03.049%26sid%3Dliteratum%253Aachs%26aulast%3DOdlo%26aufirst%3DK.%26aulast%3DHentzen%26aufirst%3DJ.%26aulast%3Ddit%2BChabert%26aufirst%3DJ.%2BF.%26aulast%3DDucki%26aufirst%3DS.%26aulast%3DGani%26aufirst%3DO.%2BA.%2BB.%2BS.%2BM.%26aulast%3DSylte%26aufirst%3DI.%26aulast%3DSkrede%26aufirst%3DM.%26aulast%3DFlorenes%26aufirst%3DV.%2BA.%26aulast%3DHansen%26aufirst%3DT.%2BV.%26atitle%3D1%252C5-Disubstituted%25201%252C2%252C3-triazoles%2520as%2520cis-restricted%2520analogues%2520of%2520combretastatin%2520A-4%253A%2520Synthesis%252C%2520molecular%2520modeling%2520and%2520evaluation%2520as%2520cytotoxic%2520agents%2520and%2520inhibitors%2520of%2520tubulin%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D4829%26epage%3D4838%26doi%3D10.1016%2Fj.bmc.2008.03.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Martins, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakshandehroo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jascur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shales, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorrentino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemons, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamji, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogan, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandyopadhyay, S.</span><span> </span><span class="NLM_article-title">Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-14-0552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1158%2F2159-8290.CD-14-0552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=154-167&author=M.+M.+Martinsauthor=A.+Y.+Zhouauthor=A.+Corellaauthor=D.+Horiuchiauthor=C.+Yauauthor=T.+Rakshandehrooauthor=J.+D.+Gordanauthor=R.+S.+Levinauthor=J.+Johnsonauthor=J.+Jascurauthor=M.+Shalesauthor=A.+Sorrentinoauthor=J.+Cheahauthor=P.+A.+Clemonsauthor=A.+F.+Shamjiauthor=S.+L.+Schreiberauthor=N.+J.+Kroganauthor=K.+M.+Shokatauthor=F.+McCormickauthor=A.+Gogaauthor=S.+Bandyopadhyay&title=Linking+tumor+mutations+to+drug+responses+via+a+quantitative+chemical-genetic+interaction+map&doi=10.1158%2F2159-8290.CD-14-0552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-14-0552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-14-0552%26sid%3Dliteratum%253Aachs%26aulast%3DMartins%26aufirst%3DM.%2BM.%26aulast%3DZhou%26aufirst%3DA.%2BY.%26aulast%3DCorella%26aufirst%3DA.%26aulast%3DHoriuchi%26aufirst%3DD.%26aulast%3DYau%26aufirst%3DC.%26aulast%3DRakshandehroo%26aufirst%3DT.%26aulast%3DGordan%26aufirst%3DJ.%2BD.%26aulast%3DLevin%26aufirst%3DR.%2BS.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DJascur%26aufirst%3DJ.%26aulast%3DShales%26aufirst%3DM.%26aulast%3DSorrentino%26aufirst%3DA.%26aulast%3DCheah%26aufirst%3DJ.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DKrogan%26aufirst%3DN.%2BJ.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DGoga%26aufirst%3DA.%26aulast%3DBandyopadhyay%26aufirst%3DS.%26atitle%3DLinking%2520tumor%2520mutations%2520to%2520drug%2520responses%2520via%2520a%2520quantitative%2520chemical-genetic%2520interaction%2520map%26jtitle%3DCancer%2520Discovery%26date%3D2015%26volume%3D5%26spage%3D154%26epage%3D167%26doi%3D10.1158%2F2159-8290.CD-14-0552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Radulescu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgueiro, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgway, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGhee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stones, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tselepis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansom, O. J.</span><span> </span><span class="NLM_article-title">Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2Fj.celrep.2012.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=22884366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCjsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=270-282&author=S.+Radulescuauthor=M.+J.+Brookesauthor=P.+Salgueiroauthor=R.+A.+Ridgwayauthor=E.+McGheeauthor=K.+Andersonauthor=S.+J.+Fordauthor=D.+H.+Stonesauthor=T.+H.+Iqbalauthor=C.+Tselepisauthor=O.+J.+Sansom&title=Luminal+iron+levels+govern+intestinal+tumorigenesis+after+Apc+loss+in+vivo&doi=10.1016%2Fj.celrep.2012.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo</span></div><div class="casAuthors">Radulescu, Sorina; Brookes, Matthew J.; Salgueiro, Pedro; Ridgway, Rachel A.; McGhee, Ewan; Anderson, Kurt; Ford, Samuel J.; Stones, Daniel H.; Iqbal, Tariq H.; Tselepis, Chris; Sansom, Owen J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">270-282</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">It is clear from epidemiol. studies that excess iron is assocd. with increased risk of colorectal cancer; however, questions regarding the mechanism of how iron increases cancer risk, the source of the excess iron (circulating or luminal), and whether iron redn. represents a potential therapeutic option remain unanswered.  In this study, we show that after Apc deletion, the cellular iron acquisition proteins TfR1 and DMT1 are rapidly induced.  Conversely, restoration of APC reduces cellular iron due to repression of these proteins.  To test the functional importance of these findings, we performed in vivo investigations of the impact of iron levels on intestinal tumorigenesis.  Strikingly, depletion of luminal (but not systemic) iron strongly suppressed murine intestinal tumorigenesis, whereas increased luminal iron strongly promoted tumorigenesis.  Taken together, our data definitively delineate iron as a potent modifier of intestinal tumorigenesis and have important implications for dietary iron supplementation in patients at high risk of colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWuYH5lJ7awLVg90H21EOLACvtfcHk0ljnNiRzDvV10w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCjsr%252FP&md5=2f2895e029503b9c26b1a2d32218375d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DRadulescu%26aufirst%3DS.%26aulast%3DBrookes%26aufirst%3DM.%2BJ.%26aulast%3DSalgueiro%26aufirst%3DP.%26aulast%3DRidgway%26aufirst%3DR.%2BA.%26aulast%3DMcGhee%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DFord%26aufirst%3DS.%2BJ.%26aulast%3DStones%26aufirst%3DD.%2BH.%26aulast%3DIqbal%26aufirst%3DT.%2BH.%26aulast%3DTselepis%26aufirst%3DC.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26atitle%3DLuminal%2520iron%2520levels%2520govern%2520intestinal%2520tumorigenesis%2520after%2520Apc%2520loss%2520in%2520vivo%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D2%26spage%3D270%26epage%3D282%26doi%3D10.1016%2Fj.celrep.2012.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Yang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2008.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2Fj.chembiol.2008.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=18355723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Klsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=234-245&author=W.+S.+Yangauthor=B.+R.+Stockwell&title=Synthetic+lethal+screening+identifies+compounds+activating+iron-dependent%2C+nonapoptotic+cell+death+in+oncogenic-RAS-harboring+cancer+cells&doi=10.1016%2Fj.chembiol.2008.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells</span></div><div class="casAuthors">Yang, Wan Seok; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">234-245</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: We screened small mols. to identify two compds., which we named RSL3 (I) and RSL5 (II), that have increased lethality in the presence of oncogenic RAS.  Counter screening with biol. active compds. defined aspects of the mechanism of action for RSL3 and RSL5, such as a nonapoptotic, MEK-dependent, and iron-dependent oxidative cell death.  Erastin, a previously reported compd. with RAS-selective lethality, showed similar properties.  RNA interference expts. targeting voltage-dependent anion channel 3 (VDAC3), a target of erastin, demonstrated that RSL5 is a scaffold that acts through VDACs to activate the obsd. pathway.  RSL3 activated a similar death mechanism but in a VDAC-independent manner.  We found that cells transformed with oncogenic RAS have increased iron content relative to their normal cell counterparts through upregulation of transferrin receptor 1 and downregulation of ferritin heavy chain 1 and ferritin light chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXT1YSFisD5bVg90H21EOLACvtfcHk0ljnNiRzDvV10w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Klsrs%253D&md5=edf260b5dd32621038445ec981d307fb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DSynthetic%2520lethal%2520screening%2520identifies%2520compounds%2520activating%2520iron-dependent%252C%2520nonapoptotic%2520cell%2520death%2520in%2520oncogenic-RAS-harboring%2520cancer%2520cells%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D234%26epage%3D245%26doi%3D10.1016%2Fj.chembiol.2008.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">3642</span><span class="NLM_x">–</span> <span class="NLM_lpage">3649</span><span class="refDoi"> DOI: 10.1073/pnas.92.9.3642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1073%2Fpnas.92.9.3642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=7731958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADyaK2MXlsVSlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=3642-3649&author=D.+L.+Bogerauthor=D.+S.+Johnson&title=CC-1065+and+the+duocarmycins%3A+unraveling+the+keys+to+a+new+class+of+naturally+derived+DNA+alkylating+agents&doi=10.1073%2Fpnas.92.9.3642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents</span></div><div class="casAuthors">Boger, Dale L.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3642-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review, with 97 refs. on key studies defining the DNA alkylation properties and selectivity of a new class of exceptionally potent, naturally occurring antitumor antibiotics including CC-1065, duocarmycin A, and duocarmycin SA.  Recent studies conducted with synthetic agents contg. deep-seated structural changes and the unnatural enantiomers of the natural products and related analogs have defined the structural basis for the sequence-selective alkylation of duplex DNA and fundamental relationships between chem. structure, functional reactivity, and biol. properties.  The agents undergo a reversible, stereoelectronically controlled adenine-N3 addn. to the least substituted carbon of the activated cyclopropane within selected AT-rich sites.  The preferential AT-rich noncovalent binding selectivity of the agents within the narrower, deeper AT-rich minor groove and the steric accessibility to the alkylation site that accompanies deep AT-rich minor groove penetration control the sequence-selective DNA alkylation reaction and stabilize the resulting adduct.  For the agents that possess sufficient reactivity to alkylate DNA, a direct relation between chem. or functional stability and biol. potency has been defined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKRM8k1oAPLbVg90H21EOLACvtfcHk0ljLB9es_znFrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsVSlt7g%253D&md5=8e16def16016d5009b0dc00e59e4c895</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.9.3642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.9.3642%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DCC-1065%2520and%2520the%2520duocarmycins%253A%2520unraveling%2520the%2520keys%2520to%2520a%2520new%2520class%2520of%2520naturally%2520derived%2520DNA%2520alkylating%2520agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D3642%26epage%3D3649%26doi%3D10.1073%2Fpnas.92.9.3642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">A new short synthesis of 3-substituted 5-amino-1-(chloromethyl)-1,2-dihydro-3H-benzo[e]indoles (amino-CBIs)</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">8958</span><span class="NLM_x">–</span> <span class="NLM_lpage">8961</span><span class="refDoi"> DOI: 10.1021/jo0263115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0263115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=8958-8961&author=S.+Yangauthor=W.+A.+Denny&title=A+new+short+synthesis+of+3-substituted+5-amino-1-%28chloromethyl%29-1%2C2-dihydro-3H-benzo%5Be%5Dindoles+%28amino-CBIs%29&doi=10.1021%2Fjo0263115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjo0263115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0263115%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DA%2520new%2520short%2520synthesis%2520of%25203-substituted%25205-amino-1-%2528chloromethyl%2529-1%252C2-dihydro-3H-benzo%255Be%255Dindoles%2520%2528amino-CBIs%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D8958%26epage%3D8961%26doi%3D10.1021%2Fjo0263115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Atwell, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbank, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">5-Amino-1-(chloromethyl)-1,2-dihydro-3H-benz[e]indoles: relationships between structure and cytotoxicity for analogues bearing different DNA minor groove binding subunits</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3400</span><span class="NLM_x">–</span> <span class="NLM_lpage">3411</span><span class="refDoi"> DOI: 10.1021/jm990136b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990136b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3400-3411&author=G.+J.+Atwellauthor=J.+J.+Milbankauthor=W.+R.+Wilsonauthor=A.+Hoggauthor=W.+A.+Denny&title=5-Amino-1-%28chloromethyl%29-1%2C2-dihydro-3H-benz%5Be%5Dindoles%3A+relationships+between+structure+and+cytotoxicity+for+analogues+bearing+different+DNA+minor+groove+binding+subunits&doi=10.1021%2Fjm990136b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm990136b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990136b%26sid%3Dliteratum%253Aachs%26aulast%3DAtwell%26aufirst%3DG.%2BJ.%26aulast%3DMilbank%26aufirst%3DJ.%2BJ.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DHogg%26aufirst%3DA.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3D5-Amino-1-%2528chloromethyl%2529-1%252C2-dihydro-3H-benz%255Be%255Dindoles%253A%2520relationships%2520between%2520structure%2520and%2520cytotoxicity%2520for%2520analogues%2520bearing%2520different%2520DNA%2520minor%2520groove%2520binding%2520subunits%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3400%26epage%3D3411%26doi%3D10.1021%2Fjm990136b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Jeffrey, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torgov, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreyka, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddington, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerveny, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senter, P. D.</span><span> </span><span class="NLM_article-title">Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1344</span><span class="NLM_x">–</span> <span class="NLM_lpage">1358</span><span class="refDoi"> DOI: 10.1021/jm040137q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040137q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVSnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1344-1358&author=S.+C.+Jeffreyauthor=M.+Y.+Torgovauthor=J.+B.+Andreykaauthor=L.+Boddingtonauthor=C.+G.+Cervenyauthor=W.+A.+Dennyauthor=K.+A.+Gordonauthor=D.+Gustinauthor=J.+Haugenauthor=T.+Klineauthor=M.+T.+Nguyenauthor=P.+D.+Senter&title=Design%2C+synthesis%2C+and+in+vitro+evaluation+of+dipeptide-based+antibody+minor+groove+binder+conjugates&doi=10.1021%2Fjm040137q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and in Vitro Evaluation of Dipeptide-Based Antibody Minor Groove Binder Conjugates</span></div><div class="casAuthors">Jeffrey, Scott C.; Torgov, Michael Y.; Andreyka, Jamie B.; Boddington, Laura; Cerveny, Charles G.; Denny, William A.; Gordon, Kristine A.; Gustin, Darin; Haugen, Jennifer; Kline, Toni; Nguyen, Minh T.; Senter, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1344-1358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antibody-drug conjugates (ADCs) were prepd. consisting of DNA minor groove binder drugs (MGBs) attached to monoclonal antibodies (mAbs) through peptide linkers designed to release drugs inside the lysosomes of target cells.  The site of linker attachment on the MGB was at the 5-position on the B-ring, since model studies showed that attachment of an electron-withdrawing group (i.e., acyl, carbamoyl) at this position increased the stability of the mol.  Because of the hydrophobic nature of the MGBs, several measures were required to overcome their tendencies to induce mAb aggregation upon conjugation.  This is exemplified in the series of ADCs contg. the amino-CBI drug (I).  Initial adducts were prepd. using the peptide sequence valine-citrulline, attached to a self-immolative para-aminobenzyl carbamate spacer.  The resulting ADCs were completely aggregated.  Removal of the self-immolative spacer, introduction of a more hydrophilic valine-lysine sequence, and incorporation of a tetraethyleneglycol unit between the mAb and the peptide resulted in conjugates that were nonaggregated, even with as many as eight drugs per mAb.  These results were extended to include the hydroxy aza-CBI drug (II), which was linked to the valine-lysine sequence through a para-aminobenzyl ether self-immolative spacer.  The resulting mAb conjugates were monomeric and released the hydroxy aza-CBI drug upon treatment with human cathepsin B.  In vitro cytotoxicity assays established that the mAb-MGB drug conjugates were highly cytotoxic and effected immunol. specific cell kill at subsaturating doses.  The results provide a general strategy for MGB prodrug design and illustrate the importance of linker hydrophilicity in making nonaggregated, active mAb-MGB conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojSaAmWEWKcbVg90H21EOLACvtfcHk0ljLB9es_znFrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVSnu7k%253D&md5=bd19b623b875301786914e3b958247c7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm040137q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040137q%26sid%3Dliteratum%253Aachs%26aulast%3DJeffrey%26aufirst%3DS.%2BC.%26aulast%3DTorgov%26aufirst%3DM.%2BY.%26aulast%3DAndreyka%26aufirst%3DJ.%2BB.%26aulast%3DBoddington%26aufirst%3DL.%26aulast%3DCerveny%26aufirst%3DC.%2BG.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DGordon%26aufirst%3DK.%2BA.%26aulast%3DGustin%26aufirst%3DD.%26aulast%3DHaugen%26aufirst%3DJ.%26aulast%3DKline%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DM.%2BT.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520in%2520vitro%2520evaluation%2520of%2520dipeptide-based%2520antibody%2520minor%2520groove%2520binder%2520conjugates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1344%26epage%3D1358%26doi%3D10.1021%2Fjm040137q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">McGovren, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKoning, T. F.</span><span> </span><span class="NLM_article-title">Preliminary toxicity studies with the DNA-binding antibiotic, CC-1065</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.7164/antibiotics.37.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.7164%2Fantibiotics.37.63" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1984&pages=63-70&author=J.+P.+McGovrenauthor=G.+L.+Clarkeauthor=E.+A.+Prattauthor=T.+F.+DeKoning&title=Preliminary+toxicity+studies+with+the+DNA-binding+antibiotic%2C+CC-1065&doi=10.7164%2Fantibiotics.37.63"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.37.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.37.63%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovren%26aufirst%3DJ.%2BP.%26aulast%3DClarke%26aufirst%3DG.%2BL.%26aulast%3DPratt%26aufirst%3DE.%2BA.%26aulast%3DDeKoning%26aufirst%3DT.%2BF.%26atitle%3DPreliminary%2520toxicity%2520studies%2520with%2520the%2520DNA-binding%2520antibiotic%252C%2520CC-1065%26jtitle%3DJ.%2520Antibiot.%26date%3D1984%26volume%3D37%26spage%3D63%26epage%3D70%26doi%3D10.7164%2Fantibiotics.37.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Markovic, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suman, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vukov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillman, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberts, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braich, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitch, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creagan, E. T.</span><span> </span><span class="NLM_article-title">Phase II trial of KW2189 in patients with advanced malignant melanoma</span> <span class="citation_source-journal">Am. J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1097/00000421-200206000-00022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1097%2F00000421-200206000-00022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=12040295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A280%3ADC%252BD38zisFynsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=308-312&author=S.+N.+Markovicauthor=V.+J.+Sumanauthor=A.+M.+Vukovauthor=T.+R.+Fitchauthor=D.+W.+Hillmanauthor=A.+A.+Adjeiauthor=S.+R.+Albertsauthor=J.+S.+Kaurauthor=T.+A.+Braichauthor=J.+M.+Leitchauthor=E.+T.+Creagan&title=Phase+II+trial+of+KW2189+in+patients+with+advanced+malignant+melanoma&doi=10.1097%2F00000421-200206000-00022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of KW2189 in patients with advanced malignant melanoma</span></div><div class="casAuthors">Markovic Svetomir N; Suman Vera J; Vukov Allen M; Fitch Tom R; Hillman David W; Adjei Alex A; Alberts Steven R; Kaur Judith S; Braich Theodore A; Leitch John M; Creagan Edward T</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-12</span>
        ISSN:<span class="NLM_cas:issn">0277-3732</span>.
    </div><div class="casAbstract">KW-2189, a semisynthetic duocarmycine antibiotic has been shown to exert antiproliferative effects against human tumor cell lines in vitro and animal tumor models in vivo.  Phase I studies identified myelosuppression as the most noteworthy adverse effect.  Presented are two concurrent phase II studies assessing the antitumor and toxicity profile of KW-2189 in metastatic melanoma patients.  One of the studies accrued patients with a history of prior melanoma therapy and the other accrued patients without a history of prior melanoma therapy.  KW-2189 was administered at 0.4 mg/m2 to previously treated patients and 0.5 mg/m2 to the previously untreated.  Treatment was administered intravenously on day 1 of a 6-week cycle.  Thirty previously untreated and 15 previously treated patients were accrued.  The toxicity profiles of the both groups of patients were similar.  Of the 15 previously treated patients, 8 completed once cycle of treatment, 2 completed 2 cycles, and 5 completed 3 cycles.  Dose modification for neutropenia/ thrombocytopenia was necessary in six patients.  Among the previously untreated cohort (30 patients), 16 completed 1 cycle, 5 completed 2 cycles, 4 completed 3 cycles, 3 completed 4 cycles, and 2 completed 6 cycles.  Doses were modified (neutropenia or thrombocytopenia) in 11 patients.  None of the 15 previously treated patients responded to therapy.  Four patients remained stable during two cycles.  Five of the previously untreated patients achieved a partial remission/regression.  Response duration ranged from 2.8 to 16.6 months.  Overall objective response rate was 17%.  Regarding survival, one previously treated patient is still alive 2.9 years after study entry, and three previously untreated patients are still alive 1.6, 2.3, and 2.9 years after study entry.  The 1-year survival rate for previously treated patients is 27% and for the untreated patients is 23%.  In summary, the lack of significant antitumor activity of KW-2189 and its associated toxicity suggest that further testing of this regimen in patients with stage IV melanoma is not warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSvdwC6qOSWOvW160gIxP_fW6udTcc2eZHQ1LC3b5NN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zisFynsw%253D%253D&md5=0af88af2e707ebed278c745db165c8c1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1097%2F00000421-200206000-00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000421-200206000-00022%26sid%3Dliteratum%253Aachs%26aulast%3DMarkovic%26aufirst%3DS.%2BN.%26aulast%3DSuman%26aufirst%3DV.%2BJ.%26aulast%3DVukov%26aufirst%3DA.%2BM.%26aulast%3DFitch%26aufirst%3DT.%2BR.%26aulast%3DHillman%26aufirst%3DD.%2BW.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DAlberts%26aufirst%3DS.%2BR.%26aulast%3DKaur%26aufirst%3DJ.%2BS.%26aulast%3DBraich%26aufirst%3DT.%2BA.%26aulast%3DLeitch%26aufirst%3DJ.%2BM.%26aulast%3DCreagan%26aufirst%3DE.%2BT.%26atitle%3DPhase%2520II%2520trial%2520of%2520KW2189%2520in%2520patients%2520with%2520advanced%2520malignant%2520melanoma%26jtitle%3DAm.%2520J.%2520Clin.%2520Oncol.%26date%3D2002%26volume%3D25%26spage%3D308%26epage%3D312%26doi%3D10.1097%2F00000421-200206000-00022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Genomics and the second golden era of cancer drug development</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1039/b501751n</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1039%2Fb501751n" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=16948194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslelsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=17-26&author=P.+Workman&title=Genomics+and+the+second+golden+era+of+cancer+drug+development&doi=10.1039%2Fb501751n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Genomics and the second golden era of cancer drug development</span></div><div class="casAuthors">Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-26</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The first golden era of cancer drug development was initiated in the 1940s and gave rise to the cytotoxic agents that dominate current cancer medicine.  The second golden era is now underway in which cancer genomics will direct drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOzn_xJLTRp7Vg90H21EOLACvtfcHk0lhmB0Gnx7n8rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslelsrg%253D&md5=4c9d39b781fa0b7a0f786f9cc3f7ee10</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fb501751n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb501751n%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DGenomics%2520and%2520the%2520second%2520golden%2520era%2520of%2520cancer%2520drug%2520development%26jtitle%3DMol.%2520BioSyst.%26date%3D2005%26volume%3D1%26spage%3D17%26epage%3D26%26doi%3D10.1039%2Fb501751n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">The DNA damage response and cancer therapy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">481</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1038/nature10760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnature10760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=22258607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1GmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=481&publication_year=2012&pages=287-294&author=C.+J.+Lordauthor=A.+Ashworth&title=The+DNA+damage+response+and+cancer+therapy&doi=10.1038%2Fnature10760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The DNA damage response and cancer therapy</span></div><div class="casAuthors">Lord, Christopher J.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">481</span>
        (<span class="NLM_cas:issue">7381</span>),
    <span class="NLM_cas:pages">287-294</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genomic instability is one of the most pervasive characteristics of tumor cells and is probably the combined effect of DNA damage, tumor-specific DNA repair defects, and a failure to stop or stall the cell cycle before the damaged DNA is passed on to daughter cells.  Although these processes drive genomic instability and ultimately the disease process, they also provide therapeutic opportunities.  A better understanding of the cellular response to DNA damage will not only inform our knowledge of cancer development but also help to refine the classification as well as the treatment of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUS1sAbqFhmrVg90H21EOLACvtfcHk0lhmB0Gnx7n8rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1GmsQ%253D%253D&md5=75d12cdb52e8c9a39bced1611bf90298</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnature10760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10760%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DThe%2520DNA%2520damage%2520response%2520and%2520cancer%2520therapy%26jtitle%3DNature%26date%3D2012%26volume%3D481%26spage%3D287%26epage%3D294%26doi%3D10.1038%2Fnature10760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Taylor, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childress-Fields, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeoman, L. C.</span><span> </span><span class="NLM_article-title">Sensitivity of nuclear c-Myc levels and induction to differentiation-inducing agents in human colon tumor cell lines</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/0304-3835(92)90179-Y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2F0304-3835%2892%2990179-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1540946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADyaK38Xitlaqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1992&pages=95-105&author=C.+W.+Taylorauthor=Y.+S.+Kimauthor=K.+E.+Childress-Fieldsauthor=L.+C.+Yeoman&title=Sensitivity+of+nuclear+c-Myc+levels+and+induction+to+differentiation-inducing+agents+in+human+colon+tumor+cell+lines&doi=10.1016%2F0304-3835%2892%2990179-Y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon tumor cell lines</span></div><div class="casAuthors">Taylor, C. W.; Kim, Y. S.; Childress-Fields, K. E.; Yeoman, L. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    </div><div class="casAbstract">Six human colon tumor cell lines were analyzed for their constitutive levels of the c-myc protein.  The nuclear proto-oncogene, c-myc, was detected as an expressed product in all of the human colon tumor cell lines analyzed.  The poorly differentiated cell lines HCT116, RKO and C showed c-myc levels that averaged 2-fold greater than their well-differentiated counterparts, i.e., GEO, CBS and FET.  When c-myc levels and responses to serum induction were analyzed in the presence of inducers of differentiation, i.e., DMF, retinoic acid, sodium butyrate, and TGF-β, distinct patterns of sensitivity and resistance emerged.  Nuclear c-myc levels were reduced in all the colon cell phenotypes treated with DMF or sodium butyrate.  Only the well differentiated human colon tumor cell lines were responsive to transforming growth factor-β.  Only one of the human colon tumor cell lines (GEO) responded to retinoic acid.  Increased levels of c-myc protein were found to correlate well with greater growth rates and with poor differentiation class.  Similarly, a parallel sensitivity to down-regulation of c-myc levels and attenuation of c-myc induction curves for inducers of differentiation were obsd. in growth-sensitive human colon tumor cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo23xasBXdVLVg90H21EOLACvtfcHk0lhlfOtV1Rvelw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlaqs7w%253D&md5=f9b8fee32f2c2b6dc8190313d40ce68e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0304-3835%2892%2990179-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3835%252892%252990179-Y%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DC.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DChildress-Fields%26aufirst%3DK.%2BE.%26aulast%3DYeoman%26aufirst%3DL.%2BC.%26atitle%3DSensitivity%2520of%2520nuclear%2520c-Myc%2520levels%2520and%2520induction%2520to%2520differentiation-inducing%2520agents%2520in%2520human%2520colon%2520tumor%2520cell%2520lines%26jtitle%3DCancer%2520Lett.%26date%3D1992%26volume%3D62%26spage%3D95%26epage%3D105%26doi%3D10.1016%2F0304-3835%2892%2990179-Y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Horiuchi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goga, A.</span><span> </span><span class="NLM_article-title">Taking on Challenging Targets: Making Myc druggable</span> <span class="citation_source-journal">Am. Soc. Clin. Oncol. Educ. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">e497</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.14694/EdBook_AM.2014.34.e497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.14694%2FEdBook_AM.2014.34.e497" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=e497-502&author=D.+Horiuchiauthor=B.+Andertonauthor=A.+Goga&title=Taking+on+Challenging+Targets%3A+Making+Myc+druggable&doi=10.14694%2FEdBook_AM.2014.34.e497"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.14694%2FEdBook_AM.2014.34.e497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14694%252FEdBook_AM.2014.34.e497%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DD.%26aulast%3DAnderton%26aufirst%3DB.%26aulast%3DGoga%26aufirst%3DA.%26atitle%3DTaking%2520on%2520Challenging%2520Targets%253A%2520Making%2520Myc%2520druggable%26jtitle%3DAm.%2520Soc.%2520Clin.%2520Oncol.%2520Educ.%2520B%26date%3D2014%26volume%3D34%26spage%3De497%26epage%3D502%26doi%3D10.14694%2FEdBook_AM.2014.34.e497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Brian R. Blank, Poulami Talukder, Ryan K. Muir, Erin R. Green, Eric P. Skaar, <span class="NLM_string-name hlFld-ContribAuthor">Adam R. Renslo</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Mobilization of Ferrous Iron in Pseudomonas aeruginosa Infection with an Iron(II)-Caged LpxC Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (8)
                                     , 1366-1375. <a href="https://doi.org/10.1021/acsinfecdis.9b00057" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00057%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DTargeting%252BMobilization%252Bof%252BFerrous%252BIron%252Bin%252BPseudomonas%252Baeruginosa%252BInfection%252Bwith%252Ban%252BIron%252528II%252529-Caged%252BLpxC%252BInhibitor%26aulast%3DBlank%26aufirst%3DBrian%2BR.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12022019%26date%3D11062019%26date%3D29052019%26volume%3D5%26issue%3D8%26spage%3D1366%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ryan K. Muir, Ning Zhao, Junnian Wei, Yung-hua Wang, Anna Moroz, Yangjie Huang, Ying-Chu Chen, Renuka Sriram, John Kurhanewicz, Davide Ruggero, Adam R. Renslo, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Evans</span>. </span><span class="cited-content_cbyCitation_article-title">Measuring Dynamic Changes in the Labile Iron Pool in Vivo with a Reactivity-Based Probe for Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2019,</strong> <em>5 </em>
                                    (4)
                                     , 727-736. <a href="https://doi.org/10.1021/acscentsci.9b00240" title="DOI URL">https://doi.org/10.1021/acscentsci.9b00240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.9b00240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.9b00240%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DMeasuring%252BDynamic%252BChanges%252Bin%252Bthe%252BLabile%252BIron%252BPool%252Bin%252BVivo%252Bwith%252Ba%252BReactivity-Based%252BProbe%252Bfor%252BPositron%252BEmission%252BTomography%26aulast%3DMuir%26aufirst%3DRyan%2BK.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07032019%26date%3D03042019%26volume%3D5%26issue%3D4%26spage%3D727%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benjamin Spangler, Toni Kline, Jeffrey Hanson, Xiaofan Li, Sihong Zhou, James A. Wells, Aaron K. Sato, <span class="NLM_string-name hlFld-ContribAuthor">Adam R. Renslo</span>. </span><span class="cited-content_cbyCitation_article-title">Toward a Ferrous Iron-Cleavable Linker for Antibody–Drug Conjugates. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (5)
                                     , 2054-2059. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00242" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00242%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DToward%252Ba%252BFerrous%252BIron-Cleavable%252BLinker%252Bfor%252BAntibody%2525E2%252580%252593Drug%252BConjugates%26aulast%3DSpangler%26aufirst%3DBenjamin%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06032018%26date%3D18032018%26date%3D23032018%26volume%3D15%26issue%3D5%26spage%3D2054%26epage%3D2059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moana  Tercel</span>, <span class="hlFld-ContribAuthor ">Ho H.  Lee</span>, <span class="hlFld-ContribAuthor ">Sunali Y.  Mehta</span>, <span class="hlFld-ContribAuthor ">Jean-Jacques  Youte Tendoung</span>, <span class="hlFld-ContribAuthor ">Sally Y.  Bai</span>, <span class="hlFld-ContribAuthor ">H. D. Sarath  Liyanage</span>, and <span class="hlFld-ContribAuthor ">Frederik B.  Pruijn</span>  . </span><span class="cited-content_cbyCitation_article-title">Influence of a Basic Side Chain on the Properties of Hypoxia-Selective Nitro Analogues of the Duocarmycins: Demonstration of Substantial Anticancer Activity in Combination with Irradiation or Chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5834-5856. <a href="https://doi.org/10.1021/acs.jmedchem.7b00563" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00563%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInfluence%252Bof%252Ba%252BBasic%252BSide%252BChain%252Bon%252Bthe%252BProperties%252Bof%252BHypoxia-Selective%252BNitro%252BAnalogues%252Bof%252Bthe%252BDuocarmycins%25253A%252BDemonstration%252Bof%252BSubstantial%252BAnticancer%252BActivity%252Bin%252BCombination%252Bwith%252BIrradiation%252Bor%252BChemotherapy%26aulast%3DTercel%26aufirst%3DMoana%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D11042017%26date%3D23062017%26date%3D13072017%26volume%3D60%26issue%3D13%26spage%3D5834%26epage%3D5856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Su</span>, <span class="hlFld-ContribAuthor ">Dian  Xiao</span>, <span class="hlFld-ContribAuthor ">Fei  Xie</span>, <span class="hlFld-ContribAuthor ">Lianqi  Liu</span>, <span class="hlFld-ContribAuthor ">Yanming  Wang</span>, <span class="hlFld-ContribAuthor ">Shiyong  Fan</span>, <span class="hlFld-ContribAuthor ">Xinbo  Zhou</span>, <span class="hlFld-ContribAuthor ">Song  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody–drug conjugates: Recent advances in linker chemistry. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.1016/j.apsb.2021.03.042" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.042%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DAntibody%2525E2%252580%252593drug%252Bconjugates%25253A%252BRecent%252Badvances%252Bin%252Blinker%252Bchemistry%26aulast%3DSu%26aufirst%3DZheng%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoë  Jukes</span>, <span class="hlFld-ContribAuthor ">Goreti Ribeiro  Morais</span>, <span class="hlFld-ContribAuthor ">Paul M.  Loadman</span>, <span class="hlFld-ContribAuthor ">Klaus  Pors</span>. </span><span class="cited-content_cbyCitation_article-title">How can the potential of the duocarmycins be unlocked for cancer therapy?. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>26 </em>
                                    (2)
                                     , 577-584. <a href="https://doi.org/10.1016/j.drudis.2020.11.020" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.11.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.11.020%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DHow%252Bcan%252Bthe%252Bpotential%252Bof%252Bthe%252Bduocarmycins%252Bbe%252Bunlocked%252Bfor%252Bcancer%252Btherapy%25253F%26aulast%3DJukes%26aufirst%3DZo%25C3%25AB%26date%3D2021%26volume%3D26%26issue%3D2%26spage%3D577%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan L.  Gonciarz</span>, <span class="hlFld-ContribAuthor ">Eric A.  Collisson</span>, <span class="hlFld-ContribAuthor ">Adam R.  Renslo</span>. </span><span class="cited-content_cbyCitation_article-title">Ferrous Iron-Dependent Pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (1)
                                     , 7-18. <a href="https://doi.org/10.1016/j.tips.2020.11.003" title="DOI URL">https://doi.org/10.1016/j.tips.2020.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2020.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2020.11.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DFerrous%252BIron-Dependent%252BPharmacology%26aulast%3DGonciarz%26aufirst%3DRyan%2BL.%26date%3D2021%26volume%3D42%26issue%3D1%26spage%3D7%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Grignano</span>, <span class="hlFld-ContribAuthor ">Rudy  Birsen</span>, <span class="hlFld-ContribAuthor ">Nicolas  Chapuis</span>, <span class="hlFld-ContribAuthor ">Didier  Bouscary</span>. </span><span class="cited-content_cbyCitation_article-title">From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.586530" title="DOI URL">https://doi.org/10.3389/fonc.2020.586530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.586530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.586530%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DFrom%252BIron%252BChelation%252Bto%252BOverload%252Bas%252Ba%252BTherapeutic%252BStrategy%252Bto%252BInduce%252BFerroptosis%252Bin%252BLeukemic%252BCells%26aulast%3DGrignano%26aufirst%3DEric%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rikki A. M.  Brown</span>, <span class="hlFld-ContribAuthor ">Kirsty L.  Richardson</span>, <span class="hlFld-ContribAuthor ">Tasnuva D.  Kabir</span>, <span class="hlFld-ContribAuthor ">Debbie  Trinder</span>, <span class="hlFld-ContribAuthor ">Ruth  Ganss</span>, <span class="hlFld-ContribAuthor ">Peter J.  Leedman</span>. </span><span class="cited-content_cbyCitation_article-title">Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.00476" title="DOI URL">https://doi.org/10.3389/fonc.2020.00476</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.00476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.00476%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DAltered%252BIron%252BMetabolism%252Band%252BImpact%252Bin%252BCancer%252BBiology%25252C%252BMetastasis%25252C%252Band%252BImmunology%26aulast%3DBrown%26aufirst%3DRikki%2BA.%2BM.%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shumon  Koga</span>, <span class="hlFld-ContribAuthor ">Miroslav  Krstic</span>. </span><span class="cited-content_cbyCitation_article-title">Open Problems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 299-311. <a href="https://doi.org/10.1007/978-3-030-58490-0_12" title="DOI URL">https://doi.org/10.1007/978-3-030-58490-0_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-58490-0_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-58490-0_12%26sid%3Dliteratum%253Aachs%26atitle%3DOpen%252BProblems%26aulast%3DKoga%26aufirst%3DShumon%26date%3D2020%26date%3D2020%26spage%3D299%26epage%3D311%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DMaterials%252BPhase%252BChange%252BPDE%252BControl%252B%252526%252BEstimation%26aulast%3DKoga%26aufirst%3DShumon%26date%3D2020%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Z.  Bayat</span>, <span class="hlFld-ContribAuthor ">A.  Gholizadeh</span>. </span><span class="cited-content_cbyCitation_article-title">Calculations of Geometric Parameters and Physicochemical Properties of Complexes Formed of FE(II)-Reactive 1,2,4-Trioxolane Ring and Some Anti-Malaria Drugs Via Traceless Linker. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Chemistry Journal</span><span> <strong>2019,</strong> <em>53 </em>
                                    (5)
                                     , 411-418. <a href="https://doi.org/10.1007/s11094-019-02012-0" title="DOI URL">https://doi.org/10.1007/s11094-019-02012-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11094-019-02012-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11094-019-02012-0%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Chemistry%2520Journal%26atitle%3DCalculations%252Bof%252BGeometric%252BParameters%252Band%252BPhysicochemical%252BProperties%252Bof%252BComplexes%252BFormed%252Bof%252BFE%252528II%252529-Reactive%252B1%25252C2%25252C4-Trioxolane%252BRing%252Band%252BSome%252BAnti-Malaria%252BDrugs%252BVia%252BTraceless%252BLinker%26aulast%3DBayat%26aufirst%3DZ.%26date%3D2019%26date%3D2019%26volume%3D53%26issue%3D5%26spage%3D411%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Zhang</span>, <span class="hlFld-ContribAuthor ">Balakrishna  Moku</span>, <span class="hlFld-ContribAuthor ">Jing  Leng</span>, <span class="hlFld-ContribAuthor ">K. P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">2-Azidoethane-1-sulfonylfluoride (ASF): A Versatile
              Bis
              -clickable Reagent for SuFEx and CuAAC Click Reactions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (8)
                                     , 1763-1769. <a href="https://doi.org/10.1002/ejoc.201801825" title="DOI URL">https://doi.org/10.1002/ejoc.201801825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201801825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201801825%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D2-Azidoethane-1-sulfonylfluoride%252B%252528ASF%252529%25253A%252BA%252BVersatile%252BBis%252B-clickable%252BReagent%252Bfor%252BSuFEx%252Band%252BCuAAC%252BClick%252BReactions%26aulast%3DZhang%26aufirst%3DXu%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D8%26spage%3D1763%26epage%3D1769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Zhang</span>, <span class="hlFld-ContribAuthor ">K. P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-metal-free regioselective construction of 1,5-diaryl-1,2,3-triazoles through dehydrative cycloaddition of alcohols with aryl azides mediated by SO
              2
              F
              2. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (19)
                                     , 2845-2848. <a href="https://doi.org/10.1039/C8CC09693G" title="DOI URL">https://doi.org/10.1039/C8CC09693G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC09693G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC09693G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTransition-metal-free%252Bregioselective%252Bconstruction%252Bof%252B1%25252C5-diaryl-1%25252C2%25252C3-triazoles%252Bthrough%252Bdehydrative%252Bcycloaddition%252Bof%252Balcohols%252Bwith%252Baryl%252Bazides%252Bmediated%252Bby%252BSO%252B2%252BF%252B2%26aulast%3DZhang%26aufirst%3DXu%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D19%26spage%3D2845%26epage%3D2848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Coghi</span>, <span class="hlFld-ContribAuthor ">Ivan A.  Yaremenko</span>, <span class="hlFld-ContribAuthor ">Parichat  Prommana</span>, <span class="hlFld-ContribAuthor ">Peter S.  Radulov</span>, <span class="hlFld-ContribAuthor ">Mikhail A.  Syroeshkin</span>, <span class="hlFld-ContribAuthor ">Yu Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Jia Ying  Gao</span>, <span class="hlFld-ContribAuthor ">Floria M.  Gordillo</span>, <span class="hlFld-ContribAuthor ">Simon  Mok</span>, <span class="hlFld-ContribAuthor ">Vincent Kam Wai  Wong</span>, <span class="hlFld-ContribAuthor ">Chairat  Uthaipibull</span>, <span class="hlFld-ContribAuthor ">Alexander O.  Terent'ev</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Peroxides as Promising Anticancer Agents with Unexpected Depressed Antimalarial Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (9)
                                     , 902-908. <a href="https://doi.org/10.1002/cmdc.201700804" title="DOI URL">https://doi.org/10.1002/cmdc.201700804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700804%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNovel%252BPeroxides%252Bas%252BPromising%252BAnticancer%252BAgents%252Bwith%252BUnexpected%252BDepressed%252BAntimalarial%252BActivity%26aulast%3DCoghi%26aufirst%3DPaolo%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D9%26spage%3D902%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael M.  Gaschler</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Andia</span>, <span class="hlFld-ContribAuthor ">Hengrui  Liu</span>, <span class="hlFld-ContribAuthor ">Joleen M.  Csuka</span>, <span class="hlFld-ContribAuthor ">Brisa  Hurlocker</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Vaiana</span>, <span class="hlFld-ContribAuthor ">Daniel W.  Heindel</span>, <span class="hlFld-ContribAuthor ">Dylan S.  Zuckerman</span>, <span class="hlFld-ContribAuthor ">Pieter H.  Bos</span>, <span class="hlFld-ContribAuthor ">Eduard  Reznik</span>, <span class="hlFld-ContribAuthor ">Ling F.  Ye</span>, <span class="hlFld-ContribAuthor ">Yulia Y.  Tyurina</span>, <span class="hlFld-ContribAuthor ">Annie J.  Lin</span>, <span class="hlFld-ContribAuthor ">Mikhail S.  Shchepinov</span>, <span class="hlFld-ContribAuthor ">Amy Y.  Chan</span>, <span class="hlFld-ContribAuthor ">Eveliz  Peguero-Pereira</span>, <span class="hlFld-ContribAuthor ">Maksim A.  Fomich</span>, <span class="hlFld-ContribAuthor ">Jacob. D.  Daniels</span>, <span class="hlFld-ContribAuthor ">Andrei V.  Bekish</span>, <span class="hlFld-ContribAuthor ">Vadim V.  Shmanai</span>, <span class="hlFld-ContribAuthor ">Valerian E.  Kagan</span>, <span class="hlFld-ContribAuthor ">Lara K.  Mahal</span>, <span class="hlFld-ContribAuthor ">K. A.  Woerpel</span>, <span class="hlFld-ContribAuthor ">Brent R.  Stockwell</span>. </span><span class="cited-content_cbyCitation_article-title">FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2018,</strong> <em>14 </em>
                                    (5)
                                     , 507-515. <a href="https://doi.org/10.1038/s41589-018-0031-6" title="DOI URL">https://doi.org/10.1038/s41589-018-0031-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-018-0031-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-018-0031-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DFINO2%252Binitiates%252Bferroptosis%252Bthrough%252BGPX4%252Binactivation%252Band%252Biron%252Boxidation%26aulast%3DGaschler%26aufirst%3DMichael%2BM.%26date%3D2018%26date%3D2018%26volume%3D14%26issue%3D5%26spage%3D507%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allegra T.  Aron</span>, <span class="hlFld-ContribAuthor ">Marie C.  Heffern</span>, <span class="hlFld-ContribAuthor ">Zachery R.  Lonergan</span>, <span class="hlFld-ContribAuthor ">Mark N.  Vander Wal</span>, <span class="hlFld-ContribAuthor ">Brian R.  Blank</span>, <span class="hlFld-ContribAuthor ">Benjamin  Spangler</span>, <span class="hlFld-ContribAuthor ">Yaofang  Zhang</span>, <span class="hlFld-ContribAuthor ">Hyo Min  Park</span>, <span class="hlFld-ContribAuthor ">Andreas  Stahl</span>, <span class="hlFld-ContribAuthor ">Adam R.  Renslo</span>, <span class="hlFld-ContribAuthor ">Eric P.  Skaar</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo bioluminescence imaging of labile iron accumulation in a murine model of
              Acinetobacter baumannii
              infection. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2017,</strong> <em>114 </em>
                                    (48)
                                     , 12669-12674. <a href="https://doi.org/10.1073/pnas.1708747114" title="DOI URL">https://doi.org/10.1073/pnas.1708747114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1708747114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1708747114%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DIn%252Bvivo%252Bbioluminescence%252Bimaging%252Bof%252Blabile%252Biron%252Baccumulation%252Bin%252Ba%252Bmurine%252Bmodel%252Bof%252BAcinetobacter%252Bbaumannii%252Binfection%26aulast%3DAron%26aufirst%3DAllegra%2BT.%26date%3D2017%26date%3D2017%26volume%3D114%26issue%3D48%26spage%3D12669%26epage%3D12674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Ni</span>, <span class="hlFld-ContribAuthor ">Wen-Jun  Zeng</span>, <span class="hlFld-ContribAuthor ">Xin  Xie</span>, <span class="hlFld-ContribAuthor ">Ze-Lin  Chen</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>, <span class="hlFld-ContribAuthor ">Chang-Min  Yu</span>, <span class="hlFld-ContribAuthor ">Bo-Wen  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Intracellular enzyme-activatable prodrug for real-time monitoring of chlorambucil delivery and imaging. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2017,</strong> <em>28 </em>
                                    (6)
                                     , 1345-1351. <a href="https://doi.org/10.1016/j.cclet.2017.04.024" title="DOI URL">https://doi.org/10.1016/j.cclet.2017.04.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2017.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2017.04.024%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DIntracellular%252Benzyme-activatable%252Bprodrug%252Bfor%252Breal-time%252Bmonitoring%252Bof%252Bchlorambucil%252Bdelivery%252Band%252Bimaging%26aulast%3DNi%26aufirst%3DMeng%26date%3D2017%26volume%3D28%26issue%3D6%26spage%3D1345%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mechanism of iron(II)-dependent payload release from 1,2,4-trioxolane conjugates. Iron(II)-promoted Fenton-type reduction of the trioxolane ring affords the cyclohexanone species shown which then undergoes spontaneous β-elimination and decarboxylation to release free payload. This process occurs with high efficiency and ferrous-iron selectivity in mammalian cancer cell lines, as described recently.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Exploiting augmented ferrous iron pools for selective drug delivery. (a) Chemical structure of microtubule inhibitor <b>1</b> and corresponding conjugates and controls <b>2</b>–<b>4</b>. (b) Cytotoxicity of compounds <b>1</b>–<b>4</b> in MDA-MB-231 cells after 24 h of exposure as determined by cell counting (<i>n</i> = 3; error bar, mean ± SEM). (c) Cytotoxicity of <b>1</b> and its trioxolane-conjugate <b>2</b> after 24 h of exposure in MDA-MB-231 and MCF10A cells as determined by cell counting (<i>n</i> = 3; error bar, mean ± SEM). The shift in EC<sub>50</sub> value for <b>1</b> and its trioxolane conjugate <b>2</b> is illustrated. Dividing the EC<sub>50</sub> value for <b>1</b> by that for <b>2</b> in a given cell line produces an “EC<sub>50</sub> ratio” that is used to compare the efficiency of drug release across cell lines. This ratio is 0.54 for sensitive MDA-MB-231 cells (2-fold EC<sub>50</sub> shift) and 0.04 for relatively resistant, nontumorigenic MCF10A cells (25-fold EC<sub>50</sub> shift). (d) EC<sub>50</sub> ratios calculated as described in (c) for a small panel of cell lines. Error bars represent SEM from three individual experiments each conducted in biological triplicates. (e) EC<sub>50</sub> ratios for an expanded panel of mammalian cell lines. The EC<sub>50</sub> values for <b>1</b> and <b>2</b> were determined after a 72 h incubation using the CellTiter-Glo cell viability assay. Error bars represent SEM (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Profiling the effects of oncogenic transformation on the ferrous iron pool of MCF10A cells. (a) Relative mRNA levels for ferroportin, ferritin, and the ferrireductase STEAP3 in MCF10A cells stably transfected with empty vector (control) or with vectors expressing the oncogenes Myc or Hras (<i>n</i> = 3; error bar, mean ± SEM; (∗∗) <i>P</i> ≤ 0.01, (∗∗∗∗) <i>P</i> ≤ 0.0001, two-way ANOVA with Dunnett’s multiple comparisons test). (b) EC<sub>50</sub> ratio (<b>1</b>/<b>2</b>) for MCF10A cells stably transfected with HRas or cMyc oncogenes or the empty vector (control) as assessed by cell counting after 24 h of compound exposure. Error bars represent SEM from three independent experiments each conducted in biological triplicates ((∗∗) <i>P</i> ≤ 0.01, one-way ANOVA with Dunnett’s multiple comparisons test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures and in vitro activity of trioxolane–duocarmycin conjugates. (a) Structure of duocarmycin type DNA-alkylator <i>seco</i>-<b>5</b> (latent form), the corresponding activated form <b>5</b> that reacts with nucleophilic bases of DNA (:Nu), trioxolane–duocarmycin conjugate <b>6</b>, and negative control dioxolane-conjugate <b>7</b>. (b) Cytotoxicity of compounds <b>5</b> and <b>6</b> in PC-3 cells after 72 h of exposure as determined by cell counting (<i>n</i> = 3; error bar, mean ± SEM). (c) Cytotoxicity of compounds <b>5</b> and <b>6</b> in MDA-MB-231 cells after 72 h of exposure as determined by cell counting (<i>n</i> = 3; error bar, mean ± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Pharmacokinetic profile and in vivo tolerability of <b>5</b> and its trioxolane conjugate <b>6</b>. (a) Plasma concentrations of <b>5</b> in female NSG mice following a single 0.3 mg/kg ip dose. Three mice were sampled at each time point. (b) Plasma concentrations of <b>6</b>, released <b>5</b>, and the retro-Michael intermediate <b>16</b> in female NSG mice following a single 7.5 mg/kg ip dose of <b>6</b>. An authentic sample of <b>16</b> was synthesized as described in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf" class="ext-link">Supporting Information</a>. The study design and numbers of mice per group were the same as in (a). (c) Measured levels of alkaline phosphatase (Alk. Phosp.), serum alanine aminotransferases (ALT), aspartate aminotransferase (AST), and creatine phosphokinase (CPK) in blood samples from mice treated with either <b>5</b> (0.3 mg/kg) or trioxolane-conjugate <b>6</b> (7.5 mg/kg). (d) Microscopic histology stains of representative mouse liver samples show only mildly increased reactive changes in the group receiving 0.3 mg/kg <b>5</b>, including minimally increased lobular lymphohistiocytic infiltrates. In mice receiving the higher 7.5 mg/kg dose of <b>6</b> (right column), only mild simple steatosis was detected. Top two rows of images show representative H&E sections of centrizonal or periportal areas. Bottom row of images show representative trichrome stains for evaluation of relative fibrosis, which shows no significant fibrosis; scale bars are in μm as indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/medium/jm-2016-01470e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Efficacy of <b>5</b> and <b>6</b> in mouse xenograft models. (a) Changes in tumor volume over time as determined by calipers in MDA-MB-231 xenograft bearing female SCID-beige mice treated with the indicated doses of <b>5</b> or <b>6</b> via ip administration on a Q4d dosing schedule (3 total doses) as compared to mice treated with vehicle. Error bars represent SEM from dosing cohorts of 8 mice per condition. (b) Changes in mouse weight over time for the mice in (a). (c) Changes in tumor volume over time as determined by calipers in PC-3 xenograft bearing female nude mice (NCR nu/nu, Taconic) treated with the indicated doses of <b>5</b> or <b>6</b> via ip administration on a Q4d dosing schedule (3 total doses) as compared to mice treated with vehicle. Mice treated with the highest dose of <b>6</b> (15 mg/kg, orange line) received three ip doses on a Q7d schedule. Error bars represent SEM from dosing cohorts of 8 mice per condition. (d) Changes in mouse weight over time for the mice in (c).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-24/acs.jmedchem.6b01470/20161223/images/large/jm-2016-01470e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01470&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lorusso, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bever, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malburg, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span> </span><span class="NLM_article-title">Phase I study of folate conjugate EC145 (vintafolide) in patients with refractory solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4011</span><span class="NLM_x">–</span> <span class="NLM_lpage">4016</span><span class="refDoi"> DOI: 10.1200/JCO.2011.41.4946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1200%2FJCO.2011.41.4946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=23032618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FitFCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=4011-4016&author=P.+M.+Lorussoauthor=M.+J.+Edelmanauthor=S.+L.+Beverauthor=K.+M.+Formanauthor=M.+Pilatauthor=M.+F.+Quinnauthor=J.+Liauthor=E.+I.+Heathauthor=L.+M.+Malburgauthor=P.+J.+Kleinauthor=C.+P.+Leamonauthor=R.+A.+Messmannauthor=E.+A.+Sausville&title=Phase+I+study+of+folate+conjugate+EC145+%28vintafolide%29+in+patients+with+refractory+solid+tumors&doi=10.1200%2FJCO.2011.41.4946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumors</span></div><div class="casAuthors">Lorusso Patricia M; Edelman Martin J; Bever Susan L; Forman Karen M; Pilat Maryjo; Quinn Mary F; Li Jing; Heath Elisabeth I; Malburg Lisa M; Klein Patrick J; Leamon Christopher P; Messmann Richard A; Sausville Edward A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4011-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  EC145 (vintafolide), a conjugate of folic acid and the vinca alkaloid desacetylvinblastine hydrazide (DAVLBH), is a ligand for the folate receptor (FR), with activity against FR-positive tumor xenografts in vivo.  This phase I study determined the maximum-tolerated dose (MTD) of EC145 administered as a bolus intravenous injection or 1-hour infusion in patients with refractory solid tumors.  PATIENTS AND METHODS:  EC145 was administered as a bolus injection or 1-hour infusion on days 1, 3, and 5 and days 15, 17, and 19 of each 28-day cycle with dose escalation in cohorts of three to six patients until the MTD was identified.  Plasma pharmacokinetics were determined on days 1 and 3 of the first cycle.  RESULTS:  The MTD of EC145 was 2.5 mg when administered as either a bolus injection or 1-hour infusion.  Constipation was the dose-limiting toxicity with both routes.  Constipation, nausea, fatigue, and vomiting were the most commonly reported adverse events.  One partial response to therapy was observed in a patient with metastatic ovarian cancer.  CONCLUSION:  EC145 administered by bolus injection or as a 1-hour infusion at a dose of 2.5 mg on days 1, 3, and 5 and days 15, 17, and 19 of a 28-day cycle has an acceptable safety profile in patients with advanced cancer.  On the basis of these findings, phase II studies of EC145 have been initiated in patients with advanced epithelial ovarian cancer and non-small-cell lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTgjStBWJ3DPJQHPYJuLg8TfW6udTcc2ebXGceOMa0OZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FitFCrsA%253D%253D&md5=cfbc76346785033ebb51e7cf4494cd68</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1200%2FJCO.2011.41.4946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2011.41.4946%26sid%3Dliteratum%253Aachs%26aulast%3DLorusso%26aufirst%3DP.%2BM.%26aulast%3DEdelman%26aufirst%3DM.%2BJ.%26aulast%3DBever%26aufirst%3DS.%2BL.%26aulast%3DForman%26aufirst%3DK.%2BM.%26aulast%3DPilat%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DM.%2BF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHeath%26aufirst%3DE.%2BI.%26aulast%3DMalburg%26aufirst%3DL.%2BM.%26aulast%3DKlein%26aufirst%3DP.%2BJ.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DMessmann%26aufirst%3DR.%2BA.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DPhase%2520I%2520study%2520of%2520folate%2520conjugate%2520EC145%2520%2528vintafolide%2529%2520in%2520patients%2520with%2520refractory%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D30%26spage%3D4011%26epage%3D4016%26doi%3D10.1200%2FJCO.2011.41.4946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Beck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, J. M.</span><span> </span><span class="NLM_article-title">Antibody-drug conjugates: present and future</span> <span class="citation_source-journal">MAbs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.4161/mabs.27436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.4161%2Fmabs.27436" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=15-17&author=A.+Beckauthor=J.+M.+Reichert&title=Antibody-drug+conjugates%3A+present+and+future&doi=10.4161%2Fmabs.27436"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4161%2Fmabs.27436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fmabs.27436%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DA.%26aulast%3DReichert%26aufirst%3DJ.%2BM.%26atitle%3DAntibody-drug%2520conjugates%253A%2520present%2520and%2520future%26jtitle%3DMAbs.%26date%3D2014%26volume%3D6%26spage%3D15%26epage%3D17%26doi%3D10.4161%2Fmabs.27436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kratz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryppa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnecke, A.</span><span> </span><span class="NLM_article-title">Prodrug strategies in anticancer chemotherapy</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1002/cmdc.200700159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1002%2Fcmdc.200700159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=17963208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1KqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=20-53&author=F.+Kratzauthor=I.+A.+M%C3%BCllerauthor=C.+Ryppaauthor=A.+Warnecke&title=Prodrug+strategies+in+anticancer+chemotherapy&doi=10.1002%2Fcmdc.200700159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrug strategies in anticancer chemotherapy</span></div><div class="casAuthors">Kratz, Felix; Mueller, Ivonne A.; Ryppa, Claudia; Warnecke, Andre</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-53</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The majority of clin. approved anticancer drugs are characterized by a narrow therapeutic window that results mainly from a high systemic toxicity of the drugs in combination with an evident lack of tumor selectivity.  Besides the development of suitable galenic formulations such as liposomes or micelles, several promising prodrug approaches have been followed in the last decades with the aim of improving chemotherapy.  In this review we elucidate the two main concepts that underlie the design of most anticancer prodrugs: drug targeting and controlled release of the drug at the tumor site.  Consequently, active and passive targeting using tumor-specific ligands or macromol. carriers are discussed as well as release strategies that are based on tumor-specific characteristics such as low pH or the expression of tumor-assocd. enzymes.  Furthermore, other strategies such as ADEPT (antibody-directed enzyme prodrug therapy) and the design of self-eliminating structures are introduced.  Chem. realization of prodrug approaches is illustrated by drug candidates that have or may have clin. importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7KWHTS-qaUbVg90H21EOLACvtfcHk0lh6Z7BCIyaslA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1KqsrY%253D&md5=1f43c66a71a6291f392f01cc73380479</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700159%26sid%3Dliteratum%253Aachs%26aulast%3DKratz%26aufirst%3DF.%26aulast%3DM%25C3%25BCller%26aufirst%3DI.%2BA.%26aulast%3DRyppa%26aufirst%3DC.%26aulast%3DWarnecke%26aufirst%3DA.%26atitle%3DProdrug%2520strategies%2520in%2520anticancer%2520chemotherapy%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D20%26epage%3D53%26doi%3D10.1002%2Fcmdc.200700159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Brown, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccia, A. J.</span><span> </span><span class="NLM_article-title">The unique physiology of solid tumors: opportunities (and problems) for cancer therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1408</span><span class="NLM_x">–</span> <span class="NLM_lpage">1416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=9537241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A280%3ADyaK1c7ps1Ggsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=1408-1416&author=J.+M.+Brownauthor=A.+J.+Giaccia&title=The+unique+physiology+of+solid+tumors%3A+opportunities+%28and+problems%29+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The unique physiology of solid tumors: opportunities (and problems) for cancer therapy</span></div><div class="casAuthors">Brown J M; Giaccia A J</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1408-16</span>
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">The physiology of solid tumors differs from that of normal tissues in a number of important aspects, the majority of which stem from differences between the two vasculatures.  Compared with the regular, ordered vasculature of normal tissues, blood vessels in tumors are often highly abnormal, distended capillaries with leaky walls and sluggish flow.  Tumor growth also requires continuous new vessel growth, or angiogenesis.  These physiological differences can be problems for cancer treatment; for example, hypoxia in solid tumors leads to resistance to radiotherapy and to some anticancer drugs.  However, these differences can also be exploited for selective cancer treatment.  Here we review four such areas that are under active investigation: (a) hypoxia-selective cytotoxins take advantage of the unique low oxygen tension in the majority of human solid tumors.  Tirapazamine, a drug in the final stages of clinical trials, is one of the more promising of these agents; (b) leaky tumor blood vessels can be exploited using liposomes that have been sterically stabilized to have a long intravascular half-life, allowing them to selectively accumulate in solid tumors; (c) the tumor microenvironment is a stimulus to angiogenenesis, and inhibition of angiogenesis can be a powerful anticancer therapy not susceptible to acquired drug resistance; and (d) we discuss attempts to use gene therapy activated either by the low oxygen environment or by necrotic regions of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbGK72nOV2SmPgL4LrC-0VfW6udTcc2eYtWAk-d0dP17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7ps1Ggsw%253D%253D&md5=dda0dfcc02cdcf971a6754b04dcc1a1a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520unique%2520physiology%2520of%2520solid%2520tumors%253A%2520opportunities%2520%2528and%2520problems%2529%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D1408%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Brown, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, W. R.</span><span> </span><span class="NLM_article-title">Exploiting tumour hypoxia in cancer treatment</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1038/nrc1367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnrc1367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=15170446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVaisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=437-447&author=J.+M.+Brownauthor=W.+R.+Wilson&title=Exploiting+tumour+hypoxia+in+cancer+treatment&doi=10.1038%2Fnrc1367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting tumor hypoxia in cancer treatment</span></div><div class="casAuthors">Brown, J. Martin; Wilson, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">437-447</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Solid tumors contain regions at very low oxygen concns. (hypoxia), often surrounding areas of necrosis.  The cells in these hypoxic regions are resistant to both radiotherapy and chemotherapy.  However, the existence of hypoxia and necrosis also provides an opportunity for tumor-selective therapy, including prodrugs activated by hypoxia, hypoxia-specific gene therapy, targeting the hypoxia-inducible factor 1 transcription factor, and recombinant anaerobic bacteria.  These strategies could turn what is now an impediment into a significant advantage for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy-CURLXLUoLVg90H21EOLACvtfcHk0lh6Z7BCIyaslA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVaisbs%253D&md5=25e29e73de40c207277fe8b61a19e675</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc1367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1367%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26atitle%3DExploiting%2520tumour%2520hypoxia%2520in%2520cancer%2520treatment%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D437%26epage%3D447%26doi%3D10.1038%2Fnrc1367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Torti, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torti, F. M.</span><span> </span><span class="NLM_article-title">Iron and cancer: more ore to be mined</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1038/nrc3495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnrc3495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=23594855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvF2isL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=342-355&author=S.+V.+Tortiauthor=F.+M.+Torti&title=Iron+and+cancer%3A+more+ore+to+be+mined&doi=10.1038%2Fnrc3495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Iron and cancer: more ore to be mined</span></div><div class="casAuthors">Torti, Suzy V.; Torti, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">342-355</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Iron is an essential nutrient that facilitates cell proliferation and growth.  However, iron also has the capacity to engage in redox cycling and free radical formation.  Therefore, iron can contribute to both tumor initiation and tumor growth; recent work has also shown that iron has a role in the tumor microenvironment and in metastasis.  Pathways of iron acquisition, efflux, storage and regulation are all perturbed in cancer, suggesting that reprogramming of iron metab. is a central aspect of tumor cell survival.  Signalling through hypoxia-inducible factor (HIF) and WNT pathways may contribute to altered iron metab. in cancer.  Targeting iron metabolic pathways may provide new tools for cancer prognosis and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo77TD3b0CvrVg90H21EOLACvtfcHk0li8HZE_-0uKmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvF2isL8%253D&md5=9d950f3dab0010974d1ef25f8c9c1733</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrc3495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3495%26sid%3Dliteratum%253Aachs%26aulast%3DTorti%26aufirst%3DS.%2BV.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26atitle%3DIron%2520and%2520cancer%253A%2520more%2520ore%2520to%2520be%2520mined%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D342%26epage%3D355%26doi%3D10.1038%2Fnrc3495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chaturvedi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goswami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saikia, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barua, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. G.</span><span> </span><span class="NLM_article-title">Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span><span class="refDoi"> DOI: 10.1039/B816679J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1039%2FB816679J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=20111769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1WltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=435-454&author=D.+Chaturvediauthor=A.+Goswamiauthor=P.+P.+Saikiaauthor=N.+C.+Baruaauthor=P.+G.+Rao&title=Artemisinin+and+its+derivatives%3A+a+novel+class+of+anti-malarial+and+anti-cancer+agents&doi=10.1039%2FB816679J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents</span></div><div class="casAuthors">Chaturvedi, Devdutt; Goswami, Abhishek; Pratim Saikia, Partha; Barua, Nabin C.; Rao, Paruchuri G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">435-454</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this tutorial review, an effort towards presentation of a comprehensive account of the recent developments on various kinds of artemisinin derivs. including artemisinin dimers, trimers and tetramers has been made and their efficacy towards malaria parasites and different cancer cells lines was compared with that of artemisinins, and various other anti-malarial and anti-cancer drugs.  It is expected that this review will provide first-hand information on artemisinin chem. to org./medicinal chemists, and pharmacologists working on anticancer and anti-malarial drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIvZuubFYF1rVg90H21EOLACvtfcHk0li8HZE_-0uKmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1WltLg%253D&md5=57707fe746adeda3ef58828da251c8d3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2FB816679J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB816679J%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DD.%26aulast%3DGoswami%26aufirst%3DA.%26aulast%3DSaikia%26aufirst%3DP.%2BP.%26aulast%3DBarua%26aufirst%3DN.%2BC.%26aulast%3DRao%26aufirst%3DP.%2BG.%26atitle%3DArtemisinin%2520and%2520its%2520derivatives%253A%2520a%2520novel%2520class%2520of%2520anti-malarial%2520and%2520anti-cancer%2520agents%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2010%26volume%3D39%26spage%3D435%26epage%3D454%26doi%3D10.1039%2FB816679J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">O’Neill, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posner, G. H.</span><span> </span><span class="NLM_article-title">A medicinal chemistry perspective on artemisinin and related endoperoxides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2945</span><span class="NLM_x">–</span> <span class="NLM_lpage">2964</span><span class="refDoi"> DOI: 10.1021/jm030571c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030571c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVSgsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2945-2964&author=P.+M.+O%E2%80%99Neillauthor=G.+H.+Posner&title=A+medicinal+chemistry+perspective+on+artemisinin+and+related+endoperoxides&doi=10.1021%2Fjm030571c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemistry Perspective on Artemisinin and Related Endoperoxides</span></div><div class="casAuthors">O'Neill, Paul M.; Posner, Gary H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2945-2964</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on aspects of the chem., mechanism of action, metab., and toxicity of the endoperoxide class of antimalarial drugs with a focus on lead compds. (semisynthetic and synthetic) that have emerged as potential next-generation analogs.  The authors also briefly cover artemisinin combination therapy (ACT) of malaria and discuss the potential of drug hybrids and prodrugs as new approaches to delivering combination chemotherapy through a sing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH6vj_Dt15orVg90H21EOLACvtfcHk0li8HZE_-0uKmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVSgsrc%253D&md5=d39dbc04bfb86ab753bbe96d52411070</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm030571c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030571c%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DPosner%26aufirst%3DG.%2BH.%26atitle%3DA%2520medicinal%2520chemistry%2520perspective%2520on%2520artemisinin%2520and%2520related%2520endoperoxides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2945%26epage%3D2964%26doi%3D10.1021%2Fjm030571c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mercer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copple, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. K.</span><span> </span><span class="NLM_article-title">The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span><span class="refDoi"> DOI: 10.1074/jbc.M110.144188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1074%2Fjbc.M110.144188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=987-996&author=A.+E.+Mercerauthor=I.+M.+Coppleauthor=J.+L.+Maggsauthor=P.+M.+O%E2%80%99Neillauthor=B.+K.+Park&title=The+role+of+heme+and+the+mitochondrion+in+the+chemical+and+molecular+mechanisms+of+mammalian+cell+death+induced+by+the+artemisinin+antimalarials&doi=10.1074%2Fjbc.M110.144188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.144188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.144188%26sid%3Dliteratum%253Aachs%26aulast%3DMercer%26aufirst%3DA.%2BE.%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DThe%2520role%2520of%2520heme%2520and%2520the%2520mitochondrion%2520in%2520the%2520chemical%2520and%2520molecular%2520mechanisms%2520of%2520mammalian%2520cell%2520death%2520induced%2520by%2520the%2520artemisinin%2520antimalarials%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D987%26epage%3D996%26doi%3D10.1074%2Fjbc.M110.144188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Mercer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadwick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. K.</span><span> </span><span class="NLM_article-title">Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">9372</span><span class="NLM_x">–</span> <span class="NLM_lpage">9382</span><span class="refDoi"> DOI: 10.1074/jbc.M610375200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1074%2Fjbc.M610375200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=9372-9382&author=A.+E.+Mercerauthor=J.+L.+Maggsauthor=X.-M.+Sunauthor=G.+M.+Cohenauthor=J.+Chadwickauthor=P.+M.+O%E2%80%99Neillauthor=B.+K.+Park&title=Evidence+for+the+involvement+of+carbon-centered+radicals+in+the+induction+of+apoptotic+cell+death+by+artemisinin+compounds&doi=10.1074%2Fjbc.M610375200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M610375200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M610375200%26sid%3Dliteratum%253Aachs%26aulast%3DMercer%26aufirst%3DA.%2BE.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DSun%26aufirst%3DX.-M.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26aulast%3DChadwick%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DEvidence%2520for%2520the%2520involvement%2520of%2520carbon-centered%2520radicals%2520in%2520the%2520induction%2520of%2520apoptotic%2520cell%2520death%2520by%2520artemisinin%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D9372%26epage%3D9382%26doi%3D10.1074%2Fjbc.M610375200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Dixon, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">The role of iron and reactive oxygen species in cell death</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1038/nchembio.1416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnchembio.1416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=24346035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCjtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=9-17&author=S.+J.+Dixonauthor=B.+R.+Stockwell&title=The+role+of+iron+and+reactive+oxygen+species+in+cell+death&doi=10.1038%2Fnchembio.1416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The role of iron and reactive oxygen species in cell death</span></div><div class="casAuthors">Dixon, Scott J.; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The transition metal, Fe, is essential for life, yet potentially toxic Fe-catalyzed reactive O species (ROS) are unavoidable in an O2-rich environment.  Fe and ROS are increasingly recognized as important initiators and mediators of cell death in a variety of organisms and pathol. situations.  Here, the authors review recent discoveries regarding the mechanism by which Fe and ROS participate in cell death.  The authors describe the different roles of Fe in triggering cell death, targets of Fe-dependent ROS that mediate cell death and a new form of Fe-dependent cell death termed ferroptosis.  Recent advances in understanding the role of Fe and ROS in cell death offer unexpected surprises and suggest new therapeutic avenues to treat cancer, organ damage, and degenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP3ojDaWMX-LVg90H21EOLACvtfcHk0liKWKcyXvmqSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCjtrzO&md5=bc9a0c19f4740dd450e0aa855e4da139</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1416%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DThe%2520role%2520of%2520iron%2520and%2520reactive%2520oxygen%2520species%2520in%2520cell%2520death%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D9%26epage%3D17%26doi%3D10.1038%2Fnchembio.1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Pantopoulos, K.</span><span> </span><span class="NLM_article-title">Iron metabolism and the IRE/IRP regulatory system: an update</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1196/annals.1306.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1196%2Fannals.1306.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=15105251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVOnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1012&publication_year=2004&pages=1-13&author=K.+Pantopoulos&title=Iron+metabolism+and+the+IRE%2FIRP+regulatory+system%3A+an+update&doi=10.1196%2Fannals.1306.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Iron metabolism and the IRE/IRP regulatory system: An update</span></div><div class="casAuthors">Pantopoulos, Kostas</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Cellular iron homeostasis is accomplished by the coordinated regulated expression of the transferrin receptor and ferritin, which mediate iron uptake and storage, resp.  The mechanism is posttranscriptional and involves two cytoplasmic iron regulatory proteins, IRP1 and IRP2.  Under conditions of iron starvation, IRPs stabilize the transferrin receptor and inhibit the translation of ferritin mRNAs by binding to "iron responsive elements" (IREs) within their untranslated regions.  The IRE/IRP system also controls the expression of addnl. IRE-contg. mRNAs, encoding proteins of iron and energy metab.  The activities of IRP1 and IRP2 are regulated by distinct posttranslational mechanisms in response to cellular iron levels.  Thus, in iron-replete cells, IRP1 assembles a cubane iron-sulfur cluster, which prevents IRE binding, while IRP2 undergoes proteasomal degrdn.  IRP1 and IRP2 also respond, albeit differently, to iron-independent signals, such as hydrogen peroxide, hypoxia, or nitric oxide.  Basic principles of the IRE/IRP system and recent advances in understanding the regulation and the function of IRP1 and IRP2 are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI7JVY6X9b7LVg90H21EOLACvtfcHk0liKWKcyXvmqSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVOnu78%253D&md5=454cf46ba6b836d1d5d0d174dccedb69</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1196%2Fannals.1306.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1306.001%26sid%3Dliteratum%253Aachs%26aulast%3DPantopoulos%26aufirst%3DK.%26atitle%3DIron%2520metabolism%2520and%2520the%2520IRE%252FIRP%2520regulatory%2520system%253A%2520an%2520update%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1012%26spage%3D1%26epage%3D13%26doi%3D10.1196%2Fannals.1306.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantopoulos, K.</span><span> </span><span class="NLM_article-title">Regulation of cellular iron metabolism</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1042/BJ20101825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1042%2FBJ20101825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=21348856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVajtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2011&pages=365-381&author=J.+Wangauthor=K.+Pantopoulos&title=Regulation+of+cellular+iron+metabolism&doi=10.1042%2FBJ20101825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of cellular iron metabolism</span></div><div class="casAuthors">Wang, Jian; Pantopoulos, Kostas</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-381</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Iron is an essential but potentially hazardous biometal.  Mammalian cells require sufficient amts. of iron to satisfy metabolic needs or to accomplish specialized functions.  Iron is delivered to tissues by circulating transferrin, a transporter that captures iron released into the plasma mainly from intestinal enterocytes or reticuloendothelial macrophages.  The binding of iron-laden transferrin to the cell-surface transferrin receptor 1 results in endocytosis and uptake of the metal cargo.  Internalized iron is transported to mitochondria for the synthesis of heme or iron-sulfur clusters, which are integral parts of several metalloproteins, and excess iron is stored and detoxified in cytosolic ferritin.  Iron metab. is controlled at different levels and by diverse mechanisms.  The present review summarizes basic concepts of iron transport, use and storage and focuses on the IRE (iron-responsive element)/IRP (iron-regulatory protein) system, a well known post-transcriptional regulatory circuit that not only maintains iron homeostasis in various cell types, but also contributes to systemic iron balance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDvcVkfIpAJLVg90H21EOLACvtfcHk0liKWKcyXvmqSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVajtb8%253D&md5=b7f566a85726694f9921e6eb0a489f15</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2FBJ20101825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20101825%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPantopoulos%26aufirst%3DK.%26atitle%3DRegulation%2520of%2520cellular%2520iron%2520metabolism%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D434%26spage%3D365%26epage%3D381%26doi%3D10.1042%2FBJ20101825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Richardson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponka, P.</span><span> </span><span class="NLM_article-title">The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1331</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/S0304-4157(96)00014-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2FS0304-4157%2896%2900014-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=9325434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADyaK2sXhsFKmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1331&publication_year=1997&pages=1-40&author=D.+R.+Richardsonauthor=P.+Ponka&title=The+molecular+mechanisms+of+the+metabolism+and+transport+of+iron+in+normal+and+neoplastic+cells&doi=10.1016%2FS0304-4157%2896%2900014-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells</span></div><div class="casAuthors">Richardson, Des R.; Ponka, Prem</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Biomembranes</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1331</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-40</span>CODEN:
                <span class="NLM_cas:coden">BRBMC5</span>;
        ISSN:<span class="NLM_cas:issn">0304-4157</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 518 refs.  Topics discussed include iron transport in the serum bound to transferrin; the transferrin receptor; mechanisms of iron uptake by normal and neoplastic cells; pathophysiol. significance of iron uptake mediated by the human melanoma-assocd. tumor antigen, melanotransferrin (p97); intracellular iron metab.; and coordinate regulation of iron uptake storage and utilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3uHZXIV2Ec7Vg90H21EOLACvtfcHk0lifLJLdYomN-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsFKmt7g%253D&md5=9a7860ca58dc4f07ffc35d16d534793d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0304-4157%2896%2900014-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-4157%252896%252900014-7%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26aulast%3DPonka%26aufirst%3DP.%26atitle%3DThe%2520molecular%2520mechanisms%2520of%2520the%2520metabolism%2520and%2520transport%2520of%2520iron%2520in%2520normal%2520and%2520neoplastic%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Biomembr.%26date%3D1997%26volume%3D1331%26spage%3D1%26epage%3D40%26doi%3D10.1016%2FS0304-4157%2896%2900014-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Boult, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bury, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spychal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tselepis, C.</span><span> </span><span class="NLM_article-title">Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-07-1054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1158%2F1078-0432.CCR-07-1054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=18223212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=379-387&author=J.+Boultauthor=K.+Robertsauthor=M.+J.+Brookesauthor=S.+Hughesauthor=J.+P.+Buryauthor=S.+S.+Crossauthor=G.+J.+Andersonauthor=R.+Spychalauthor=T.+Iqbalauthor=C.+Tselepis&title=Overexpression+of+cellular+iron+import+proteins+is+associated+with+malignant+progression+of+esophageal+adenocarcinoma&doi=10.1158%2F1078-0432.CCR-07-1054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Cellular Iron Import Proteins Is Associated with Malignant Progression of Esophageal Adenocarcinoma</span></div><div class="casAuthors">Boult, Jessica; Roberts, Keith; Brookes, Matthew J.; Hughes, Sharon; Bury, Jonathan P.; Cross, Simon S.; Anderson, Gregory J.; Spychal, Robert; Iqbal, Tariq; Tselepis, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-387</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: There is growing evidence that iron is important in esophageal adenocarcinoma, a cancer whose incidence is rising faster than any other in the Western world.  However, how iron mediates carcinogenesis at the mol. level remains unclear.  In this study, we investigated the expression of iron transport proteins involved in cellular iron import, export, and storage in the premalignant lesion Barrett's metaplasia and esophageal adenocarcinoma.  Exptl. Design: Perls' staining was used to examine iron deposition in tissue. mRNA expression in samples of Barrett's metaplasia matched with esophageal adenocarcinoma and samples of Barrett's metaplasia without evidence of adenocarcinoma were examd. by real-time PCR.  Semiquant. immunohistochem. was used to examine cellular localization and protein levels.  The effect of iron loading on cellular proliferation and iron transporter expression was detd. in esophageal cell lines OE33 and SEG-1 using a bromodeoxyuridine assay and real-time PCR, resp.  RESULTS: In the progression of Barrett's metaplasia to adenocarcinoma, there was overexpression of divalent metal transporter 1 (DMT1), transferrin receptor 1, duodenal cytochrome b, ferroportin, and H-ferritin, and these changes were assocd. with increased iron deposition.  Overexpression of DMT1 was further assocd. with metastatic adenocarcinoma.  Iron loading OE33 and SEG-1 cells caused increased cellular proliferation, which was assocd. with increased H-ferritin and decreased transferrin receptor 1 and DMT1 expression.  CONCLUSIONS: Progression to adenocarcinoma is assocd. with increased expression of iron import proteins.  These events culminate in increased intracellular iron and cellular proliferation.  This may represent a novel mechanism of esophageal carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq418Mt92Q23bVg90H21EOLACvtfcHk0lifLJLdYomN-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKitrY%253D&md5=666b13ad311f20ad57e1b3fc8bd8998e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1054%26sid%3Dliteratum%253Aachs%26aulast%3DBoult%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DK.%26aulast%3DBrookes%26aufirst%3DM.%2BJ.%26aulast%3DHughes%26aufirst%3DS.%26aulast%3DBury%26aufirst%3DJ.%2BP.%26aulast%3DCross%26aufirst%3DS.%2BS.%26aulast%3DAnderson%26aufirst%3DG.%2BJ.%26aulast%3DSpychal%26aufirst%3DR.%26aulast%3DIqbal%26aufirst%3DT.%26aulast%3DTselepis%26aufirst%3DC.%26atitle%3DOverexpression%2520of%2520cellular%2520iron%2520import%2520proteins%2520is%2520associated%2520with%2520malignant%2520progression%2520of%2520esophageal%2520adenocarcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D379%26epage%3D387%26doi%3D10.1158%2F1078-0432.CCR-07-1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kakhlon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruenbaum, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabantchik, Z.</span><span> </span><span class="NLM_article-title">Ferritin expression modulates cell cycle dynamics and cell responsiveness to H-ras-induced growth via expansion of the labile iron pool</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span><span class="refDoi"> DOI: 10.1042/bj3630431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1042%2Fbj3630431" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2002&pages=431-436&author=O.+Kakhlonauthor=Y.+Gruenbaumauthor=Z.+Cabantchik&title=Ferritin+expression+modulates+cell+cycle+dynamics+and+cell+responsiveness+to+H-ras-induced+growth+via+expansion+of+the+labile+iron+pool&doi=10.1042%2Fbj3630431"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1042%2Fbj3630431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3630431%26sid%3Dliteratum%253Aachs%26aulast%3DKakhlon%26aufirst%3DO.%26aulast%3DGruenbaum%26aufirst%3DY.%26aulast%3DCabantchik%26aufirst%3DZ.%26atitle%3DFerritin%2520expression%2520modulates%2520cell%2520cycle%2520dynamics%2520and%2520cell%2520responsiveness%2520to%2520H-ras-induced%2520growth%2520via%2520expansion%2520of%2520the%2520labile%2520iron%2520pool%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D363%26spage%3D431%26epage%3D436%26doi%3D10.1042%2Fbj3630431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Pinnix, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Agostino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kute, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willingham, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesfay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torti, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torti, F. M.</span><span> </span><span class="NLM_article-title">Ferroportin and iron regulation in breast cancer progression and prognosis</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">43ra56</span><span class="refDoi"> DOI: 10.1126/scisignal.3001127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1126%2Fscisignal.3001127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=20686179" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=43ra56&author=Z.+K.+Pinnixauthor=L.+D.+Millerauthor=W.+Wangauthor=R.+D%E2%80%99Agostinoauthor=T.+Kuteauthor=M.+C.+Willinghamauthor=H.+Hatcherauthor=L.+Tesfayauthor=G.+Suiauthor=X.+Diauthor=S.+V.+Tortiauthor=F.+M.+Torti&title=Ferroportin+and+iron+regulation+in+breast+cancer+progression+and+prognosis&doi=10.1126%2Fscisignal.3001127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.3001127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.3001127%26sid%3Dliteratum%253Aachs%26aulast%3DPinnix%26aufirst%3DZ.%2BK.%26aulast%3DMiller%26aufirst%3DL.%2BD.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DD%25E2%2580%2599Agostino%26aufirst%3DR.%26aulast%3DKute%26aufirst%3DT.%26aulast%3DWillingham%26aufirst%3DM.%2BC.%26aulast%3DHatcher%26aufirst%3DH.%26aulast%3DTesfay%26aufirst%3DL.%26aulast%3DSui%26aufirst%3DG.%26aulast%3DDi%26aufirst%3DX.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26atitle%3DFerroportin%2520and%2520iron%2520regulation%2520in%2520breast%2520cancer%2520progression%2520and%2520prognosis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D43ra56%26doi%3D10.1126%2Fscisignal.3001127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wu, K.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalla-Favera, R.</span><span> </span><span class="NLM_article-title">Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">676</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span><span class="refDoi"> DOI: 10.1126/science.283.5402.676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1126%2Fscience.283.5402.676" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1999&pages=676-679&author=K.-J.+Wuauthor=A.+Polackauthor=R.+Dalla-Favera&title=Coordinated+regulation+of+iron-controlling+genes%2C+H-ferritin+and+IRP2%2C+by+c-MYC&doi=10.1126%2Fscience.283.5402.676"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.283.5402.676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.283.5402.676%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.-J.%26aulast%3DPolack%26aufirst%3DA.%26aulast%3DDalla-Favera%26aufirst%3DR.%26atitle%3DCoordinated%2520regulation%2520of%2520iron-controlling%2520genes%252C%2520H-ferritin%2520and%2520IRP2%252C%2520by%2520c-MYC%26jtitle%3DScience%26date%3D1999%26volume%3D283%26spage%3D676%26epage%3D679%26doi%3D10.1126%2Fscience.283.5402.676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Toyokuni, S.</span><span> </span><span class="NLM_article-title">Role of iron in carcinogenesis: cancer as a ferrotoxic disease</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1111/j.1349-7006.2008.01001.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1111%2Fj.1349-7006.2008.01001.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=19018762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2009&pages=9-16&author=S.+Toyokuni&title=Role+of+iron+in+carcinogenesis%3A+cancer+as+a+ferrotoxic+disease&doi=10.1111%2Fj.1349-7006.2008.01001.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Role of iron in carcinogenesis: cancer as a ferrotoxic disease</span></div><div class="casAuthors">Toyokuni, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-16</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Iron is abundant universally.  During the evolutionary processes, humans have selected iron as a carrier of oxygen inside the body.  However, iron works as a double-edged sword, and its excess is a risk for cancer, presumably via generation of reactive oxygen species.  Thus far, pathol. conditions such as hemochromatosis, chronic viral hepatitis B and C, exposure to asbestos fibers, as well as endometriosis have been recognized as iron overload-assocd. risks for human cancer.  Indeed, iron is carcinogenic in animal expts.  These reports unexpectedly revealed that there are target genes in iron-induced carcinogenesis and that iron-catalyzed oxidative DNA damage is not random in vivo.  Several iron transporters and hepcidin, a peptide hormone regulating iron metab., were discovered in the past decade.  Furthermore, a recent epidemiol. study reported that iron redn. by phlebotomy decreased cancer risk in the apparently normal population.  These results warrant reconsideration of the role of iron in carcinogenesis and suggest that fine control of body iron stores would be a wise strategy for cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3SZCdLhvdsrVg90H21EOLACvtfcHk0lh7QXg0KTleSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGguro%253D&md5=6e3682d8e895bbc72a1a091ee6ce92e6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.01001.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.01001.x%26sid%3Dliteratum%253Aachs%26aulast%3DToyokuni%26aufirst%3DS.%26atitle%3DRole%2520of%2520iron%2520in%2520carcinogenesis%253A%2520cancer%2520as%2520a%2520ferrotoxic%2520disease%26jtitle%3DCancer%2520Sci.%26date%3D2009%26volume%3D100%26spage%3D9%26epage%3D16%26doi%3D10.1111%2Fj.1349-7006.2008.01001.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Miller, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Agostino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torti, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torti, F. M.</span><span> </span><span class="NLM_article-title">An iron regulatory gene signature predicts outcome in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">6728</span><span class="NLM_x">–</span> <span class="NLM_lpage">6737</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-1870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1158%2F0008-5472.CAN-11-1870" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=6728-6737&author=L.+D.+Millerauthor=L.+G.+Coffmanauthor=J.+W.+Chouauthor=M.+A.+Blackauthor=J.+Berghauthor=R.+D%E2%80%99Agostinoauthor=S.+V.+Tortiauthor=F.+M.+Torti&title=An+iron+regulatory+gene+signature+predicts+outcome+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-11-1870"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-1870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-1870%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BD.%26aulast%3DCoffman%26aufirst%3DL.%2BG.%26aulast%3DChou%26aufirst%3DJ.%2BW.%26aulast%3DBlack%26aufirst%3DM.%2BA.%26aulast%3DBergh%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Agostino%26aufirst%3DR.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26atitle%3DAn%2520iron%2520regulatory%2520gene%2520signature%2520predicts%2520outcome%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D6728%26epage%3D6737%26doi%3D10.1158%2F0008-5472.CAN-11-1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Valecha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Looareesuwan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martensson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdulla, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krudsood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tangpukdee, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohanty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moehrle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paliwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dash, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björkman, A.</span><span> </span><span class="NLM_article-title">Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1086/655831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1086%2F655831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=20687837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yhsbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=684-691&author=N.+Valechaauthor=S.+Looareesuwanauthor=A.+Martenssonauthor=S.+M.+Abdullaauthor=S.+Krudsoodauthor=N.+Tangpukdeeauthor=S.+Mohantyauthor=S.+K.+Mishraauthor=P.+K.+Tyagiauthor=S.+K.+Sharmaauthor=J.+Moehrleauthor=A.+Gautamauthor=A.+Royauthor=J.+K.+Paliwalauthor=M.+Kothariauthor=N.+Sahaauthor=A.+P.+Dashauthor=A.+Bj%C3%B6rkman&title=Arterolane%2C+a+new+synthetic+trioxolane+for+treatment+of+uncomplicated+Plasmodium+falciparum+malaria%3A+a+phase+II%2C+multicenter%2C+randomized%2C+dose-finding+clinical+trial&doi=10.1086%2F655831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial</span></div><div class="casAuthors">Valecha, Neena; Looareesuwan, Sornchai; Martensson, Andreas; Abdulla, Salim Mohammed; Krudsood, Srivicha; Tangpukdee, Noppadon; Mohanty, Sanjib; Mishra, Saroj K.; Tyagi, P. K.; Sharma, S. K.; Moehrle, Joerg; Gautam, Anirudh; Roy, Arjun; Paliwal, Jyoti K.; Kothari, Monica; Saha, Nilanjan; Dash, Aditya P.; Bjorkman, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">684-691</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background. Drug-resistant Plasmodium falciparum malaria necessitates development of novel drugs for treatment.  The present study assessed the efficacy and safety of 3 dose levels of arterolane (RBx 11160), a synthetic trioxolane, for treatment of acute uncomplicated falciparum malaria.  Methods. In this randomized, double-blind, multicenter, parallel-group, dose-finding, phase II trial, 230 patients from 4 centers in Thailand, India, and Tanzania (mainland and Zanzibar) received either 50 mg (n = 78), 100 mg (n = 76), or 200 mg (n = 76) of arterolane once daily for 7 days.  Patients (aged 13-65 years) with asexual parasite d. of 1000-100,000 parasites/μL were included and were followed up for 28 days.  The median time to 90% parasite clearance (PC90) was evaluated.  Results. The median PC90 was longer in the group receiving the 50-mg dose (19.4 h), compared with the groups receiving the 100-mg dose (12.8 h) and 200-mg dose (12.6 h) (P<.01).  The polymerase chain reaction-cor. adequate clin. and parasitol. responses on day 28 were 63%, 71%, and 72% for the groups receiving the 50-mg, 100-mg, and 200-mg doses, resp., by intention-to-treat anal. (odds ratio, 1.55; 95% confidence interval, 0.78-3.06, for comparison of the 200-mg and 50-mg dose groups).  Treatment was generally well tolerated.  No patient died or experienced any serious adverse event.  Mild complaints were reported in <10% of the patients and were similar in the 3 groups.  Biochem. and hematol. analyses did not show any sign of drug toxicity in any patient.  Conclusion. Arterolane at daily doses of 100 and 200 mg is a rapidly acting, effective, and safe synthetic antimalarial drug, which may potentially represent an alternative to artemisinin derivs. in antimalarial combination therapy.  Trial registration. ClinicalTrials.gov identifier NCT00362050.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlfwUJP3cnerVg90H21EOLACvtfcHk0lh7QXg0KTleSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yhsbfM&md5=c02d01aebc2d7d6dcf341db9e0fc23c5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1086%2F655831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F655831%26sid%3Dliteratum%253Aachs%26aulast%3DValecha%26aufirst%3DN.%26aulast%3DLooareesuwan%26aufirst%3DS.%26aulast%3DMartensson%26aufirst%3DA.%26aulast%3DAbdulla%26aufirst%3DS.%2BM.%26aulast%3DKrudsood%26aufirst%3DS.%26aulast%3DTangpukdee%26aufirst%3DN.%26aulast%3DMohanty%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DS.%2BK.%26aulast%3DTyagi%26aufirst%3DP.%2BK.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DMoehrle%26aufirst%3DJ.%26aulast%3DGautam%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DPaliwal%26aufirst%3DJ.%2BK.%26aulast%3DKothari%26aufirst%3DM.%26aulast%3DSaha%26aufirst%3DN.%26aulast%3DDash%26aufirst%3DA.%2BP.%26aulast%3DBj%25C3%25B6rkman%26aufirst%3DA.%26atitle%3DArterolane%252C%2520a%2520new%2520synthetic%2520trioxolane%2520for%2520treatment%2520of%2520uncomplicated%2520Plasmodium%2520falciparum%2520malaria%253A%2520a%2520phase%2520II%252C%2520multicenter%252C%2520randomized%252C%2520dose-finding%2520clinical%2520trial%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2010%26volume%3D51%26spage%3D684%26epage%3D691%26doi%3D10.1086%2F655831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Borstnik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paik, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posner, G. H.</span><span> </span><span class="NLM_article-title">Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds</span> <span class="citation_source-journal">Int. J. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1661</span><span class="NLM_x">–</span> <span class="NLM_lpage">1667</span><span class="refDoi"> DOI: 10.1016/S0020-7519(02)00195-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2FS0020-7519%2802%2900195-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=12435451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFCitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=1661-1667&author=K.+Borstnikauthor=I.+Paikauthor=T.+A.+Shapiroauthor=G.+H.+Posner&title=Antimalarial+chemotherapeutic+peroxides%3A+artemisinin%2C+yingzhaosu+A+and+related+compounds&doi=10.1016%2FS0020-7519%2802%2900195-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds</span></div><div class="casAuthors">Borstnik, Kristina; Paik, Ik-hyeon; Shapiro, Theresa A.; Posner, Gary H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal for Parasitology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1661-1667</span>CODEN:
                <span class="NLM_cas:coden">IJPYBT</span>;
        ISSN:<span class="NLM_cas:issn">0020-7519</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Mechanism-based rational design and gram-scale chem. synthesis have produced some new trioxane and endoperoxide antimalarial drug candidates that are efficacious and safe.  This review summarizes recent achievements in this area of peroxide drug development for malaria chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMoMg8blhpBbVg90H21EOLACvtfcHk0lh7QXg0KTleSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFCitbo%253D&md5=2ce9858e952cba87115571bb9ff4c801</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0020-7519%2802%2900195-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-7519%252802%252900195-9%26sid%3Dliteratum%253Aachs%26aulast%3DBorstnik%26aufirst%3DK.%26aulast%3DPaik%26aufirst%3DI.%26aulast%3DShapiro%26aufirst%3DT.%2BA.%26aulast%3DPosner%26aufirst%3DG.%2BH.%26atitle%3DAntimalarial%2520chemotherapeutic%2520peroxides%253A%2520artemisinin%252C%2520yingzhaosu%2520A%2520and%2520related%2520compounds%26jtitle%3DInt.%2520J.%2520Parasitol.%26date%3D2002%26volume%3D32%26spage%3D1661%26epage%3D1667%26doi%3D10.1016%2FS0020-7519%2802%2900195-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbe-Barnes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunziker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanilayam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santo Tomas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorneaux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span> </span><span class="NLM_article-title">Identification of an antimalarial synthetic trioxolane drug development candidate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1038/nature02779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnature02779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=15318224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslCnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2004&pages=900-904&author=J.+L.+Vennerstromauthor=S.+Arbe-Barnesauthor=R.+Brunauthor=S.+A.+Charmanauthor=F.+C.+Chiuauthor=J.+Cholletauthor=Y.+Dongauthor=A.+Dornauthor=D.+Hunzikerauthor=H.+Matileauthor=K.+McIntoshauthor=M.+Padmanilayamauthor=J.+Santo+Tomasauthor=C.+Scheurerauthor=B.+Scorneauxauthor=Y.+Tangauthor=H.+Urwylerauthor=S.+Wittlinauthor=W.+N.+Charman&title=Identification+of+an+antimalarial+synthetic+trioxolane+drug+development+candidate&doi=10.1038%2Fnature02779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an antimalarial synthetic trioxolane drug development candidate</span></div><div class="casAuthors">Vennerstrom, Jonathan L.; Arbe-Barnes, Sarah; Brun, Reto; Charman, Susan A.; Chiu, Francis C. K.; Chollet, Jacques; Dong, Yuxiang; Dorn, Arnulf; Hunziker, Daniel; Matile, Hugues; McIntosh, Kylie; Padmanilayam, Maniyan; Santo Tomas, Josefina; Scheurer, Christian; Scorneaux, Bernard; Tang, Yuanqing; Urwyler, Heinrich; Wittlin, Sergio; Charman, William N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">7002</span>),
    <span class="NLM_cas:pages">900-904</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The discovery of artemisinin more than 30 yr ago provided a completely new antimalarial structural prototype; i.e., a mol. with a pharmacophoric peroxide bond in a unique 1,2,4-trioxane heterocycle.  Available evidence suggests that artemisinin and related peroxidic antimalarial drugs exert their parasiticidal activity subsequent to reductive activation by hem, released as a result of Hb digestion by the malaria-causing parasite.  This irreversible redox reaction produces carbon-centered free radicals, leading to alkylation of hem and proteins (enzymes), one of which-the sarcoplasmic-endoplasmic reticulum ATPase PfATP6 (ref. 7)-may be crit. to parasite survival.  Notably, there is no evidence of drug resistance to any member of the artemisinin family of drugs.  The chemotherapy of malaria has benefited greatly from the semi-synthetic artemisinins artemether and artesunate as they rapidly reduce parasite burden, have good therapeutic indexes and provide for successful treatment outcomes.  However, as a drug class, the artemisinins suffer from chem. (semi-synthetic availability, purity and cost), biopharmaceutical (poor bioavailability and limiting pharmacokinetics) and treatment (noncompliance with long treatment regimens and recrudescence) issues that limit their therapeutic potential.  Here the authors describe how a synthetic peroxide antimalarial drug development candidate was identified in a collaborative drug discovery project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFwBOuKiqjSbVg90H21EOLACvtfcHk0lhN1ilz0QK4pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslCnurY%253D&md5=71070255d32c12fe3c227d5091225b31</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature02779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02779%26sid%3Dliteratum%253Aachs%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DArbe-Barnes%26aufirst%3DS.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DChiu%26aufirst%3DF.%2BC.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DHunziker%26aufirst%3DD.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DK.%26aulast%3DPadmanilayam%26aufirst%3DM.%26aulast%3DSanto%2BTomas%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DScorneaux%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26atitle%3DIdentification%2520of%2520an%2520antimalarial%2520synthetic%2520trioxolane%2520drug%2520development%2520candidate%26jtitle%3DNature%26date%3D2004%26volume%3D430%26spage%3D900%26epage%3D904%26doi%3D10.1038%2Fnature02779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Valecha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krudsood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tangpukdee, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohanty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anvikar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohanty, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J. P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paliwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saha, N.</span><span> </span><span class="NLM_article-title">Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated plasmodium falciparum malaria: A comparative, multicenter, randomized clinical trial</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span><span class="refDoi"> DOI: 10.1093/cid/cis475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1093%2Fcid%2Fcis475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=22586253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ajsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=663-671&author=N.+Valechaauthor=S.+Krudsoodauthor=N.+Tangpukdeeauthor=S.+Mohantyauthor=S.+K.+Sharmaauthor=P.+K.+Tyagiauthor=A.+Anvikarauthor=R.+Mohantyauthor=B.+S.+Raoauthor=A.+C.+Jhaauthor=B.+Shahiauthor=J.+P.+N.+Singhauthor=A.+Royauthor=P.+Kaurauthor=M.+Kothariauthor=S.+Mehtaauthor=A.+Gautamauthor=J.+K.+Paliwalauthor=S.+Aroraauthor=N.+Saha&title=Arterolane+maleate+plus+piperaquine+phosphate+for+treatment+of+uncomplicated+plasmodium+falciparum+malaria%3A+A+comparative%2C+multicenter%2C+randomized+clinical+trial&doi=10.1093%2Fcid%2Fcis475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial</span></div><div class="casAuthors">Valecha, Neena; Krudsood, Srivicha; Tangpukdee, Noppadon; Mohanty, Sanjib; Sharma, S. K.; Tyagi, P. K.; Anvikar, Anupkumar; Mohanty, Rajesh; Rao, B. S.; Jha, A. C.; Shahi, B.; Singh, Jai Prakash Narayan; Roy, Arjun; Kaur, Pawandeep; Kothari, Monica; Mehta, Shantanu; Gautam, Anirudh; Paliwal, Jyoti K.; Arora, Sudershan; Saha, Nilanjan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">663-671</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Arterolane, a rapidly acting synthetic trioxolane in combination with piperaquine, exhibits similar safety and efficacy to Coartem for the treatment of patients with uncomplicated P. falciparum malaria in a multicentre clin. trial in Thailand and India.  Background.  Artemisinin-based combination therapy is the first-line treatment for uncomplicated falciparum malaria.  This study assessed the antimalarial efficacy and safety of a combination of 150 mg of arterolane maleate and 750 mg of piperaquine phosphate (AM-PQP) in comparison to Coartem (artemether and lumefantrine) in patients with acute uncomplicated P. falciparum malaria.  Methods. In this open-label, randomized, multicentric, parallel group clin. trial, 240 patients were randomized to receive AM-PQP (160 patients) or Coartem (80 patients).  Patients with P. falciparum monoinfection and initial parasite densities ranging from 1000 to 100 000 asexual parasites/μL of blood were followed for 28 days.  Polymerase chain reaction-cor. adequate clin. and parasitol. response on day 28, parasite clearance time, and fever clearance time were evaluated.  Results. A total of 151 (94.4%) of 160 patients in the AM-PQP group completed the trial, while 77 (96.3%) of 80 patients in the Coartem group completed the trial.  No treatment failure was noted in the AM-PQP group, while one patient receiving Coartem failed treatment on day 28.  There was no difference in the median parasite clearance time (30 h in both groups) or median fever clearance time (24 h in both groups) after administration of the 2 study treatments.  Conclusions.  The available data support the evaluation of a drug combination in a larger population as a fixed-dose combination.  Clin. Trials Registration.  CTRI/2007/091/000031.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot63AoQHyfUrVg90H21EOLACvtfcHk0lhN1ilz0QK4pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ajsr%252FJ&md5=f58d676f3462b61743cbda82acee963b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcis475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcis475%26sid%3Dliteratum%253Aachs%26aulast%3DValecha%26aufirst%3DN.%26aulast%3DKrudsood%26aufirst%3DS.%26aulast%3DTangpukdee%26aufirst%3DN.%26aulast%3DMohanty%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DTyagi%26aufirst%3DP.%2BK.%26aulast%3DAnvikar%26aufirst%3DA.%26aulast%3DMohanty%26aufirst%3DR.%26aulast%3DRao%26aufirst%3DB.%2BS.%26aulast%3DJha%26aufirst%3DA.%2BC.%26aulast%3DShahi%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DJ.%2BP.%2BN.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DKothari%26aufirst%3DM.%26aulast%3DMehta%26aufirst%3DS.%26aulast%3DGautam%26aufirst%3DA.%26aulast%3DPaliwal%26aufirst%3DJ.%2BK.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DSaha%26aufirst%3DN.%26atitle%3DArterolane%2520maleate%2520plus%2520piperaquine%2520phosphate%2520for%2520treatment%2520of%2520uncomplicated%2520plasmodium%2520falciparum%2520malaria%253A%2520A%2520comparative%252C%2520multicenter%252C%2520randomized%2520clinical%2520trial%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26spage%3D663%26epage%3D671%26doi%3D10.1093%2Fcid%2Fcis475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prankerd, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span> </span><span class="NLM_article-title">Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span><span class="refDoi"> DOI: 10.1128/AAC.01033-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1128%2FAAC.01033-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=18268087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFajsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1291-1296&author=D.+J.+Creekauthor=W.+N.+Charmanauthor=F.+C.+K.+Chiuauthor=R.+J.+Prankerdauthor=Y.+Dongauthor=J.+L.+Vennerstromauthor=S.+A.+Charman&title=Relationship+between+antimalarial+activity+and+heme+alkylation+for+spiro-+and+dispiro-1%2C2%2C4-trioxolane+antimalarials&doi=10.1128%2FAAC.01033-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials</span></div><div class="casAuthors">Creek, Darren J.; Charman, William N.; Chiu, Francis C. K.; Prankerd, Richard J.; Dong, Yuxiang; Vennerstrom, Jonathan L.; Charman, Susan A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1291-1296</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The reaction of spiro- and dispiro-1,2,4-trioxolane antimalarials with heme has been investigated to provide further insight into the mechanism of action for this important class of antimalarials.  A series of trioxolanes with various antimalarial potencies was found to be unreactive in the presence of Fe(III) hemin, but all were rapidly degraded by reduced Fe(II) heme.  The major reaction product from the heme-mediated degrdn. of biol. active trioxolanes was an alkylated heme adduct resulting from addn. of a radical intermediate.  Under standardized reaction conditions, a correlation (R2 = 0.88) was found between the extent of heme alkylation and in vitro antimalarial activity, suggesting that heme alkylation may be related to the mechanism of action for these trioxolanes.  Significantly less heme alkylation was obsd. for the clin. utilized artemisinin derivs. compared to the equipotent trioxolanes included in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7LyAjV9hg6rVg90H21EOLACvtfcHk0lg5KGEvYiHI1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFajsbc%253D&md5=2fca35fc91ffbb69fa8220d7b050e393</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.01033-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01033-07%26sid%3Dliteratum%253Aachs%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DPrankerd%26aufirst%3DR.%2BJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26atitle%3DRelationship%2520between%2520antimalarial%2520activity%2520and%2520heme%2520alkylation%2520for%2520spiro-%2520and%2520dispiro-1%252C2%252C4-trioxolane%2520antimalarials%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1291%26epage%3D1296%26doi%3D10.1128%2FAAC.01033-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Creek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prankerd, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mccullough, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span> </span><span class="NLM_article-title">Iron-mediated degradation kinetics of substituted dispiro-1, 2, 4-trioxolane antimalarials</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">2945</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1002/jps.20958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1002%2Fjps.20958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=2945-56&author=D.+Creekauthor=W.+Charmanauthor=F.+C.+K.+Chiuauthor=R.+J.+Prankerdauthor=K.+J.+Mcculloughauthor=Y.+Dongauthor=J.+L.+Vennerstromauthor=S.+A.+Charman&title=Iron-mediated+degradation+kinetics+of+substituted+dispiro-1%2C+2%2C+4-trioxolane+antimalarials&doi=10.1002%2Fjps.20958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fjps.20958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20958%26sid%3Dliteratum%253Aachs%26aulast%3DCreek%26aufirst%3DD.%26aulast%3DCharman%26aufirst%3DW.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DPrankerd%26aufirst%3DR.%2BJ.%26aulast%3DMccullough%26aufirst%3DK.%2BJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26atitle%3DIron-mediated%2520degradation%2520kinetics%2520of%2520substituted%2520dispiro-1%252C%25202%252C%25204-trioxolane%2520antimalarials%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D2945%26epage%3D56%26doi%3D10.1002%2Fjps.20958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriraghavan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">Dispiro-1,2,4-trioxane analogues of a prototype dispiro-1,2,4-trioxolane: mechanistic comparators for artemisinin in the context of reaction pathways with iron(II)</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">5103</span><span class="NLM_x">–</span> <span class="NLM_lpage">5110</span><span class="refDoi"> DOI: 10.1021/jo050385+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo050385%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVWjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=5103-5110&author=Y.+Tangauthor=Y.+Dongauthor=X.+Wangauthor=K.+Sriraghavanauthor=J.+K.+Woodauthor=J.+L.+Vennerstrom&title=Dispiro-1%2C2%2C4-trioxane+analogues+of+a+prototype+dispiro-1%2C2%2C4-trioxolane%3A+mechanistic+comparators+for+artemisinin+in+the+context+of+reaction+pathways+with+iron%28II%29&doi=10.1021%2Fjo050385%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Dispiro-1,2,4-trioxane Analogues of a Prototype Dispiro-1,2,4-trioxolane: Mechanistic Comparators for Artemisinin in the Context of Reaction Pathways with Iron(II)</span></div><div class="casAuthors">Tang, Yuanqing; Dong, Yuxiang; Wang, Xiaofang; Sriraghavan, Kamaraj; Wood, James K.; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5103-5110</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Single electron redn. of the 1,2,4-trioxane heterocycle of artemisinin (I) forms primary and secondary carbon-centered radicals.  The complex structure of I does not lend itself to a satisfactory dissection of the electronic and steric effects that influence the formation and subsequent reaction of these carbon-centered free radicals.  To help demarcate these effects, we characterized the reactions of achiral dispiro-1,2,4-trioxolane II and dispiro-1,2,4-trioxanes III (X = O, Y = CH2; X = CH2, Y = O) and IV with ferrous bromide and 4-oxo-TEMPO.  Our results suggest a small preference for attack of Fe(II) on the nonketal peroxide oxygen atom of I.  For II , but not for III, there was a strong preference for attack of Fe(II) on the less hindered peroxide bond oxygen atom.  The steric hindrance afforded by a spiroadamantane in a five-membered trioxolane is evidently much greater than that for a corresponding six-membered trioxane.  Unlike I, III and IV fragment by entropically favored β-scission pathways forming relatively stable α-oxa carbon-centered radicals.  These data suggest that formation of either primary or secondary carbon-centered radicals is a necessary but insufficient criterion for antimalarial activity of I and synthetic peroxides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkp2I-noVZcLVg90H21EOLACvtfcHk0lg5KGEvYiHI1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVWjt7w%253D&md5=2901899c9c998ed80e9403f7d9e4b24b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo050385%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050385%252B%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSriraghavan%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BK.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DDispiro-1%252C2%252C4-trioxane%2520analogues%2520of%2520a%2520prototype%2520dispiro-1%252C2%252C4-trioxolane%253A%2520mechanistic%2520comparators%2520for%2520artemisinin%2520in%2520the%2520context%2520of%2520reaction%2520pathways%2520with%2520iron%2528II%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D5103%26epage%3D5110%26doi%3D10.1021%2Fjo050385%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiaffo, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">Spiroadamantyl 1,2,4-trioxolane, 1,2,4-trioxane, and 1,2,4-trioxepane pairs: relationship between peroxide bond iron(II) reactivity, heme alkylation efficiency, and antimalarial activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4542</span><span class="NLM_x">–</span> <span class="NLM_lpage">4545</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2Fj.bmcl.2009.07.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4542-4545&author=X.+Wangauthor=D.+J.+Creekauthor=C.+E.+Schiaffoauthor=Y.+Dongauthor=J.+Cholletauthor=C.+Scheurerauthor=S.+Wittlinauthor=S.+A.+Charmanauthor=P.+H.+Dussaultauthor=J.+K.+Woodauthor=J.+L.+Vennerstrom&title=Spiroadamantyl+1%2C2%2C4-trioxolane%2C+1%2C2%2C4-trioxane%2C+and+1%2C2%2C4-trioxepane+pairs%3A+relationship+between+peroxide+bond+iron%28II%29+reactivity%2C+heme+alkylation+efficiency%2C+and+antimalarial+activity&doi=10.1016%2Fj.bmcl.2009.07.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DSchiaffo%26aufirst%3DC.%2BE.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDussault%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DJ.%2BK.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DSpiroadamantyl%25201%252C2%252C4-trioxolane%252C%25201%252C2%252C4-trioxane%252C%2520and%25201%252C2%252C4-trioxepane%2520pairs%253A%2520relationship%2520between%2520peroxide%2520bond%2520iron%2528II%2529%2520reactivity%252C%2520heme%2520alkylation%2520efficiency%252C%2520and%2520antimalarial%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4542%26epage%3D4545%26doi%3D10.1016%2Fj.bmcl.2009.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fontaine, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dipasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Efficient and Stereocontrolled Synthesis of 1,2,4-trioxolanes useful for ferrous iron-dependent drug delivery</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5776</span><span class="NLM_x">–</span> <span class="NLM_lpage">5779</span><span class="refDoi"> DOI: 10.1021/ol5028392</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5028392" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOlurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=5776-5779&author=S.+D.+Fontaineauthor=A.+G.+Dipasqualeauthor=A.+R.+Renslo&title=Efficient+and+Stereocontrolled+Synthesis+of+1%2C2%2C4-trioxolanes+useful+for+ferrous+iron-dependent+drug+delivery&doi=10.1021%2Fol5028392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and Stereocontrolled Synthesis of 1,2,4-Trioxolanes Useful for Ferrous Iron-Dependent Drug Delivery</span></div><div class="casAuthors">Fontaine, Shaun D.; DiPasquale, Antonio G.; Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5776-5779</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ferrous iron-promoted redn. of a hindered peroxide bond underlies the antimalarial action of the 1,2,4-trioxane artemisinin and the 1,2,4-trioxolane arterolane.  In appropriately designed systems, a 1,2,4-trioxolane ring can serve as a trigger to realize ferrous iron-dependent and parasite-selective drug delivery, both in vitro and in vivo.  A stereocontrolled, expeditious (three steps), and efficient (67-71% overall yield) synthesis of 1,2,4-trioxolanes, e.g., I possessing the requisite 3'' substitution pattern that enables ferrous iron-dependent drug delivery is reported.  The key synthetic step involves a diastereoselective Griesbaum co-ozonolysis reaction to afford primarily products with a trans relationship between the 3'' substituent and the peroxide bridge, as confirmed by X-ray structural anal. of a 3''-substituted 4-nitrobenzoate analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofRW_OGGkPS7Vg90H21EOLACvtfcHk0lh9eRAhfZLKVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOlurvE&md5=960d52771a3c0b91d4fc3b07c2d4a0ba</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fol5028392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5028392%26sid%3Dliteratum%253Aachs%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DDipasquale%26aufirst%3DA.%2BG.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DEfficient%2520and%2520Stereocontrolled%2520Synthesis%2520of%25201%252C2%252C4-trioxolanes%2520useful%2520for%2520ferrous%2520iron-dependent%2520drug%2520delivery%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D5776%26epage%3D5779%26doi%3D10.1021%2Fol5028392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Fontaine, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauterwasser, E. M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Drug delivery to the malaria parasite using an arterolane-like scaffold</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1002/cmdc.201402362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1002%2Fcmdc.201402362" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=47-51&author=S.+D.+Fontaineauthor=B.+Spanglerauthor=J.+Gutauthor=E.+M.+W.+Lauterwasserauthor=P.+J.+Rosenthalauthor=A.+R.+Renslo&title=Drug+delivery+to+the+malaria+parasite+using+an+arterolane-like+scaffold&doi=10.1002%2Fcmdc.201402362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402362%26sid%3Dliteratum%253Aachs%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DSpangler%26aufirst%3DB.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DLauterwasser%26aufirst%3DE.%2BM.%2BW.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DDrug%2520delivery%2520to%2520the%2520malaria%2520parasite%2520using%2520an%2520arterolane-like%2520scaffold%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D47%26epage%3D51%26doi%3D10.1002%2Fcmdc.201402362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Mahajan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauterwasser, E. M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyva, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">A fragmenting hybrid approach for targeted delivery of multiple therapeutic agents to the malaria parasite</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1002/cmdc.201100002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1002%2Fcmdc.201100002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=21360816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFCjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=415-419&author=S.+S.+Mahajanauthor=E.+Deuauthor=E.+M.+W.+Lauterwasserauthor=M.+J.+Leyvaauthor=J.+A.+Ellmanauthor=M.+Bogyoauthor=A.+R.+Renslo&title=A+fragmenting+hybrid+approach+for+targeted+delivery+of+multiple+therapeutic+agents+to+the+malaria+parasite&doi=10.1002%2Fcmdc.201100002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A fragmenting hybrid approach for targeted delivery of multiple therapeutic agents to the malaria parasite</span></div><div class="casAuthors">Mahajan, Sumit S.; Deu, Edgar; Lauterwasser, Erica M. W.; Leyva, Melissa J.; Ellman, Jonathan A.; Bogyo, Matthew; Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">415-419</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Artemisinin combination therapies (ACT) represent the current std. of care in the treatment of uncomplicated malaria.  The authors set out to explore a single-mol. fragmenting hybrid strategy in which an artemisinin-like peroxide is employed to deliver a partner drug, only upon activation by ferrous iron in the parasite.  Thus, the authors prepd. artemisinin deriv.-ML4118S (DPAP1 inhibitor) hybrid with a carbamate, and demonstrated the successful release of the potent and irreversible ML4118S from the fragmenting hybrid in living parasites (P. falciparum).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofwQpt2b-28LVg90H21EOLACvtfcHk0lh9eRAhfZLKVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFCjsL0%253D&md5=81cbc03fa36f85d472abd776309d0cf4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100002%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DS.%2BS.%26aulast%3DDeu%26aufirst%3DE.%26aulast%3DLauterwasser%26aufirst%3DE.%2BM.%2BW.%26aulast%3DLeyva%26aufirst%3DM.%2BJ.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DA%2520fragmenting%2520hybrid%2520approach%2520for%2520targeted%2520delivery%2520of%2520multiple%2520therapeutic%2520agents%2520to%2520the%2520malaria%2520parasite%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D415%26epage%3D419%26doi%3D10.1002%2Fcmdc.201100002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Deu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauterwasser, E. M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valderramos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgington, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span> </span><span class="NLM_article-title">Ferrous iron-dependent drug delivery enables controlled and selective release of therapeutic agents in vivo</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">18244</span><span class="NLM_x">–</span> <span class="NLM_lpage">18249</span><span class="refDoi"> DOI: 10.1073/pnas.1312782110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1073%2Fpnas.1312782110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=18244-18249&author=E.+Deuauthor=I.+T.+Chenauthor=E.+M.+W.+Lauterwasserauthor=J.+Valderramosauthor=H.+Liauthor=L.+E.+Edgingtonauthor=A.+R.+Rensloauthor=M.+Bogyo&title=Ferrous+iron-dependent+drug+delivery+enables+controlled+and+selective+release+of+therapeutic+agents+in+vivo&doi=10.1073%2Fpnas.1312782110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1312782110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1312782110%26sid%3Dliteratum%253Aachs%26aulast%3DDeu%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DI.%2BT.%26aulast%3DLauterwasser%26aufirst%3DE.%2BM.%2BW.%26aulast%3DValderramos%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DEdgington%26aufirst%3DL.%2BE.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DFerrous%2520iron-dependent%2520drug%2520delivery%2520enables%2520controlled%2520and%2520selective%2520release%2520of%2520therapeutic%2520agents%2520in%2520vivo%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D18244%26epage%3D18249%26doi%3D10.1073%2Fpnas.1312782110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lauterwasser, E. M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katneni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Trioxolane-mediated delivery of mefloquine limits brain exposure in a mouse model of malaria</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1149</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1145-1149&author=E.+M.+W.+Lauterwasserauthor=S.+D.+Fontaineauthor=H.+Liauthor=J.+Gutauthor=K.+Katneniauthor=S.+A.+Charmanauthor=P.+J.+Rosenthalauthor=M.+Bogyoauthor=A.+R.+Renslo&title=Trioxolane-mediated+delivery+of+mefloquine+limits+brain+exposure+in+a+mouse+model+of+malaria&doi=10.1021%2Facsmedchemlett.5b00296"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00296%26sid%3Dliteratum%253Aachs%26aulast%3DLauterwasser%26aufirst%3DE.%2BM.%2BW.%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DTrioxolane-mediated%2520delivery%2520of%2520mefloquine%2520limits%2520brain%2520exposure%2520in%2520a%2520mouse%2520model%2520of%2520malaria%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D1145%26epage%3D1149%26doi%3D10.1021%2Facsmedchemlett.5b00296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Spangler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vander Wal, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">A reactivity-based probe of the intracellular labile ferrous iron pool</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span><span class="refDoi"> DOI: 10.1038/nchembio.2116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnchembio.2116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=27376690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKntLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=680-685&author=B.+Spanglerauthor=C.+W.+Morganauthor=S.+D.+Fontaineauthor=M.+N.+Vander+Walauthor=C.+J.+Changauthor=J.+A.+Wellsauthor=A.+R.+Renslo&title=A+reactivity-based+probe+of+the+intracellular+labile+ferrous+iron+pool&doi=10.1038%2Fnchembio.2116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A reactivity-based probe of the intracellular labile ferrous iron pool</span></div><div class="casAuthors">Spangler, Benjamin; Morgan, Charles W.; Fontaine, Shaun D.; Vander Wal, Mark N.; Chang, Christopher J.; Wells, James A.; Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">680-685</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Improved methods for studying intracellular reactive Fe(II) are of significant interest for studies of iron metab. and disease-relevant changes in iron homeostasis.  Here we describe a highly selective reactivity-based probe in which a Fenton-type reaction with intracellular labile Fe(II) leads to unmasking of the aminonucleoside puromycin.  Puromycin leaves a permanent and dose-dependent mark on treated cells that can be detected with high sensitivity and precision using a high-content, plate-based immunofluorescence assay.  Using this new probe and screening approach, we detected alteration of cellular labile Fe(II) in response extracellular iron conditioning, overexpression of iron storage and/or export proteins, and post-translational regulation of iron export.  We also used this new tool to demonstrate that labile Fe(II) pools are larger in cancer cells than in nontumorigenic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJOkZyEdhXbbVg90H21EOLACvtfcHk0lhUXhAIEPgJuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKntLfO&md5=3f09730054cfb57e487ca7fc48e41a19</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2116%26sid%3Dliteratum%253Aachs%26aulast%3DSpangler%26aufirst%3DB.%26aulast%3DMorgan%26aufirst%3DC.%2BW.%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DVander%2BWal%26aufirst%3DM.%2BN.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DA%2520reactivity-based%2520probe%2520of%2520the%2520intracellular%2520labile%2520ferrous%2520iron%2520pool%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D680%26epage%3D685%26doi%3D10.1038%2Fnchembio.2116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Odlo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentzen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dit Chabert, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gani, O. A. B. S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylte, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florenes, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, T. V.</span><span> </span><span class="NLM_article-title">1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4829</span><span class="NLM_x">–</span> <span class="NLM_lpage">4838</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.03.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2Fj.bmc.2008.03.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=18396050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=4829-4838&author=K.+Odloauthor=J.+Hentzenauthor=J.+F.+dit+Chabertauthor=S.+Duckiauthor=O.+A.+B.+S.+M.+Ganiauthor=I.+Sylteauthor=M.+Skredeauthor=V.+A.+Florenesauthor=T.+V.+Hansen&title=1%2C5-Disubstituted+1%2C2%2C3-triazoles+as+cis-restricted+analogues+of+combretastatin+A-4%3A+Synthesis%2C+molecular+modeling+and+evaluation+as+cytotoxic+agents+and+inhibitors+of+tubulin&doi=10.1016%2Fj.bmc.2008.03.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin</span></div><div class="casAuthors">Odlo, Kristin; Hentzen, Jean; Fournier, Jeremie; Ducki, Sylvie; Gani, Osman A. B. S. M.; Sylte, Ingebrigt; Skrede, Martina; Florenes, Vivi Ann; Hansen, Trond Vidar</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4829-4838</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of cis-restricted 1,5-disubstituted 1,2,3-triazole analogs of combretastatin A-4 (1) have been prepd.  The triazole 12f, 2-methoxy-5-(1-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-5-yl)aniline, displayed potent cytotoxic activity against several cancer cell lines with IC50 values in the nanomolar range.  The ability of triazoles to inhibit tubulin polymn. has been evaluated, and 12f inhibited tubulin polymn. with IC50 = 4.8 μM.  Mol. modeling expts. involving 12f and the colchicine binding site of α,β-tubulin showed that the triazole moiety interacts with β-tubulin via hydrogen bonding with several amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv-nZt2OlVYrVg90H21EOLACvtfcHk0lhUXhAIEPgJuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSqtrk%253D&md5=de08d18064b626f65a8979bdd6e5a85f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.03.049%26sid%3Dliteratum%253Aachs%26aulast%3DOdlo%26aufirst%3DK.%26aulast%3DHentzen%26aufirst%3DJ.%26aulast%3Ddit%2BChabert%26aufirst%3DJ.%2BF.%26aulast%3DDucki%26aufirst%3DS.%26aulast%3DGani%26aufirst%3DO.%2BA.%2BB.%2BS.%2BM.%26aulast%3DSylte%26aufirst%3DI.%26aulast%3DSkrede%26aufirst%3DM.%26aulast%3DFlorenes%26aufirst%3DV.%2BA.%26aulast%3DHansen%26aufirst%3DT.%2BV.%26atitle%3D1%252C5-Disubstituted%25201%252C2%252C3-triazoles%2520as%2520cis-restricted%2520analogues%2520of%2520combretastatin%2520A-4%253A%2520Synthesis%252C%2520molecular%2520modeling%2520and%2520evaluation%2520as%2520cytotoxic%2520agents%2520and%2520inhibitors%2520of%2520tubulin%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D4829%26epage%3D4838%26doi%3D10.1016%2Fj.bmc.2008.03.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Martins, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakshandehroo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jascur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shales, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorrentino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemons, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamji, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogan, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandyopadhyay, S.</span><span> </span><span class="NLM_article-title">Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-14-0552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1158%2F2159-8290.CD-14-0552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=154-167&author=M.+M.+Martinsauthor=A.+Y.+Zhouauthor=A.+Corellaauthor=D.+Horiuchiauthor=C.+Yauauthor=T.+Rakshandehrooauthor=J.+D.+Gordanauthor=R.+S.+Levinauthor=J.+Johnsonauthor=J.+Jascurauthor=M.+Shalesauthor=A.+Sorrentinoauthor=J.+Cheahauthor=P.+A.+Clemonsauthor=A.+F.+Shamjiauthor=S.+L.+Schreiberauthor=N.+J.+Kroganauthor=K.+M.+Shokatauthor=F.+McCormickauthor=A.+Gogaauthor=S.+Bandyopadhyay&title=Linking+tumor+mutations+to+drug+responses+via+a+quantitative+chemical-genetic+interaction+map&doi=10.1158%2F2159-8290.CD-14-0552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-14-0552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-14-0552%26sid%3Dliteratum%253Aachs%26aulast%3DMartins%26aufirst%3DM.%2BM.%26aulast%3DZhou%26aufirst%3DA.%2BY.%26aulast%3DCorella%26aufirst%3DA.%26aulast%3DHoriuchi%26aufirst%3DD.%26aulast%3DYau%26aufirst%3DC.%26aulast%3DRakshandehroo%26aufirst%3DT.%26aulast%3DGordan%26aufirst%3DJ.%2BD.%26aulast%3DLevin%26aufirst%3DR.%2BS.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DJascur%26aufirst%3DJ.%26aulast%3DShales%26aufirst%3DM.%26aulast%3DSorrentino%26aufirst%3DA.%26aulast%3DCheah%26aufirst%3DJ.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DKrogan%26aufirst%3DN.%2BJ.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DGoga%26aufirst%3DA.%26aulast%3DBandyopadhyay%26aufirst%3DS.%26atitle%3DLinking%2520tumor%2520mutations%2520to%2520drug%2520responses%2520via%2520a%2520quantitative%2520chemical-genetic%2520interaction%2520map%26jtitle%3DCancer%2520Discovery%26date%3D2015%26volume%3D5%26spage%3D154%26epage%3D167%26doi%3D10.1158%2F2159-8290.CD-14-0552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Radulescu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgueiro, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgway, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGhee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stones, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tselepis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansom, O. J.</span><span> </span><span class="NLM_article-title">Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2Fj.celrep.2012.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=22884366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCjsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=270-282&author=S.+Radulescuauthor=M.+J.+Brookesauthor=P.+Salgueiroauthor=R.+A.+Ridgwayauthor=E.+McGheeauthor=K.+Andersonauthor=S.+J.+Fordauthor=D.+H.+Stonesauthor=T.+H.+Iqbalauthor=C.+Tselepisauthor=O.+J.+Sansom&title=Luminal+iron+levels+govern+intestinal+tumorigenesis+after+Apc+loss+in+vivo&doi=10.1016%2Fj.celrep.2012.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo</span></div><div class="casAuthors">Radulescu, Sorina; Brookes, Matthew J.; Salgueiro, Pedro; Ridgway, Rachel A.; McGhee, Ewan; Anderson, Kurt; Ford, Samuel J.; Stones, Daniel H.; Iqbal, Tariq H.; Tselepis, Chris; Sansom, Owen J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">270-282</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">It is clear from epidemiol. studies that excess iron is assocd. with increased risk of colorectal cancer; however, questions regarding the mechanism of how iron increases cancer risk, the source of the excess iron (circulating or luminal), and whether iron redn. represents a potential therapeutic option remain unanswered.  In this study, we show that after Apc deletion, the cellular iron acquisition proteins TfR1 and DMT1 are rapidly induced.  Conversely, restoration of APC reduces cellular iron due to repression of these proteins.  To test the functional importance of these findings, we performed in vivo investigations of the impact of iron levels on intestinal tumorigenesis.  Strikingly, depletion of luminal (but not systemic) iron strongly suppressed murine intestinal tumorigenesis, whereas increased luminal iron strongly promoted tumorigenesis.  Taken together, our data definitively delineate iron as a potent modifier of intestinal tumorigenesis and have important implications for dietary iron supplementation in patients at high risk of colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWuYH5lJ7awLVg90H21EOLACvtfcHk0lheAxMgEqY03w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCjsr%252FP&md5=2f2895e029503b9c26b1a2d32218375d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DRadulescu%26aufirst%3DS.%26aulast%3DBrookes%26aufirst%3DM.%2BJ.%26aulast%3DSalgueiro%26aufirst%3DP.%26aulast%3DRidgway%26aufirst%3DR.%2BA.%26aulast%3DMcGhee%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DFord%26aufirst%3DS.%2BJ.%26aulast%3DStones%26aufirst%3DD.%2BH.%26aulast%3DIqbal%26aufirst%3DT.%2BH.%26aulast%3DTselepis%26aufirst%3DC.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26atitle%3DLuminal%2520iron%2520levels%2520govern%2520intestinal%2520tumorigenesis%2520after%2520Apc%2520loss%2520in%2520vivo%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D2%26spage%3D270%26epage%3D282%26doi%3D10.1016%2Fj.celrep.2012.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Yang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2008.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2Fj.chembiol.2008.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=18355723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Klsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=234-245&author=W.+S.+Yangauthor=B.+R.+Stockwell&title=Synthetic+lethal+screening+identifies+compounds+activating+iron-dependent%2C+nonapoptotic+cell+death+in+oncogenic-RAS-harboring+cancer+cells&doi=10.1016%2Fj.chembiol.2008.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells</span></div><div class="casAuthors">Yang, Wan Seok; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">234-245</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: We screened small mols. to identify two compds., which we named RSL3 (I) and RSL5 (II), that have increased lethality in the presence of oncogenic RAS.  Counter screening with biol. active compds. defined aspects of the mechanism of action for RSL3 and RSL5, such as a nonapoptotic, MEK-dependent, and iron-dependent oxidative cell death.  Erastin, a previously reported compd. with RAS-selective lethality, showed similar properties.  RNA interference expts. targeting voltage-dependent anion channel 3 (VDAC3), a target of erastin, demonstrated that RSL5 is a scaffold that acts through VDACs to activate the obsd. pathway.  RSL3 activated a similar death mechanism but in a VDAC-independent manner.  We found that cells transformed with oncogenic RAS have increased iron content relative to their normal cell counterparts through upregulation of transferrin receptor 1 and downregulation of ferritin heavy chain 1 and ferritin light chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXT1YSFisD5bVg90H21EOLACvtfcHk0lheAxMgEqY03w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Klsrs%253D&md5=edf260b5dd32621038445ec981d307fb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DSynthetic%2520lethal%2520screening%2520identifies%2520compounds%2520activating%2520iron-dependent%252C%2520nonapoptotic%2520cell%2520death%2520in%2520oncogenic-RAS-harboring%2520cancer%2520cells%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D234%26epage%3D245%26doi%3D10.1016%2Fj.chembiol.2008.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">3642</span><span class="NLM_x">–</span> <span class="NLM_lpage">3649</span><span class="refDoi"> DOI: 10.1073/pnas.92.9.3642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1073%2Fpnas.92.9.3642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=7731958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADyaK2MXlsVSlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=3642-3649&author=D.+L.+Bogerauthor=D.+S.+Johnson&title=CC-1065+and+the+duocarmycins%3A+unraveling+the+keys+to+a+new+class+of+naturally+derived+DNA+alkylating+agents&doi=10.1073%2Fpnas.92.9.3642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents</span></div><div class="casAuthors">Boger, Dale L.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3642-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review, with 97 refs. on key studies defining the DNA alkylation properties and selectivity of a new class of exceptionally potent, naturally occurring antitumor antibiotics including CC-1065, duocarmycin A, and duocarmycin SA.  Recent studies conducted with synthetic agents contg. deep-seated structural changes and the unnatural enantiomers of the natural products and related analogs have defined the structural basis for the sequence-selective alkylation of duplex DNA and fundamental relationships between chem. structure, functional reactivity, and biol. properties.  The agents undergo a reversible, stereoelectronically controlled adenine-N3 addn. to the least substituted carbon of the activated cyclopropane within selected AT-rich sites.  The preferential AT-rich noncovalent binding selectivity of the agents within the narrower, deeper AT-rich minor groove and the steric accessibility to the alkylation site that accompanies deep AT-rich minor groove penetration control the sequence-selective DNA alkylation reaction and stabilize the resulting adduct.  For the agents that possess sufficient reactivity to alkylate DNA, a direct relation between chem. or functional stability and biol. potency has been defined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKRM8k1oAPLbVg90H21EOLACvtfcHk0lgZXEZJlU0wug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsVSlt7g%253D&md5=8e16def16016d5009b0dc00e59e4c895</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.9.3642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.9.3642%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DCC-1065%2520and%2520the%2520duocarmycins%253A%2520unraveling%2520the%2520keys%2520to%2520a%2520new%2520class%2520of%2520naturally%2520derived%2520DNA%2520alkylating%2520agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D3642%26epage%3D3649%26doi%3D10.1073%2Fpnas.92.9.3642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">A new short synthesis of 3-substituted 5-amino-1-(chloromethyl)-1,2-dihydro-3H-benzo[e]indoles (amino-CBIs)</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">8958</span><span class="NLM_x">–</span> <span class="NLM_lpage">8961</span><span class="refDoi"> DOI: 10.1021/jo0263115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0263115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=8958-8961&author=S.+Yangauthor=W.+A.+Denny&title=A+new+short+synthesis+of+3-substituted+5-amino-1-%28chloromethyl%29-1%2C2-dihydro-3H-benzo%5Be%5Dindoles+%28amino-CBIs%29&doi=10.1021%2Fjo0263115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjo0263115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0263115%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DA%2520new%2520short%2520synthesis%2520of%25203-substituted%25205-amino-1-%2528chloromethyl%2529-1%252C2-dihydro-3H-benzo%255Be%255Dindoles%2520%2528amino-CBIs%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D8958%26epage%3D8961%26doi%3D10.1021%2Fjo0263115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Atwell, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbank, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">5-Amino-1-(chloromethyl)-1,2-dihydro-3H-benz[e]indoles: relationships between structure and cytotoxicity for analogues bearing different DNA minor groove binding subunits</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3400</span><span class="NLM_x">–</span> <span class="NLM_lpage">3411</span><span class="refDoi"> DOI: 10.1021/jm990136b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990136b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3400-3411&author=G.+J.+Atwellauthor=J.+J.+Milbankauthor=W.+R.+Wilsonauthor=A.+Hoggauthor=W.+A.+Denny&title=5-Amino-1-%28chloromethyl%29-1%2C2-dihydro-3H-benz%5Be%5Dindoles%3A+relationships+between+structure+and+cytotoxicity+for+analogues+bearing+different+DNA+minor+groove+binding+subunits&doi=10.1021%2Fjm990136b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm990136b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990136b%26sid%3Dliteratum%253Aachs%26aulast%3DAtwell%26aufirst%3DG.%2BJ.%26aulast%3DMilbank%26aufirst%3DJ.%2BJ.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DHogg%26aufirst%3DA.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3D5-Amino-1-%2528chloromethyl%2529-1%252C2-dihydro-3H-benz%255Be%255Dindoles%253A%2520relationships%2520between%2520structure%2520and%2520cytotoxicity%2520for%2520analogues%2520bearing%2520different%2520DNA%2520minor%2520groove%2520binding%2520subunits%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3400%26epage%3D3411%26doi%3D10.1021%2Fjm990136b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Jeffrey, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torgov, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreyka, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddington, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerveny, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senter, P. D.</span><span> </span><span class="NLM_article-title">Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1344</span><span class="NLM_x">–</span> <span class="NLM_lpage">1358</span><span class="refDoi"> DOI: 10.1021/jm040137q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040137q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVSnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1344-1358&author=S.+C.+Jeffreyauthor=M.+Y.+Torgovauthor=J.+B.+Andreykaauthor=L.+Boddingtonauthor=C.+G.+Cervenyauthor=W.+A.+Dennyauthor=K.+A.+Gordonauthor=D.+Gustinauthor=J.+Haugenauthor=T.+Klineauthor=M.+T.+Nguyenauthor=P.+D.+Senter&title=Design%2C+synthesis%2C+and+in+vitro+evaluation+of+dipeptide-based+antibody+minor+groove+binder+conjugates&doi=10.1021%2Fjm040137q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and in Vitro Evaluation of Dipeptide-Based Antibody Minor Groove Binder Conjugates</span></div><div class="casAuthors">Jeffrey, Scott C.; Torgov, Michael Y.; Andreyka, Jamie B.; Boddington, Laura; Cerveny, Charles G.; Denny, William A.; Gordon, Kristine A.; Gustin, Darin; Haugen, Jennifer; Kline, Toni; Nguyen, Minh T.; Senter, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1344-1358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antibody-drug conjugates (ADCs) were prepd. consisting of DNA minor groove binder drugs (MGBs) attached to monoclonal antibodies (mAbs) through peptide linkers designed to release drugs inside the lysosomes of target cells.  The site of linker attachment on the MGB was at the 5-position on the B-ring, since model studies showed that attachment of an electron-withdrawing group (i.e., acyl, carbamoyl) at this position increased the stability of the mol.  Because of the hydrophobic nature of the MGBs, several measures were required to overcome their tendencies to induce mAb aggregation upon conjugation.  This is exemplified in the series of ADCs contg. the amino-CBI drug (I).  Initial adducts were prepd. using the peptide sequence valine-citrulline, attached to a self-immolative para-aminobenzyl carbamate spacer.  The resulting ADCs were completely aggregated.  Removal of the self-immolative spacer, introduction of a more hydrophilic valine-lysine sequence, and incorporation of a tetraethyleneglycol unit between the mAb and the peptide resulted in conjugates that were nonaggregated, even with as many as eight drugs per mAb.  These results were extended to include the hydroxy aza-CBI drug (II), which was linked to the valine-lysine sequence through a para-aminobenzyl ether self-immolative spacer.  The resulting mAb conjugates were monomeric and released the hydroxy aza-CBI drug upon treatment with human cathepsin B.  In vitro cytotoxicity assays established that the mAb-MGB drug conjugates were highly cytotoxic and effected immunol. specific cell kill at subsaturating doses.  The results provide a general strategy for MGB prodrug design and illustrate the importance of linker hydrophilicity in making nonaggregated, active mAb-MGB conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojSaAmWEWKcbVg90H21EOLACvtfcHk0lg-Fo4A338JIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVSnu7k%253D&md5=bd19b623b875301786914e3b958247c7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm040137q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040137q%26sid%3Dliteratum%253Aachs%26aulast%3DJeffrey%26aufirst%3DS.%2BC.%26aulast%3DTorgov%26aufirst%3DM.%2BY.%26aulast%3DAndreyka%26aufirst%3DJ.%2BB.%26aulast%3DBoddington%26aufirst%3DL.%26aulast%3DCerveny%26aufirst%3DC.%2BG.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DGordon%26aufirst%3DK.%2BA.%26aulast%3DGustin%26aufirst%3DD.%26aulast%3DHaugen%26aufirst%3DJ.%26aulast%3DKline%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DM.%2BT.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520in%2520vitro%2520evaluation%2520of%2520dipeptide-based%2520antibody%2520minor%2520groove%2520binder%2520conjugates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1344%26epage%3D1358%26doi%3D10.1021%2Fjm040137q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">McGovren, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKoning, T. F.</span><span> </span><span class="NLM_article-title">Preliminary toxicity studies with the DNA-binding antibiotic, CC-1065</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.7164/antibiotics.37.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.7164%2Fantibiotics.37.63" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1984&pages=63-70&author=J.+P.+McGovrenauthor=G.+L.+Clarkeauthor=E.+A.+Prattauthor=T.+F.+DeKoning&title=Preliminary+toxicity+studies+with+the+DNA-binding+antibiotic%2C+CC-1065&doi=10.7164%2Fantibiotics.37.63"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.37.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.37.63%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovren%26aufirst%3DJ.%2BP.%26aulast%3DClarke%26aufirst%3DG.%2BL.%26aulast%3DPratt%26aufirst%3DE.%2BA.%26aulast%3DDeKoning%26aufirst%3DT.%2BF.%26atitle%3DPreliminary%2520toxicity%2520studies%2520with%2520the%2520DNA-binding%2520antibiotic%252C%2520CC-1065%26jtitle%3DJ.%2520Antibiot.%26date%3D1984%26volume%3D37%26spage%3D63%26epage%3D70%26doi%3D10.7164%2Fantibiotics.37.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Markovic, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suman, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vukov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillman, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberts, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braich, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitch, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creagan, E. T.</span><span> </span><span class="NLM_article-title">Phase II trial of KW2189 in patients with advanced malignant melanoma</span> <span class="citation_source-journal">Am. J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1097/00000421-200206000-00022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1097%2F00000421-200206000-00022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=12040295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A280%3ADC%252BD38zisFynsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=308-312&author=S.+N.+Markovicauthor=V.+J.+Sumanauthor=A.+M.+Vukovauthor=T.+R.+Fitchauthor=D.+W.+Hillmanauthor=A.+A.+Adjeiauthor=S.+R.+Albertsauthor=J.+S.+Kaurauthor=T.+A.+Braichauthor=J.+M.+Leitchauthor=E.+T.+Creagan&title=Phase+II+trial+of+KW2189+in+patients+with+advanced+malignant+melanoma&doi=10.1097%2F00000421-200206000-00022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of KW2189 in patients with advanced malignant melanoma</span></div><div class="casAuthors">Markovic Svetomir N; Suman Vera J; Vukov Allen M; Fitch Tom R; Hillman David W; Adjei Alex A; Alberts Steven R; Kaur Judith S; Braich Theodore A; Leitch John M; Creagan Edward T</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-12</span>
        ISSN:<span class="NLM_cas:issn">0277-3732</span>.
    </div><div class="casAbstract">KW-2189, a semisynthetic duocarmycine antibiotic has been shown to exert antiproliferative effects against human tumor cell lines in vitro and animal tumor models in vivo.  Phase I studies identified myelosuppression as the most noteworthy adverse effect.  Presented are two concurrent phase II studies assessing the antitumor and toxicity profile of KW-2189 in metastatic melanoma patients.  One of the studies accrued patients with a history of prior melanoma therapy and the other accrued patients without a history of prior melanoma therapy.  KW-2189 was administered at 0.4 mg/m2 to previously treated patients and 0.5 mg/m2 to the previously untreated.  Treatment was administered intravenously on day 1 of a 6-week cycle.  Thirty previously untreated and 15 previously treated patients were accrued.  The toxicity profiles of the both groups of patients were similar.  Of the 15 previously treated patients, 8 completed once cycle of treatment, 2 completed 2 cycles, and 5 completed 3 cycles.  Dose modification for neutropenia/ thrombocytopenia was necessary in six patients.  Among the previously untreated cohort (30 patients), 16 completed 1 cycle, 5 completed 2 cycles, 4 completed 3 cycles, 3 completed 4 cycles, and 2 completed 6 cycles.  Doses were modified (neutropenia or thrombocytopenia) in 11 patients.  None of the 15 previously treated patients responded to therapy.  Four patients remained stable during two cycles.  Five of the previously untreated patients achieved a partial remission/regression.  Response duration ranged from 2.8 to 16.6 months.  Overall objective response rate was 17%.  Regarding survival, one previously treated patient is still alive 2.9 years after study entry, and three previously untreated patients are still alive 1.6, 2.3, and 2.9 years after study entry.  The 1-year survival rate for previously treated patients is 27% and for the untreated patients is 23%.  In summary, the lack of significant antitumor activity of KW-2189 and its associated toxicity suggest that further testing of this regimen in patients with stage IV melanoma is not warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSvdwC6qOSWOvW160gIxP_fW6udTcc2ebZPEEO9KgRGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zisFynsw%253D%253D&md5=0af88af2e707ebed278c745db165c8c1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1097%2F00000421-200206000-00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000421-200206000-00022%26sid%3Dliteratum%253Aachs%26aulast%3DMarkovic%26aufirst%3DS.%2BN.%26aulast%3DSuman%26aufirst%3DV.%2BJ.%26aulast%3DVukov%26aufirst%3DA.%2BM.%26aulast%3DFitch%26aufirst%3DT.%2BR.%26aulast%3DHillman%26aufirst%3DD.%2BW.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DAlberts%26aufirst%3DS.%2BR.%26aulast%3DKaur%26aufirst%3DJ.%2BS.%26aulast%3DBraich%26aufirst%3DT.%2BA.%26aulast%3DLeitch%26aufirst%3DJ.%2BM.%26aulast%3DCreagan%26aufirst%3DE.%2BT.%26atitle%3DPhase%2520II%2520trial%2520of%2520KW2189%2520in%2520patients%2520with%2520advanced%2520malignant%2520melanoma%26jtitle%3DAm.%2520J.%2520Clin.%2520Oncol.%26date%3D2002%26volume%3D25%26spage%3D308%26epage%3D312%26doi%3D10.1097%2F00000421-200206000-00022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Genomics and the second golden era of cancer drug development</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1039/b501751n</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1039%2Fb501751n" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=16948194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslelsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=17-26&author=P.+Workman&title=Genomics+and+the+second+golden+era+of+cancer+drug+development&doi=10.1039%2Fb501751n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Genomics and the second golden era of cancer drug development</span></div><div class="casAuthors">Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-26</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The first golden era of cancer drug development was initiated in the 1940s and gave rise to the cytotoxic agents that dominate current cancer medicine.  The second golden era is now underway in which cancer genomics will direct drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOzn_xJLTRp7Vg90H21EOLACvtfcHk0lgReRsokEt1bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslelsrg%253D&md5=4c9d39b781fa0b7a0f786f9cc3f7ee10</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fb501751n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb501751n%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DGenomics%2520and%2520the%2520second%2520golden%2520era%2520of%2520cancer%2520drug%2520development%26jtitle%3DMol.%2520BioSyst.%26date%3D2005%26volume%3D1%26spage%3D17%26epage%3D26%26doi%3D10.1039%2Fb501751n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">The DNA damage response and cancer therapy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">481</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1038/nature10760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1038%2Fnature10760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=22258607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1GmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=481&publication_year=2012&pages=287-294&author=C.+J.+Lordauthor=A.+Ashworth&title=The+DNA+damage+response+and+cancer+therapy&doi=10.1038%2Fnature10760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The DNA damage response and cancer therapy</span></div><div class="casAuthors">Lord, Christopher J.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">481</span>
        (<span class="NLM_cas:issue">7381</span>),
    <span class="NLM_cas:pages">287-294</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genomic instability is one of the most pervasive characteristics of tumor cells and is probably the combined effect of DNA damage, tumor-specific DNA repair defects, and a failure to stop or stall the cell cycle before the damaged DNA is passed on to daughter cells.  Although these processes drive genomic instability and ultimately the disease process, they also provide therapeutic opportunities.  A better understanding of the cellular response to DNA damage will not only inform our knowledge of cancer development but also help to refine the classification as well as the treatment of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUS1sAbqFhmrVg90H21EOLACvtfcHk0lgReRsokEt1bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1GmsQ%253D%253D&md5=75d12cdb52e8c9a39bced1611bf90298</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnature10760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10760%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DThe%2520DNA%2520damage%2520response%2520and%2520cancer%2520therapy%26jtitle%3DNature%26date%3D2012%26volume%3D481%26spage%3D287%26epage%3D294%26doi%3D10.1038%2Fnature10760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Taylor, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childress-Fields, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeoman, L. C.</span><span> </span><span class="NLM_article-title">Sensitivity of nuclear c-Myc levels and induction to differentiation-inducing agents in human colon tumor cell lines</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/0304-3835(92)90179-Y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.1016%2F0304-3835%2892%2990179-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1540946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=1%3ACAS%3A528%3ADyaK38Xitlaqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1992&pages=95-105&author=C.+W.+Taylorauthor=Y.+S.+Kimauthor=K.+E.+Childress-Fieldsauthor=L.+C.+Yeoman&title=Sensitivity+of+nuclear+c-Myc+levels+and+induction+to+differentiation-inducing+agents+in+human+colon+tumor+cell+lines&doi=10.1016%2F0304-3835%2892%2990179-Y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon tumor cell lines</span></div><div class="casAuthors">Taylor, C. W.; Kim, Y. S.; Childress-Fields, K. E.; Yeoman, L. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    </div><div class="casAbstract">Six human colon tumor cell lines were analyzed for their constitutive levels of the c-myc protein.  The nuclear proto-oncogene, c-myc, was detected as an expressed product in all of the human colon tumor cell lines analyzed.  The poorly differentiated cell lines HCT116, RKO and C showed c-myc levels that averaged 2-fold greater than their well-differentiated counterparts, i.e., GEO, CBS and FET.  When c-myc levels and responses to serum induction were analyzed in the presence of inducers of differentiation, i.e., DMF, retinoic acid, sodium butyrate, and TGF-β, distinct patterns of sensitivity and resistance emerged.  Nuclear c-myc levels were reduced in all the colon cell phenotypes treated with DMF or sodium butyrate.  Only the well differentiated human colon tumor cell lines were responsive to transforming growth factor-β.  Only one of the human colon tumor cell lines (GEO) responded to retinoic acid.  Increased levels of c-myc protein were found to correlate well with greater growth rates and with poor differentiation class.  Similarly, a parallel sensitivity to down-regulation of c-myc levels and attenuation of c-myc induction curves for inducers of differentiation were obsd. in growth-sensitive human colon tumor cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo23xasBXdVLVg90H21EOLACvtfcHk0lgrwjeR5c-BlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlaqs7w%253D&md5=f9b8fee32f2c2b6dc8190313d40ce68e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0304-3835%2892%2990179-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3835%252892%252990179-Y%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DC.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DChildress-Fields%26aufirst%3DK.%2BE.%26aulast%3DYeoman%26aufirst%3DL.%2BC.%26atitle%3DSensitivity%2520of%2520nuclear%2520c-Myc%2520levels%2520and%2520induction%2520to%2520differentiation-inducing%2520agents%2520in%2520human%2520colon%2520tumor%2520cell%2520lines%26jtitle%3DCancer%2520Lett.%26date%3D1992%26volume%3D62%26spage%3D95%26epage%3D105%26doi%3D10.1016%2F0304-3835%2892%2990179-Y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Horiuchi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goga, A.</span><span> </span><span class="NLM_article-title">Taking on Challenging Targets: Making Myc druggable</span> <span class="citation_source-journal">Am. Soc. Clin. Oncol. Educ. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">e497</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.14694/EdBook_AM.2014.34.e497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;key=10.14694%2FEdBook_AM.2014.34.e497" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=e497-502&author=D.+Horiuchiauthor=B.+Andertonauthor=A.+Goga&title=Taking+on+Challenging+Targets%3A+Making+Myc+druggable&doi=10.14694%2FEdBook_AM.2014.34.e497"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.14694%2FEdBook_AM.2014.34.e497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14694%252FEdBook_AM.2014.34.e497%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DD.%26aulast%3DAnderton%26aufirst%3DB.%26aulast%3DGoga%26aufirst%3DA.%26atitle%3DTaking%2520on%2520Challenging%2520Targets%253A%2520Making%2520Myc%2520druggable%26jtitle%3DAm.%2520Soc.%2520Clin.%2520Oncol.%2520Educ.%2520B%26date%3D2014%26volume%3D34%26spage%3De497%26epage%3D502%26doi%3D10.14694%2FEdBook_AM.2014.34.e497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i15"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01470">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80750"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01470">10.1021/acs.jmedchem.6b01470</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Supplemental tables, figures and schemes; synthetic procedures and compound characterization for new compounds; animal welfare statement; and a list of gene-specific primers used for qRT-PCR analysis (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_liveslides.mp4">jm6b01470_liveslides.mp4 (6.19 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_001.pdf">jm6b01470_si_001.pdf (1.13 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01470/suppl_file/jm6b01470_si_002.csv">jm6b01470_si_002.csv (2.51 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01470&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01470%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01470" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667989e07b162410","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
